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List of Abbreviations 
[Ca' ],,, cytosolic calcium 
[Ca"']i intracellular calcium 
"Ca"']n, mitochondrial calcium 
[Ca"']o extracellular calcium 
'K']„ extracellular potassium 
[Na ]i intracellular sodium 
ADCC antibody-dependent cell-mediated cytotoxicity 
BBB blood-brain barrier 
bp base pair 
cAMP cyclic adenosine monophosphate 
CaSR calcium-sensing receptor 
CDMEM complete Dulbecco's Modified Eagle medium 
CrCR Ca''-induced Ca'' release 
CLSM confocal laser scanning microscopy 
CM cerebral malaria 
CNF ciliary neurotrophic factor 
CNS central nervous system 
CRE cAMP response element 
CSF cerebrospinal fluid 
DVEM Dulbecco's Modified Eagle medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid 
EGTA ethylene glycol-bis(P-aminoethyl ether-N, N, N', N'-tetraacetic acid 
ER endoplasmic reticulum 
FBS fetal bovine serum 
Fluo-3/AM fluo-3, acetoxymethyl ester 
GABA gamma-aminobutyric acid 
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GFAP glial fibrillary acidic protein 
G-protein guanine-nucleotide-binding regulatory protein 
GS glutamate synthetase 
HEPES N-[2-hydroxyethyl]piperazine-N'-[2-ethanesuIfonic acid: 
HIV human immunodeficiency virus 
ICAM-1 intercellular adhesion molecule-1 
IEGs intermediate early genes 








IP3 inositol l,4,5-triphosphate 
KD IC current 
Kj dissociation constant 
LPS lipopolysaccharides 
MBP myelin basic protein 
MHC histocompatibility complex 
mRNA messenger ribonucleic acid 
MS multiple sclerosis 
MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
NGF nerve growth factor 
NMDA N-methyl-D-aspartate 
NTFs neurotrophic factors 
0-2A oligodendrocyte-type-2A 
PAF platelet-activating factor 
PBS phosphate buffer saline 
PCR polymerase chain reaction 
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PDA PhorboI-12, l3-diacetate 
PG postaglandins 
PKC protein kinase C 
PLD phospholipase D 
PMA phorbol ester phorbol 12-myristate 13 acetate 
PSF penicillin, streptomycin and fungizone 
PTX pentoxifylline 
Ro3 I-8220 3-{ 1 -[ 1 -(Amidinothiopropyl]-3-indoIyl}-4-{ I-methyI-3-indolyl)-1H-
pyrrole-2, 5-dione methanesulfonate 
RT reverse transcription 
RT-PCR reverse transcription-polymerase chain reaction 
SDS sodium dodecylsulfate 
SRE semm response element 
TBE Tris-borate EDTA buffer 
TBI traumatic brain injury 
TBP tumour necrosis factor binding protein 
TGF-P transforming growth factor-P 
TNF tumour necrosis factor 
TNF-KO TNF-knockout 
TNF-R1 tumour necrosis factor-receptor 1 
TNF-R2 tumour necrosis factor-receptor 2 





Cytokines, a group ofregulatory proteins are mainly found in the immune system, have 
been shown to induce various biological responses in the central nervous system (CNS). Now， 
cytokines including tumour necrosis factor-a (TNP-a), interleukin-1 (IL-1), interleukin-6 (IL-
6) and y-interferon (y-IFN) were found to be synthesized and secreted by glial cells of the 
CNS and they initiate their actions by binding to specific cell-surface receptors. 
Astrocytes，the major glial cells in the CNS，in addition to their well-known functions 
of controlling the environment of surrounding nerve ceils and supporting the structure of 
neuronal network, have been found to proliferate following brain injury and subsequently to 
form scars. Recently, TNF-a and its mRNA were found to be elevated in injured brain and 
that anti-TNF-a substances improved the outcome of injury. This, together with the finding 
that TNP-a was produced largely by astrocytes, suggest a close connection between the 
increase of TNF-a and astrocytes proliferation and possibly scar formation. However，the 
signal transduction pathways involved in the TNF-a-induced astrogliosis are still unclear. 
In the present study，changes in intracellular calcium ([Ca^^]i) and protein kinase C 
(PKC) in C6 cells were focused as (1) Ca?+ is an important second messenger in many cell 
types and that this cation has been shown to be involved in astrocytes proliferation, 
astrogliosis and processes in brain injury, and (2) PKC has been shown to play important roles 
in neuronal transduction and brain injury. Moreover, the effects of TNF-a on the expression 
of some relevant genes - TNF-a, TNF-receptors (TNF-Rs), EL-ls, PKC isoforms, calcium-
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sensing receptor (CaSR), c-fos and c-jun were examined using reverse transcription-
polymerase chain reaction (RT-PCR). 
C6 rat glioma cells were used as a model of astrocytes since they behave and respond 
to cytokines like astrocytes. Moreover, they are easy to culture and can multiply quickly. 
Results obtained indicated that TNF-a, IL-la and IL-1 p, but not IL-6 and y-ffN, 
triggered C6 cell proliferation, this phenomenon suggests that the effect of these cytokines is 
selective. Besides, Ca�+ and PKC were also found to play roles in C6 ceil proliferation. 
Confocal microscopy showed that TNF-a, EL-la and EL-ip, but not EL-6 and :/-IFN, 
triggered the rise in [Ca�+] both in the cytosol and the nucleus. Moreover, the TNF-a-induced 
:Ca2+]i rise was inhibited by the addition of PKC inhibitor, Ro31-8220. Results in our study 
also indicate that addition of PKC activator，phorboI l2-myristate 13 acetate (PMA), also 
induced [Ca '^],- changes in C6 cells. These suggest that both PKC and Ca�+ play important 
roles in TNF-a-mediated cell proliferation. These notions are supported by the finding that 
Ca2+ ionophore A23187 enhanced, while a Ca^ ^ channel blocker, verapermil inhibited the 
TNF-a-induced C6 cell proliferation. The important role of Ca^" in TNF-a-induced C6 cell 
proliferation was further revealed by our finding that TNF-a increased the expression ofCaSR, 
a receptor which found to couple with the release of intracellular Ca?+ from intracellular stores, 
5 minutes after TNF-a treatment. Expression of CaSR was also increased upon A23187 
treatment. This shows that the rise in [Ca^ ]^i is responsible to the increase in gene expression 
in C6 cells. Furthermore, that Ro31-8220 inhibited the TNF-a-induced the CaSR expression, 
while PMA stimulated, showing PKC is involved in the TNF-a-mediated signal transduction 
vi 
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pathway in C6 cells. The expression of several PKC isoforms，including PKC-5, PKC-8, PKC-
y，PKC-r|, PKC-C was also specifically increased after TNF-a or A23l87 treatments. These 
fijrther show a close relationship between Ca�+ and PKC in the TNF-a-induced signalling 
pathways. Besides, the expressions of IEGs, including c-fos and c-jim were also induced 1 
hour after the TNF-a or A23l87 treatment, ln addition, TNF-a, lL-la, U^-lp, A23l87, or 
PMA treatments, stimulated the expression of TNF-receptor 2 (TNF-R2), a receptor subtype 
believed to mediate cell proliferation. This suggests that Ca"^  and PKC triggers TNF-a-
induced C6 cell proliferation by binding to TNF-R2. The TNF-a-induced TNF-R2 expression 
was blocked by the anti-TNF-R2 antibody, but not by anti-TNF-Rl antibody，further 
suggesting that TNF-a induces C6 cell proliferation by binding to TNF-R2. Furthermore, with 
TNF-a and A23 187 treatments，the endogenous TNF-a expression was also increased. This 
suggests that Ca^ " is a factor involved in the TNF-a autocrine pathway. Finally, the expression 
of EL-la was also increased following TNF-a or A23187 treatment. Therefore, EL-la may 
also be a factor involved in the TNF-a-stimulated C6 proliferation. In conclusion, our findings 
show that TNF-a stimulates C6 cell proliferation by binding to TNF-R2, mobilizing [Ca^"]i, 
then by inducing certain PKC isoforms, CaSR and TNF-R2 expression. The expression of c-
fos, c-jun and DL-la may also be the factors involved in the signalling pathways. 
As astrocyte proliferation is a process in astrogliosis and gHal scar formation, and that 
[Ca2+]i mobilization is an essential step is C6 cell proliferation, blockade of [Ca^ ]^i 





系統（CNS )細胞)《生生理反應。现今已發現，中樞神經系統中的膠質細胞（glial cell) 
口丁合成及分泌出腿瘤壞死因子（tumour necrosis factor-a, TNF-a )�白細胞間介質 -1 









在這項研究裡’我主力研究細胞內躬離子（[Ca2+L)及蛋白活性酶C ( P K C )在 
C6細胞中的改變現象。其原因是（1 ) €&2+在很多細胞裡是一重要的次級信息傳遞物 
質，它在星形細胞增生、激烈增生腦部受傷過程中扮演著重要角色；（2) PKC在腦細 
胞的信息傳遞及腦部受傷過程中也佔一重要位置。另外，我們亦使用反向轉錄多聚酶 
連鎖反應 (RT-PCR)方法來觀察1^-“及其受體�n^- l a�PKC異構體、15離子感 





我們的實驗結果顯示’ TNF-^^�DL-1 a �化 - 1 / 3可觸發C 6細胞增生’但D L - 6和 
r -CFN卻不可，由此推斷這些細胞分裂素的作用是有選擇性的。另外，Ca2+ffi PKC亦 
可以刺激C6細胞增生。在同焦點顯微鏡實驗下，顯示出TNF-a、JL-1 a、0： -^1万可 
促使細胞質和細胞核中的匚&2+增加，但DL-6和7' -ffN卻不可。再者，PKC抑制因子 
(inhibitor ) Ro31-8220可抑制1>吓-6}：誘發的[�&2+];上升°反之，PKC活化因子 
(activator)如••大載二帖醇二乙酸（phorbol-l2，13-diacetate, PDA)和肉豆寇酸乙酸 





道阻塞劑（channel blocker) verapermiI則起著抑制作用，可見這些現象能力證上述觀 
點。另外，在R:r-PCR中，&2+在^？-“誘發的C6細胞增生的重要性能進一步被肯 
定。因爲當加入TNF- a於C6細胞五分鐘後，妈離子—感受受體(calcium-sensing receptor， 
CaSR)的基因表達便相應增加。此種受體與細胞內躬離子貯藏器釋出0&2+—事有關。 
若只加入A23187 1 CaSR的基因表逹亦會增加，所以[€321,的�：升是與C6細胞的CaSR 
•的基因表達是有關的。再者’ Ro31-8220可抑制CaSR的基因表達，而PMA亦刺激其 
基因表達，由此可見，PKC是參與C6細胞內丁^?-6^誘發的信息傳遞。此外，當加入 
TNF- a 或 A23187 後’有數種 PKC 異構體，如：PKC- S�PKC- £ � P K C - 7 � P K C - 7? 
和？&€-:的基因表達相應增加，從而得見，於TNP-a誘發的信息傳遞路徑中，Ca2+ 
和PKC有著很密切的關後。除此之外，當加入TNF-a或A23187六十分鐘後，EEG， 
如：c-fos及c-jun的基因表達亦增加。另外’當無論加入TNF- a或DL-1 6^或IL-1 0或 




TNF-a誘發的TNF-R2基因表達便會抑制。但以抗-™?-!^抗體（an t i -TNF-Rl 
antibody )進行此實驗時，卻發現胃-“誘發的TNF-R2基因表達並不受影響°所以 
通過丁>1?-“或其他因子與TNF-R2結合，便會誘發C6細胞增生。另一方面，當加入 
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Chapter 1 Introduction 
CHAPTER 1 INTRODUCTION 
1.1 The General Characteristics of Glial Cells 
Neuroglia was first cited by Dutrochet in 1824, who noticed the existence in the central 
nervous system (CNS) of non-neuronal components made up of spindle-shaped ceils which 
were morphologically distinct from neurons ^Iugosson et al., 1968). These cells were 
considered as a form of connective tissues within the CNS, and were called "neuroglia", which 
means nerve glue. There are two broad sub-groups of glial cells: the macroglia, which consists 
of astrocytes, oligodendrocytes and ependymal cells, and microglia. The basic properties of 
磁-
astrocytes, oligodendrocytes and microglia are outlined below. 
1.1.1 Astrocytes 
Astrocytes are the most abundant cell type found in the CNS and have been shown to play 
many important roles in metabolic activities in CNS development, normal fiinctions and 
injuries (Frohman et aL, 1989; Landis, 1996), therefore, we take a deeper look at the possible 
roles played by these major cells in the CNS in my project. Astrocytes were named for their 
starry shape (Figure 1.1), and they come in 2 main forms: (i) fibrous astrocytes that are found 
in the white matter and (ii) protoplasmic astrocytes in the gray matter. The discovery of 
fibrillary acidic protein (GFAP), the main constituent of the intermediate glial filaments found 
in the cytoplasm of the astrocytes, has led to the proposal that they form part of the 
cytoskeleton that endows the astrocytes with their star-like overall shapes. GFAP is found only 
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Figure 1.1 The rat astrocytes. Photomicrograph of rat astrocytes. 
Cytoplasmic staining was performed on fixed cells with a monoclonal antibody 
to GFAP, followed by incubation with fluorescein isothiocyanate (FITC)-
conjugated antibody. (Adapted from Frohman etal., 1989) 
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in astrocytes and has therefore found to be an invaluable marker for identifying those cells in 
tissue culture and nerve samples ^.evi et al., 1983; Eng et al., 1989). Besides GFAP, S-lOOP 
'V 
protein is also an astrocyte specific protein (Mattson et al., 1995b). Therefore, it can also be 
used as a marker to identify the astrocytes. 
Astrocytes have a variety of active roles in maintaining normal brain physiology 
^tCimelberg and Norenberg, 1989). For example, astrocytes are known to occupy a critical 
position in the metabolism of glutamate and gamma-aminobutyric acid (GABA), which are 
important excitatory and inhibitory neurotransmitters, respectively (Kimelberg and Norenberg, 
1989; Schousboe et a/.，1992). In order for the neuronal network to fiinction smoothly, these 
transmitters, after being released into the synaptic cleft (the gaps between neurons) must be 
removed. It is now clear that some of these transmitter molecules are carried into astrocytes 
^iertz et al., 1998). In the astrocytes, both GABA and glutamate can be metabolized to form 
the amino acid glutamine, which subsequently, can serve as a precursor for making more of 
these transmitters (Kimelberg and Norenberg, 1989). 
Astrocytes also have important role in balancing the composition of ions of the region 
around the neurons that is crucial to the fiinction of the brain (Kimelberg et al, 1989; 1990a; 
1990b). Balancing the flow of these electrically charged ions across the neuronal membrane is 
responsible for generating the action potential that conveys the nerve impluse. In particular, the 
flows ofNa+ and K+ which are responsible for generation of the action potential in a neuron, 
and the levels of these ions (particularly K+), must be very finely calibrated around the neurons. 
Excess K+ in the extracellular space produced by neuronal activity is carried away by the action 
of astrocytes (Kimelberg et al, 1989, Landis, 1996). The driving force for the flow is a 
localized increase in extracellular K+ concentration due to the neuronal activity (Peng et al., 
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1994). As a result, the astrocytic membrane in the region of the local increase becomes more 
electrically positive. The difference in electric potential between that region and distant ones 
yields a current flow within the glial cell that carries the charged K+ on away from its site of 
release. Another important ion in neurotransmission is Ca!+, it is important for transmitter 
release. In astrocytes, Ca?+ is an important second messenger in many signalling pathways 
(Voet and Voet, 1990). For example, upon brain injury, swelling of astrocytes contributes to 
the release of glutamate and lactate, exacerbating the metabolic disarray of the injured tissue, 
leading to influx of Ca?+ and cell destruction (Kimlberg et “/•，1990b, Hansson et a/., 1997; 
Werayi, etal., 1999). 
Another developmental function played by astrocyte is in the induction of the blood brain 
barrier ^ECimelberg and Norenberg, 1989; Wolburg et al., 1994). In most organs of the body the 
endothelial cells form the lining of the smallest blood vessels, the capillaries, are only loosely 
joined, allowing smaller water-soluble substances in the blood to pass into the tissues. In the 
brain, however，the capillary endothelial cells are joined by so-called tight junctions, and as a 
result the brain capillaries are virtually impermeable to many substances (Kimelberg and 
Norenberg, 1989; Wolburg et al., 1994). The brain endothelial cells are surrounded by 
astrocytic foot processes covering 80-95% of the brain capillary circumference. There is 
evidence that astrocytes may have a role in inducing and upholding some blood-brain barrier 
(BBB) functions (Janzer and Raff, 1987; Abbott et al., 1992). Endothelial cells in culture lose 
their characteristics after a few passages in vitro. Co-culture with astrocytes helps the 
endothelial cells to retain their BBB characteristics (Janzer and Raff, 1987). Thus, astrocytes 
may be important for some BBB functions. 
In view of the central critical functions of astrocytes, it is not surprising that disturbances 
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in those cells can have a crucial role in certain disorders of the CNS. byury to the brain often 
results in reactive gliosis: an increase in the size and number of astrocytes (Landsay, 1986; 
Miller, 1986; Rier, 1986). Reactive astrocytes have more processes and glial filament than 
ordinary ones and also have increased metabolic activity (Landsay, 1986; Miller, 1986; Rier, 
1986; Hu et al., 1999). The result of this reaction often lead to glial scar formation. The 
relationship between reactive astrogliosis and scar formation after brain injury will be 
discussed later. 
1.12 Oligodendrocytes 
Oligodendrocytes arise from the oligodendrocyte-type-2A (0-2A) progenitor cells and 
their major fiinction is to produce myelin. Myelin sheaths are cytoplamic projections which 
extend from the oligodendrocyte cell body to wrap around nerve fibers in a spiral fashion. One 
of the well-known fiinctions of myelin is to speed up the transmission velocity in an axon. 
There are three kinds of oligodendrocyte-specific markers. The most common one is the 
galactocerebrosides, which is unique to oligodendrocytes and is a major glycolipid of myelin 
CRafF et al, 1978). The others are protein markers, including myelin basic protein, proteolipid 
protein and myelin-associated protein, are proteins for myelin development (Gebicke-Harter et 
al, 1984; Gordon et al., 1990; Golfinos et aL, 1997). Additionally, oligodendrocytes have 
several cell-specific enzymes, such as 2', 3-cyclic nucleotide 3 -phosphohydrolase and 
glycerol-3-phosphate dehydrogenase (de Vellis et al 1967; Drummond et al, 1971). They are 
also responsible for the control of myelination (Reier et al., 1975; Volpe et cd., 1975). 
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1.1.3 Microglial 
Microglia constitute less than 10% of the total glial cells. They are considered as the 
resident macrophages of the brain (Benveniste, 1992). According to their different existing 
morphology, they are divided into several major subtypes: ramified, ameboid and perivascular 
microglia. The major function of microglia is the phagocytosis of cellular debris (Perry and 
Gordon, 1988). Microglia can also be identified by a number of cell markers, including 
immuoglobulin Fc receptor (Perry et al., 1985), type-3 complement receptors (Giulian and 
Baker, 1986), p2-integrins (Akiyama and McGeer 1990), and nonspecific esterase (Suckling et 
al., 1983). However, all these known phenotypic markers for microglia are shared with other 
cell types. 
1.2 Brain Injury and Astrocyte Proliferation 
A long standing controversial issue regarding the response to CNS injury is the specific 
question of whether neuroglia proliferate as a characteristic feature of reactive gliosis (Gall, 
1979; Giulian et al., 1993; Landis, 1996), and ifthey do proliferate, which types of glia will 
proliferate? Microglia, astroglia or oligodendroglia? 
It was found that the response of neuroglia to brain injury consists of the following stages: 
(1) an early and prolonged period of phagocytic activity by microglia, (2) hypertrophy of 
astrocytes followed by division of astrocytes, (3) alignment of swollen fibrous astrocytes in 
radial arrangement around the wound, (4) formation of a connective tissue collagenous core， 
followed finally by (5) contraction ofthe wound (Gadient et al., 1990; Rudge and Silver, 1990; 
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Logan, 1992). 
By using biochemical markers, it was found that astroglia would undergo proliferation 
after CNS injury. For example, the application of antibodies to stain GFAP has proved very 
usefol not only for astrocyte identification in tissue actions and tissue culture, but as a marker 
for reactive glial cells after injury, as well as a marker for the migration of astrocytes after 
injury (Janeczko, 1988; Eng et al, 1989; Vijayan et al., 1990; Landis, 1996). During brain 
injury, it was notified that the GFAP antibodies staining increased, especially around the 
wound (Vijayan etal., 1990; Calvo etal., 1991). The expression of GFAP increases within 3 to 
4 hours after injury, which is generally known as hypertrophy. The term "hypertrophy" 
embraces an increase in cell body size, and GFAP immunoreactivity, as well as an increase in 
the surface area and volume of cell processes (Latov et al., 1979; Kreutzberg, 1989). Studies 
employing autoradiographic detection of tritiated (¾) thymidine, together with GFAP 
immunoreactivity have revealed a small number of dividing cells at the site of injury. It had 
been assumed that these cells were progeny of differentiated astrocytes which reentered the 
mitotic cycle afterthe injury. These processes are generally known as astrogliosis (Latov etaL, 
1979; Vijayan et al., 1990). As the high level of GFAP antibodies staining remained for at least 
2 months after brain injury, it is assumed that astrogliosis is highly related to brain injury. 
Nearly all injuries of the CNS trigger an astrocytic response. In relatively mild injuries, 
the homeostatic functions of astrocytes also serve to restore order, while in more severe cases, 
the characteristics of astrocytic homeostatic mechanism may actually exacerbate the initial 
insult O^andis, 1996). Injuries that kill neurons are usually accompanied by a change in the 
expression of existing astrocytic characteristics, and the acquisition of new properties. The 
astrocytic response to injury is regional, but often wider than the injury itself，suggesting that 
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astrocytes can recruit nearby astrocytes to initiate the injury response (Topp, et al., 1989; 
Landis, 1996). Severe injury and associated astrocytic response may also include interaction 
with bloodbome macrophages and immunocompetent cells, which would indicate that 
astrocytes could signal through or to vascular endothelial cells to elicit a local influx of 
extraneural cells. 
Neurons do not proliferate in adult mammalian brain, and so recovery of brain function 
after injury is due to reestablishment of preexisting interconnections, or plasticity of function 
among the surviving neurons. There is circumstantial evidence to suggest that the reactive 
astrocytes in glial scars may prevent regeneration of axons. Reactive astrocytes may express 
cetain chondroitin sulfate proteoglycans which in normal development serve as barriers to 
axon growth (Topp et cd., 1989). 
Astrocytes have been implicated in both a defensive and faciiitatory capacity for many 
toxic injuries. Evidence for a protective role of astrocytes in modulating CNS toxicity is 
afforded by observations that the toxicity of glutamate to cortical neurons is diminished upon 
astrocytic enrichment of the cell culture (Rosenberg and Aizenman，1989). In cultures of rat 
cerebral cortex in which astrocyte proliferation is stringently suppressed，glutamate 
neurotoxicity occurs at low glutamate concentrations similar to those which are normally 
found in the extracellular space in the hippocampus. Jn the presence of excess astrocytes, 
concentrations of glutamate one-hundred fold higher are required to produce equivalent 
neurotoxicity (Rosenberg and Aizenman, 1989). Recently, it was reported that astrocytes can 
facilitate the action of neurotoxins via a modulating process which takes place within the 
astrocyte or by a direct cytotoxic effect (Aschner, 1998a). Thus, the defensive andA>r 
facilitatory role of astrocytes in toxic injures require further studies. 
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1.3 Reactive Astrogliosis and Glial Scar Formation � 
Reactive Astrocytes contribute to scar formation (Hertz et al., 1990). Two 'controversial' 
hypotheses are currently considered regarding the role of glial scar in the process of tissue 
repair. The first considers the scar as a barrier that can hinder regenerative processes such as 
neurite outgrowth (Reier, 1986). Arrest of axonal growth has been shown in the proximity of 
reactive astrocytes by electron microscopy, suggesting that astrocytes express molecules 
which inhibit neurite extension (Liuzzi and Lasek, 1987). The second hypothesis conversely, 
considers the functions of reactive astrocytes beneficial for the injured CNS. In fact, glial cells 
stabilize the injured tissue by isolating necrotic tissue from neuronal cells and by filling the 
space which results from the loss of neurons (Reier, 1986). In addition, in vitro studied have 
also demonstrated that stimulated astrocytes synthesize neurotrophic factors such as nerve 
growth factor fNGF) which promote neuronal survival and neurite extension (Gadient et al., 
1990; Rudge and Silver, 1990). Astrocytes produce components which are necessary for scar 
formation, such as laminin, and which facilitate neurite growth. Moreover, transforming 
growth factor-p (TGF-p) has been found to be released by activated astrocytes. TGF-p induces 
the synthesis of molecules which may function as a chemoattractant for fibroblasts, 
contributing to the process of wound healing (Logan et al., 1992). Proteases released by 
activated astrocytes play an important role within the injured tissue by clearing up debris. The 
production of transporter molecules and enzymes involved in the metabolism of neurototoxic 
agents，like excitatory amino acids and mediators of the antioxidant pathway, may protect the 
neuronal tissue, restoring a physiological environment ^Eddleston and Mucke, 1993). 
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1.4 Astrocytes and immune response 
,�. 
Because the skull bones, the cerebrospinal fluid, the BBB, and the meninges effectively 
shield the CNS from other tissues, it was proposed that the brain is an 'immunologically 
privileged' organ (Aarli, 1983; Aschner, 1998b). However, with recent evidence that in 
response to invasion by microorganisms, resident cells, such as astrocytes and microglia can 
fully mount an immune response，this long-standing view has been rethought and revised 
(Gehrmann and Banati, 1995; Aschner, 1998b). Overthe last two decades, both astrocytes and 
microglia have been shown to synthesize and secrete numerous cytokines (Schmidt etal., 1982; 
Beutler and Cerami, 1987; Minami et a/., 1991; Taupin et al., 1993), therefore, it is at present 
widely accepted that these cells actively participate in an integrative communicative pathway 
between resident immune cells of the CNS and those of the periphery. It was clearly implicated 
in the initiation, maintenance, and suppression of immune responses, cytokines produced by 
these cells (e.g. astrocytes and microglia), as well as the responses of these cells to cytokines 
produced elsewhere, has also been shown to propagate CNS damage (Gall et a/.，1979; 
Baumann et al., 1993; Aschner, 1998a). Therefore the potential involvement of these cells in 
neurodegenerative disorders has been raised and subjected to intense experimentation. 
1.5 Cytokines 
Cytokines are members of a large family of endogenous protein and glycoproteins that are 
released by cells of the immune system and they affect the function of both local and distant 
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target cells (Tracey et aL, 1991). Additionally, they are a class of inducible, water-soluble, 
heterogeneous proteinaceous mediators of animal origin with molecular weights greater than 5, 
OOOkDa that exercise specific, receptor-mediated effects in target cells, or in mediated-
producing cells themselves (Meager, 1990). 
Cytokines are produced predominantly after cell activation by several cell types， 
including non-immune cells. These factors regulate cell functions such as migration, 
proliferation and production and other cytokines, resulting in the "cytokine cascade", which 
controls the immune response. Cytokines are usually released as soluble factors but can also 
remain expressed at the cell surface. They can act on a variety of cell types, sometimes 
displaying opposite effects (i.e. promoting or inhibiting cell proliferation) depending on the 
target cell (Tracey et al., 1991). Moreover, several cytokines may share common activities，a 
property generally referred to as functional redundancy. 
Cytokines play important roles in the events ofbrain pathology. Several diseases of the 
CNS have been characterized from the immunological aspect, and that the production of 
cytokines has been confirmed within the brain tissue as well as in the CSF. Astrocytes and 
microglia have the ability to produce a variety of cytokines, including tumour necrosis factor-
a (TNF-a), interleukin-l (EL-1) and interleukin-6 (JL-6) (Schmidt et al., 1982; Beutler and 
Cerami, 1987; Minami et al., 1991; Taupin et cd., 1993), which regulate several processes 
initiated after brain injury, with either beneflcal or deleterious consequences (Morganti-
Kossmann et al., 1992). 
The high affinity of cytokine receptors allows small concentrations of the cytokines to be 
effective for initiating a biological response. The presence of common receptor subunits for 
numerous mediators explains their functional redundancy by acting through the same signal 
11 
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transduction pathway. 
Glial cell functions can be strongly affected by the release ofimmune mediators. Recently, 
a new concept has been derived based on the definition of the brain as an immune-competent 
organ, actively participating in its own defense against inflammatory, autoimmune and 
infectious diseases. The interaction between the nervous and the immune systems occurring 
after neuronal trauma is well documented (Morganti-Kossmann and Kossmann，1995; 
Glabinski et aL, 1996; Suzumura et al., 1999). NGFs and cytokines are produced at the site of 
injury. For example, tumour necrosis factor (TNF)-a and _P, interleukins (H^s), TGF-P, and 
NGF are all factors encountered after injury of the brain which mediate cell recruitment, 
removal of debris, astrogliosis, angiogenesis and deposition of matrix (Yamasaki etal., 1996). 
1.5.1 Cytokines and the Central Nervous System (CNS) 
Cytokines involved in regulatory fiinctions mainly in the immune system, where they 
appear to have a key role in the inflammatory responses (Tracey et al., 1991). They are capable 
of mediating a wide range of biological activities, circumstances dictating whether these are 
beneficial in host defense, or produce deleterious effects. Recently, interactions between the 
immune and nervous system have been described. It was found that like the damage ofother 
tissues/organs, injury in the brain also resulted in inflammatory response (Lin, 1995; McGeer 
and McGeer，1995). Cultured brain cells are capable of generating many molecules associated 
with inflammatory and immune fiinctions. They constitute the endogenous immune response 
system of brain (McGeer and McGeer, 1995). They include complement proteins and their 
regulators, inflammatory cytokines, acute phase reactants and many protease and protease 
12 
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inhibitors. Most of them are made by microglia and astrocytes (McGeer and McGeer, 1995). 
Inflammatory cytokines like TNF-a, JL-l or y-JFN appears to perform some of these roles 
within the central nervous system. The production ofD^-l and interleukin-2 (JL-2) has been 
shown to be induced after brain trauma, which in tum stimulate the growth ofbrain glia cells. 
Furthermore, the production of cytokines such as interleukin-3-like (E.-3-like) factors， 
interleukin-6 (D^-6) or TNF-a by astrocytes or amoeboid microglial cells has also been 
reported (Munoz-Femandez et al, 1991). 
Cytokines in the mammalian central nervous system facilitate communication between 
cellular populations, and among constituent cells in a given population. The communication 
between the interacting cells is probably important in maintaining brain tissue homeostasis, but 
recent attention has been focused largely on cell interactions occurring in the course of injury 
and brain tissue responses. 
1.5.2 Cytokines and brain injury 
Studies reported that a stab injury to the adult mouse brain elicited a prompt and marked 
increase in levels of transcripts for BL-la, EL-ip, and TNF-a, which are considered to be 
microgliaAnacrophage cytokines (Rostworowski et al., 1997). In the following sections, the 
marked elevation of inflammatory cytokines is discussed in the context of astrogliosis and 
general CNS recovery. 
13 
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1.5.3 Cytokines-activated astrocytes in brain injury 
In the early phase following brain injury, it was also reported that cytokine-activated 
astrocytes rescue the damaged neurons via the synthesis and/or release of neurotrophic factors 
fNTFs) and other biologically active molecules (Yoshida and Toya, 1997). The central role of 
cytokines and brain injury is shown in Figure 1.2. In the following, some of the proposed roles 
played by cytokines, TNF-a in particular, shall be briefly discussed. 
1.5.4 Tumour Necrosis Factor-a 
Tumour necrosis factor-a (TNF-a) exists as a 17-kDa polypeptide (consisting 157 
amino-acids) pleiotropic cytokine and a 26-kDa transmembrane protein which has diverse 
biological activities (Beutler and Cerami，1987). TNF-a, also called cachectin, is produced by 
a variety of cell types, and is synthesized in large amounts by activated macrophages and 
microglia. TNF-a induces cytokine production, upregulates surface molecules，and induces 
proliferation and cell death ^'euerstein et al, 1996). Recent studies also indicated that TNF-a 
might act either as a mediator in beneficial processes of host defense, immunity and tissue 
homeostasis or in the pathogenesis ofinfection, tissue injury and inflammation (Camussi etal, 
1991). TNF-a is now established as a product of many cells including glia and neurons 
(Feuerstein et al, 1996). TNF-a is an important mediator of both inflammatory and 
immunologic responses in the brain because of its interaction with astrocytes (Chung et al, 
1992). The biological effects ofTNF-a are triggered by the binding to specific cell surface 
receptors (Camussi et al, 1991). The formation of TNF-a-receptor complex activates a variety 
14 
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ofbiochemical pathways that include the transduction of the signal at least in part controlled 
by guanine-nucleotide-binding regulatory protein (G-protein), its amplification through 
activation of adenyl cyclase, phospholipases and protein kinases with the generation of second 
messenger pathways. The transduction of selected genes in different cell types determines the 
characteristics of the cell response to TNF-a (Camussi et al, 1991) . TNF-a receptors are also 
present in the brain where they mediate glial activation and proliferation (Feuerstein et al, 
1996). 
1.5.4.1 Types ofTNF-a receptor and their structures 
There are two ways for TNF-a to carry out its effects: it can either enter the bloodstream 
to alter the biology of distant tissues, or it can behave as a paracrine mediator acting locally. 
Regardless of the pathway taken, TNF-a must bind to its specific receptor on target cells, 
which lie close to the producer cells to transduce its signal (Smith et al., 1990). The effects of 
TNF-a are mediated through two distinct, high-affinity receptors: tumour necrosis factor-
receptor 1 (TNF-R1) and tumour necrosis factor- receptor 2 (TNF-R2). TNF-R1 is a 55kDa 
receptor and TNF-R2 is a 75kDa receptor (Lewis et a/.，1991; Tartaglia and Goeddel，1992). 
Both receptors belong to type 1 membrane proteins which consist of an extracellular N-
terminal, an intracellular C-terminal and a single trans-membrane segment. The extracellular 
domain of these two receptors can be divided into four roughly repeating cysteine-rich 
domains which share significantly intersubunit sequence, 28% homology. However, there are 
no homology between the intracellular domains receptor 0^ewis et al., 1991; Tartaglia and 
Goeddel, 1992). Thus it has been suggested that they utilize distinct signalling pathways. 
16 
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1.5.4.2 Binding to TNF-a 
It was reported that the ligand-binding domain of TNF-R2 was farther from the cell 
surface than the ligand-binding domain of TNF-R1 and it was unlikely that TNF-a could 
simultaneously interact with both receptors (Smith et aL, 1990; Lewis et a/., 1991). 
Moreover, there were studies showing that TNF-R1 and TNF-R2 have different affinity to 
TNF-a. The K^ of TNF-R1 is 3.2-5 X lO'^^l while that of TNF-R2 is TXlO'^M; thus, the 
affinity of TNF-R2 to TNF-a is slightly higher than that of TNF-R1. At low TNF-a 
concentrations (below the K^ ofTNF-Rl), TNF-a would preferentially bind to TNF-R2 since 
the affinity ofTNF-a for TNF-R2 is higher than that ofTNF-Rl (Barbara et al., 1994). 
1.5.4.3 Different Roles ofthe TNF-a Receptor Subtypes 
Studies with various cell types showed that TNF-R1 is responsible for the mediation of 
inflammatory activities and the cytotoxic efFect ofTNP-a, while TNF-R2 is responsible for the 
proliferation and regeneration (Shen et al., 1997; Huang et al., 1998). It was found that the 
TNF-R1 selective mutants resulted in a decrease in superoxide anion generation, platelet-
activating factor formation, antibody-dependent cell-mediated cytotoxicity activity and 
neutrophil adherence to endothelium activity of 170-fold less than that of wild-type, implying 
a significant role forthe TNF-R1 in the mediation of these neutrophil activities. The decreased 
activity seen with these mutants was particularly evident at low TNF-a concentrations. At high 
concentrations，the TNF-Rl-selective mutants achieved the same effects as wild-type TNF-a 
indicating that TNF-R1 is the dominant receptor in the mediation of the inflammatory 
17 
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activities (Shen etal., 1997). Nonetheless, the cellular mode of action ofTNF-a cytotoxicity is 
not well-understood. In addition, the contribution of local TNF-a ligand/receptor signalling 
pathways to multiple sclerosis (MS) immunopathogenesis elevated by analyzing disease 
pathology in central nervous system-expressing TNF transgenic mice，with or without TNF-
Rlor TNF-R2 (Akassoglou et al., 1998), further supports that TNF-R1 plays a role in 
cytotoxicity. Both the cytotoxic and inflammatory effects of TNF-a were abrogated in mice 
genetically deficient for the TNF-R1 receptor demonstrating a dominant role for TNF-R1 
receptor-signalling pathways in TNF-a-mediated cytotoxicity (Akassoglou etal., 1998). 
A significant increase in the expression of TNF-R2, but not of TNF-R1, was found on 
brain microvessels at the time of brain pathogenesis, cerebral malaria (CM) in susceptible 
animals. Moreover, mice genetically deficient for TNF-R2 were significantly protected from 
experimental CM, in contrast to TNF-Rl-deficient mice, which were as susceptible as wild-
type mice. These authors concluded that the interaction between membrane TNF-a and TNF-
R2 is crucial in the development ofthis neurological syndrome 0-ucas etal., 1997). Moreover, 
these findings suggest that TNF-R2, but not TNF-R1 may play an important role in brain injury 
and thus astrogliosis. 
Also, there was evidence showing that TNF-R2 plays a protective role following injury. 
In the study with neuronal SH-SY5Y cells, it was found that cells treated by 
phosphorothioate-modified antisense oligonucleotides, which was used to inhibit the 
expression of TNF-R2 significantly increased cell death relative to treatment with TNF-
a alone (Shen et aL, 1997). However, there is still no concrete evidence to show that TNF-R2 
can transduce the regeneration effect ofTNF-a. 
Li addition, it was also suggested that one special role of TNF-R2 is to facilitate the 
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binding ofTNF-a to TNF-R1 at low concentration ofTNF-a, since the affinity for TNF-a for 
TNF-R2 higher than that ofthe TNF-R2. At low concentrations ofTNF-a, TNF-R2 diverts the 
TNF-ato TNF-R1 via ligand-passing, which is a kind of extemal facilitation (Tartaglia et al, 
1993). In addition, the recent finding that TNF-R2-associated kinase, which phosphrylates 
both TNF-a receptors, provides a mechanism whereby TNF-R2 could facilitate TNF-R1 
intracellularly, i.e. internal facilitation (Tartaglia etal., 1993). 
1.5.4.4 Role ofTNF-a and Brain Injury 
TNF-a probably does not play a very important role in normal adult brain as evidenced by 
the extremely low levels ofTNF-a mRNA and peptide. However, in response to focal cerebral 
\ 
ischemia (transient or permanent), early production ofTNF-a was demonstrated (Taupin et al., 
1993). TNF-a mRNA can be detected in the brain as early as 1 hour post-ischemia, continues 
to signal strong transcription over 6-12 hour and is still elevated for up to a week post-ischema 
OFan et al, 1996). This study also found that expression of TNF-a mRNA in specific brain 
regions following experimental lateral fluid percussion traumatic brain injury (TBI) in rats was 
increased. As the increase in TNF-a is closely related to the acute-phase reaction and 
hypermetabolic response which observed following injury, it has been suggested that brain 
injury triggers the release and/or synthesis ofTNF-a. However, the mechanism mediating the 
event is still unclear. 
Evidence also showed that TNF-a is produced in the brain in response to various 
pathological processes such was infectious agents [e.g., human immunodeficiency virus ^nV) 
and malaria], ischemia，and trauma. For example, TNF-a mRNA is rapidly produced in 
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response to brain ischemia within 1 hour, reached a peak at 6-12 hours post ischemia, and 
subsided 1-2 days later. It was found that TNF-a is present early in neuronal cells in and 
around�the ischemic tissue (penumbra), yet at later time points, the peptide was found in 
macrophages in the infarcted tissue. In addition, TNF-a has been demonstrated to cause 
expression of proadhesive molecules on the endothelium, which results in leukocyte 
accumulation, adherence, and migration from capillaries into the brain. Furthermore, TNF-a 
activates glial cells, thereby regulating tissue remodeling，gliosis，and scar formation 
(Feuerstein et al., 1994). Thus, evidence is emerging in support of a role for TNF-a in injury 
induced by infectious, immune, toxic, traumatic, and ischemic stimuli. 
I 
Recent research reported that following brain injury TNF-a level in the cerebrospinal | 
• I 
fluid (CSF) was gradually increased during the first 1 hour，rose to a maximal elevation at 3 | 
hours and 6 hours and returned to basal values by 24 hours，showing that TNF-a plays an 
important role in brain injury (Kita et al.’ 1997). Another study also found that TNF-a levels 
increased significantly in injured cortex at 1 and 4 hours after an acute pathophysiology of 
traumatic brain injury, however，TNF-a was not elevated after mild injury (Knoblach et al, 
1999). Additionally, it has been shown that intracerebroventricular administration of a 
selective TNF-a antagonist-soluble TNF-a receptor fiision protein, at 15 minutes before and 1 
hour after TBI, improved performance in a series of standardized motor tasks after injury 
(Knoblach et al, 1999). Collectively, this evidence suggests that enhanced early expression of 
TNF-a after TBI contributes to subsequent neurological dysfunction. 
The above thought is also supported by studies showing that treating the injured brain 
with pentoxifylline (PTX), a methylxanthine, which attenuates the production ofTNF-a, and 
tumour necrosis factor binding protein (TBP), a physiological inhibitor ofTNF-a, which acts 
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in vitro by competing with the cell-surface TNF-a receptor significantly lessened peak edema 
formation at 24 hours and facilitated the recovery of motor function for < 14 days postinjury 
(Shohami et al., 1996). As edema formation is one of the first inflammatory responses after 
brain injury, thus TNF-a has been suggested to be closely related to edema formation which 
appears immediately after brain injury. TBP that attenuated the further disruption of the 
blood-brain barrier and this offered a protection of hippocampal cells. PTX significantly 
lowered the brain TNF-a level by about 80%，and TBP completely abolished the activity of 
recombinant human TNF when they were added at the same time. Therefore, it has been 
suggested that a decrease in TNF-a level or the inhibition of its activity is accompanied by 
reduced brain damage (Shohami et al., 1996). 
Besides, dexanabinol, HU-211 [(+)-(3S,4S)-7-hydroxy-6^-tetrahydrocannabinol 1,1-
dimethylheptyl], a synthetic cannabinoid which exhibits pharmacological properties of N-
methyl-D-aspartate 0^[MDA)-receptor antagonist，was found to be a novel inhibitor of TNF-a 
'i i 
production at a post-transcriptional stage (Shohami et cd., 1997). These authors found that 
HU-211 treatment inhibited the surge in rat brain TNF-a acivity at 4 hours, from 2.16士0.4 in 
the control untreated group to0.25±0.13ng TNF-o/mg tissue protein in the treated group. The 
TNF-a production was inhibited by 85%. Like PTX and TBP, HU-211 also facilitates early 
recovery after CHI, however, the degree of recovery was the greatest in the case ofHU-211. 
Furthermore, HU-211 is able to reduce brain edema formation after, just like that ofPTX and 
TBP, but HU-211 gave the most pronounced effect among them (Shohami et al, 1997). 
Therefore, HU-211 is an effective neuroprotective agent in models of brain trauma, and the 
higher efficacy of this compound may be related to its action as a NMDA receptor antagonist. 
Collectively, studies with these three agents 0HU-211, PTX and TBP), which inhibit 
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TNF-a at different stages, showed that TNF-a is a primary mediator of neurotoxicity 
following head trauma. 
In the very early stages after head injury TNF-a may be harmful, but in the chronic stages, 
TNF-a is important for recovery (Scherbel et al., 1999). Using genetically-engineered mice 
deficient in TNF-a, they found that 48 hours after injury the TNF-a-knockout mice were less 
neurologically impaired than injured normal mice in tests of strength, balance, and 
coordination. The same held true for mice who underwent tests for memory retention seven 
days post-injury. But, by two to three weeks after the injury the normal mice recovered, 
whereas, TNF-a-knockout mice continued to show persistent motor deficits until at least four 
weeks. Over the long term, the TNF-a knockouts also had more cortical tissue loss than the 
normal mice did (Scherbel et aL, 1999). These findings bear out the hypothesis that in the acute 
period TNF-a is harmful to the brain, but in chronic stages TNF-a may play an important and 
beneficial role. Neuroscientists have long thought that inflammatory cytokines like TNF-a are 
deleterious to the brain in terms of promoting neurodegeneration, much like that seen in stroke, 丨 
Alzheimer's, and Parkinson's disease patients. On the other hand, in recent studies TNF-a have 
also been implicated in such regenerative processes as wound-healing，nerve repair, and 
antioxidant pathways. These suggest that although the presence of TNF-a in the acute 
posttraumatic period may be deleterious, this cytokine may play a role in facilitating long-term 
behavioral recovery and histological repair after brain injury (Scherbel et al., 1999). 
It has been suggested that drugs that can block the action ofTNF-a can be given to head 
injury patients during the acute injury phase. However, if a TNF-a blockade is continued into 
the chronic, post-traumatic phase，it could be harmful (Scherbel et al.’ 1999). Therefore, the 
drug therapy would have to be discontinued so that TNF-a naturally present in the brain could 
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promote long-term regeneration. However, the regimen of anti-TNF-a treatment for brain 
injury has not been established. 
As the elevated TNF-a observed in brain injury must carry out its action by binding to 
TNF receptors, the role played by TNF receptors is still unclear. Recently，it was reported that 
mice genetically deficient in TNF receptors (TNFR-KO) were generate to determine the action 
of TNF-a in brain cell injury responses (Bruce et al., 1996). Damage to neurons caused by 
focal cerebral ischemia and epileptic seizures was exacerbated in TNFR-KO mice, in addition, 
oxidative stress was increased and levels of an antioxidant enzyme reduced in brain cells of 
TNFR-KO mice, indicating that TNF serves a neuroprotective function (Bruce et al., 1996). 
However，the roles played by the two receptor subtypes are still unclear. Figure 1.3 
summarized the possible roles ofTNF-a in brain inflammation and injury. 
1.5.4.5 TNF-a Stimulates Proliferation of Astrocytes and C6 Glioma Cells 
！ > 
i 
Evidence presented in the previous sections showed that both astrocyte proliferation and 
increase in TNF-a level occurred after brain injury, it is not surprising that a relationship exists 
between TNF-a and astrocytes proliferation. This is a very important issue as astrocytes, the 
most abundant cell type in the CNS can synthesize and response to TNF-a. 
Besides playing an important role in brain injury, it was found that TNF-a could also 
stimulate the proliferation ofcultured astrocytes (Selmaj et al., 1990). These authors reported 
that in serum-free medium，human TNF-a was able to stimulate significantly [^i] thymidine 
incorporation by astrocytes in a dose-dependent manner. Maximal stimulation was obtained at 
a dose of 200U/ml attaining a 7.8 fold increase over the control value in a 48 hours period. 
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LPS, viral or bacterial infection, 
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Figure 1.3 TNF>a in brain inflammation and injury. Glial cells including 
astrocytes and microglia produce TNF-a after brain injury, and TNF-a was 
found to play a key role in astrocyte proliferation and then scar formation 
(Adapted from Morganti-Kossmann and Kossmann, 1995) 
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Interleukin-6 (H^-6) also showed growth promoting activity in serum-free medium, the dose of 
Dl>-6 required to induce the optimal response was 50U/ml and gave a 4.1-fold increase over the 
control value. In serum-containing medium, TNF-a again induced astrocyte proliferation. A 
5.0-fold increase of pH] thymidine incorporation over the control value was obtained with 
200U/ml in a 48 hours period. In addition, EL-la and D^-ip stimulated proliferation but only at 
high doses (500-1000U/ml). The increase over the control value was 3.9±L9- and 2.3 ±0.8-
fold for n . - l a and D^-ip, respectively. D -^6 (10 to lOOU/ml)，however, showed no 
proliferative activity in serum-containing medium. y-Interferon (y-ffN) (10 to 200U/ml) and 
interleukin-2 (JL-2) (10 to lOOU/ml) did not show any stimulatory effect on thymidine uptake 
(Selmaj et al., 1990). The above demonstrated that cytokines could stimulate the proliferation 
of astrocytes. 
In addition, studies with C6 glioma cells, a neoplasmic astrocytic cell line, showed that 
the growth of C6 cells increased upon TNF-a treatment. In the cell cycle analysis by 
cytofluorimetry, the viable cell number was determined after 24, 48 and 72 hours of culture. It 
^ 
was found that there was a substantial increase in the number of proliferating cells was 
obtained when they were cultured in the presence ofTNF-a (Munoz-Femandez et al, 1991). It 
was demonstrated by the higher proportion of cells in S+G2 phase after 24 hours and 
especially 72 hours of culture. In contrast, TNF-a has opposite effects on tumour cells from 
neural origin (Munoz-Feraandez et al, 1991). This finding suggested that TNF-a inhibits the 
growth ofneurobalstoma cells but stimulates that of glioma cells. It was previously suggested 
that some cytokines, including TNF-a, increase the growth of a type of glial cells, the 
astrocytes (Slemaj et al., 1988) while they produce damage in another type of glial cells，the 
oligodendrocytes (Slemaj et al., 1990). These findings indicate the effects ofTNF-a are cell-
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type specific. 
Besides the above findings, previous results in our laboratory had also showed that 
TNF-a could induce C6 cell proliferation in a dose-dependent and time-dependent manner 
(Liu, 1996). As C6 glioma cells can also proliferate upon the addition ofTNF-a, it is suggested 
C6 glioma cell is a good model to study the signal transduction pathways mediated the effects 
TNF-a of in astrocytes. 
1.5.5 Interleukin-1 (BL-1) 
In addition to TNF-a, other cytokines have been shown to be involved in brain injury and 
induction ofastrocyte proliferation. H^-l is a multifiinctional cytokine with a molecular weight 
of 17kDa and is expressed in two forms, a and P, with 26% homology and almost identical 
fiinction (Dinarello, 1984). Two receptor forms have been characterized, type I and type II, and 
the property of signal transduction was attributed to type I，whereas type II seemd to have j 
higher affinity for K>-ip (Dinarello, 1991). Differential expression of JL-l receptors was 
evidenced in a variety of cell types (Otero and Merrill, 1994). 
BL-1 is secreted predominantly by macrophages, although other cell types like endothelial 
cells, B-cells, microglia and astrocytes also produce it upon stimulation (Dinarello, 1991). In 
the immune system, JL-l is a potent stimulator ofT-cells, which responds with proliferation, 
secretion of JL-2 and expression of JL-2 receptors. Together with other factors, JLA can 
enhance the growth and differentiation o f B cells. Fibroblast proliferation is enhanced after 
exposure to EL-1, which plays a role in scar formation (Schmidt et al., 1982). It also promotes 
the synthesis ofadhesion molecules in endothelial cells, facilitating leukocyte adherence and 
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extravasation (Dinarello, 1992). Furthermore,化-1 induces the production of cytokines and 
other stimulating factors in a variety ofcells, such as E>-6, TNF-a, colony-stimulating factors, 
prostaglandin and DL-1 itself suggest diverse effects of this cytokine ^)inarello, 1992). Within 
the nervous system, E^-1 was found in normal tissue and localized specifically in the 
hippocampus, choroid plexus, the pituitary gland and the meninges (Ban et al., 1991). Since 
n,-l receptors are also expressed on neurons, it was suggested that JL-l plays a role in the 
maintenance of neuronal fiinction (Berkenbosch et al., 1991). 
1.5.5.1 Interleukin-1 and Brain Injury 
YL-l, which has a regulatory role in immune fiinction, may also mediate inflammation 
associated with injury to the brain. Activity ofDL-1 was detected in brains ofadult rats 10 days 
！ 
after the brains had been injured. These findings suggest that DL-1，released by inflammatory 
cells, may promote the formation of glial scars by astroglia in the damaged mammalian brain 
(Giulian and Lachman, 1985). In addition, elevated JL-l mRNA expression was demonstrated 
by Northern blot analysis in the brain ofrats after fluid percussion damage, and the activity of 
n,-l was reported to be higher in cortex homogenates when compared with the uninjured 
contralateral cortex, suggesting local induction of TL-l in the contused area of the brain 
(Minami etal., 1991; Taupin etal., 1993). Furthermore, it was found that glial cells display an 
increased expression ofD^-l receptors after brain injury (Ban et al., 1991; Haour et al., 1995) 
and the binding ofIL-l receptor antagonists to JL-l type I receptor was shown to inhibit many 
peripheral and central actions ofE^-l, including injuries following central ischemia flEisenberg 
et al, 1990; Rothwell and Relton, 1993). As a result, E>-1 may also play a role in brain injury. 
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1.5.6 Literleukin-6 (TL-6) 
-� 
The pleiotropic cytokine JL-6, which regulates immune responses, acute phase reactions 
and hematopoiesis, also plays a pivotal role in host defense mechanisms (Hirano etaL’ 1990). 
It is a 26kDa molecule and is secreted by a wide range of cells, including activated fibroblasts, 
monocytes, endothelial cells, T cells, microglia and astrocytes (for review, see van Snick, 
1990). Two main functions are attributed to this cytokine: (i) terminal differentiation ofB cells 
into immunoglobulin-producing plasma cells and (ii) hepatocyte stimulation for the synthesis 
ofacute phase proteins such as fibrinogen and C-reactive protein (Akira and Kishimoto，1992). 
n,-6 is also considered an indirect co-stimulator for T cells. Compared with EL-la and TNF-
a，n,-6 is not an immediate mediator since it is promoted by early cytokines as well. Although 
K,-6 presents a different pattern of appearance, it also shares several activity characteristics of 
other factors like D^-1. JL-6 may also play a role in the negative regulation of inflammation 
through the inhibition of early mediators (Aderka et a/., 1989). 
The receptor for D -^6 is formed by multisubunits: an external binding domain, also found 
in a soluble form, associated with a membrane glycoprotein gpl30 which initiates signal 
transduction (Kitamura et aL, 1994). The expression of the R.-6 binding domain is not 
necessary for DL-6 to exert its function. In fact，TL-6 bound to soluble receptor can associate 
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1.5.6.1 Interleukin-6 and brain injury 
化-6 was elevated in the CSF of all individuals after brain injury. NGF appeared in the 
CSF ifIL-6 levels reached high concentrations and was often detected simultaneously with or 
following an n^-6 peak. The amounts ofNGF correlated with the severity of the injury. The 
functional relationship ofD^-6 and NGF was investigated utilizing cultured mouse astrocytes 
(Kossmann et al, 1996). These authors found that DL-6-containing CSF induced NGF 
production in astrocytes, whereas control CSF without 正-6 had no effect. The induction of 
NGF was inhibited up to 100% by adding anti-EL-6 antibodies. These results were 
corroborated when astrocytes were exposed to recombinant TL-6 at different concentrations 
resulting in NGF production. Thus，the production ofD^-6 within the injured brain may likely 
contribute to the release of neurotrophic factors by astrocytes (Kossmann et al.’ 1996). 
1 
The role of E^-6 in brain injury is further supported by the following studies. The U.-6 
activity was elevated in CSF within 1 hour，peaked between 2 and 4 hours，and returned to 
control values after 24 hours (Hans et al, 1999). In situ hybridization demonstrated augmented 
n,-6 mRNA expression in several regions including cortical pyramidal cells, neurons in 
thalamic nuclei, and macrophages in the basal subarachnoid spaces. A weak constitutive 
expression of n^-6 protein was shown by immunohistochemical study in control brain. After 
injury, H -^6 increased at 1 hour and remained elevated through the first 24 hours，returning to 
normal afterward (Hans et al., 1999). Most cells producing JL-6 were cortical, thalamic, and 
hippocampal neurons as confirmed by staining for the neuronal marker, NeuN (Hans et al., 
1999). These results ftirther support D -^6 production in the CSF of patients with severe head 
trauma and demonstrate that neurons are found to be the main source of n,-6 after 
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experimental axonal injury. 
1.5.7 y-Interferon (y-WN) 
Besides the above cytokines, y-WN has been shown to be involved in brain injury. y-ESIF 
is a 34- to 50-kDa homodimeric protein secreted by CD4+ Th! lymphocytes and natural killer 
cells，but is unrelated to the DL-la or EL-ip at the DNA level. y-WN plays a major role in 
regulating the induction of an immune response by unregulating the expression a 
histocompatibility complex (MHC) Class I and Class II molecules on macrophages and 
endothelial cells (among many other cell types)，activating macrophages, and increasing the 
expression ofendothelial-cell adhesion molecules (Farrar and Schreiber, 1993). 
In addition, y-ffN can upregulate Class I expression on astrocytes，microglia, and myelin 
I 
i 
basic protein (MBP)-positive oligodendrocytes, and it can also induce Class H mRNA and | 
thereafter protein expression by astrocytes and microglia in mouse. Concomitant with Class II 
upregulation, y-JFN upregulates Fc receptor expression by microglial cells，too. In rat， 
astrocytes express a relatively high-affinity y-DFN receptor (K^ = 1.64 X 10"^  M) (Rubio and de 
Felipe, 1991), and ligand binding is associated with an activation of protein kinase C (PKC) 
and an influx of extracellular Na^(Benvensite et al., 1991). 
1.5.7.1 y-Interferon and Brain Injury 
Influence of y-HTSf on astrocytes proliferating in response to unilateral injury of the 
cerebral hemisphere has recently been reported ^*awlinski and Janeczko, 1997). These authors 
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found that no effect ofy-mS[ administration was seen 1 day after injury. However, on day 2, an 
average 43% reduction in the number of proliferating astrocytes was recorded. The reduction 
showed no dose-dependent changes. This in vivo evidence of y-HTSMnduced suppression of 
astrocyte proliferation suggests that this cytokine interacts with other determinants, e.g. other 
cytokines, in regulating of astrocyte reactivity existing in the injured brain (Pawlinski and 
Janeczko, 1997). 
Another studies showed that although y-WN is a potent microglia/macrophage activator， 
no increase in j-WN transcripts could be found at injury. Also, the administration of a 
neutralizing antibody to y-ffN did not attenuate astrogliosis. Additionally, in y-mSf-knockout 
adult mice，astrogliosis and increases in levels ofD^-la and TNF-a were induced rapidly by 
injury (Rostworowski et al., 1997). Therefore, y-WN may inhibit astrogliosis. 
1.6 Ion Channels and Astrocytes 
The above sections indicate that cytokines mainly act on astrocytes to generate various 
responses following brain injury. These responses are generate by interaction with their 
respective receptors which in tum activate, generate or release some second messenger 
systems. Among them, TNF-a has been shown to activate ion channels (Kagan et al,, 1992; 
Mattson et aL, 1995a; 1995b; Koller et al., 1996; 1998). It was reported that most of the ion 
channels discovered in glia were similar or identical to their neuronal equivalents (Barres, 
1991). Recently, astrocytes in vitro and in situ have been shown to express voltage-activated 
ion channels previously thought to be restricted to excitable cells; the voltage-activated 
channels include Na+，Ca�+, and K+ channels. Numerous studies over the past 10 years have 
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yielded detailed characterizations of astrocytic ion channels permitting comparison of their 
properties to those oftheir neuronal counterparts. For the most part of such comparisons have 
demonstrated a high degree of similarity and they also provide evidence for the expression of 
some uniquely astrocytic ion channels (Sontheimer, 1994; Hertz etal,, 1998). However, unlike 
neurons, astrocytes appear not to use these channels to generate action potentials (Sontheimer 
et aL, 1994; Oh, 1997)，instead, they use the channels to produce intracellular biochemical 
responses (Bertran et aL, 1995). It was found that astrocytic ion channels can be fiinctioned by 
activating the second-messenger pathways, allowing short-term modulation of their membrane 
properties (Sontheimer, 1994). Jn addition, some studies suggest roles for astrocyte channels in 
basic cell processes such §s cell proliferation. Thus，although the role of some astrocyte 
channels remains unclear, the understanding of astrocyte physiology is starting to take shape 
and points towards roles of ion channels not involved in electrogenesis (Sontheimer, 1992). 
Considering the expression of the astrocytic channels, an increasing number of studies indicate 
thatthe expression ofastrocytic channels is influenced by the cells' microenvironment, such as 
channels in excitable cells. The general functions of the astrocytic voltage-activated Na+，Ca^ ,^ 
and K+ channels were described below. Inwardly rectifying K+ channels in concert with 
delayed rectifying K+ channels are thought to be involved in the removal and redistribution of 
excess K+ in the brain, a process referred to as "spatial buffering". Astrocytic K+ channels may 
also be crucial in modulating astrocytes proliferation. Na+ channels appear to be important in 
fueling the astrocytic Na+y :^+-pump, and Ca!+ channels are likely involved in numerous cellular 
. events in which intracellular Ca^ ^ is a critical second messenger (Pappas et al., 1994; 
Sontheimer, 1994, Sontheimere^a/., 1996; Oh，1997). 
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1.6.1 Roles ofSodium Channels in Astrocytes 
It has been proposed that astrocytic Na+ channels constitute a "retum" pathway for 
Na7K^-ATPase function, which permit Na+ ions to enter the cells to maintain intracellular Na+ 
(pS[a+]i) at concentrations necessary for activity of the Na+/K+-ATPase. Since astrocyte 
Na+/K+-ATPase is believed to participate in extracellular K+ ([K+]�) homeostasis in the CNS, 
the coupling ofNa+ flux through voltage-activated Na+ channels to ATPase activity may also 
provide a feedback loop that participates in the regulation ofK+ ion levels in the extracellular 
space (Sontheimer et al, 1994; 1996). 
1.6.2 Roles ofPotassium Channels in Astrocytes 
hicubation of cultured cortical astrocytes with TNF-a led to a marked reduction of 
membrane potential It has been found that this depolarization depends on activation ofPKC， ^ 
since it could be blocked by the PKC antagonists, staurosporine and H7, and it could be 
mimicked by direct activation ofPKC using the phorbol ester phorbol 12-myristate 13 acetate 
^>MA). Analyses ofwhole cell currents revealed a reduction ofinwardly rectifying K+ currents 
whereas K+ outward currents were not affected. Therefore, TNF-a induces changes ofbasic 
electrophysiological properties of astrocytes which are similar to those induced by 
proliferation, or an in vitro model oftraumatic injury OVlacFarlane and Sontheimer，1997). It 
was found that astrocytes undergoing secondary, injury-induced proliferation recapitulate the 
properties of immature glial cells. The switch in predominance from inwardly rectifying K+ 
current to sustained K+ current ^CD) appears to be essential for proliferation and scar repair, 
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because both processes were inhibited by blockade ofKD (Pappas et al.，1994; MacFarlane 
and Sontheimer, 1997). 
•V 
1.6.3 Importance of Calcium Ion Channels in Astrocytes 
It has been well known that Ca"is an important second messenger in many cell types. 
Transient increases in cytosolic [Ca!+] trigger numerous cellular responses including muscle 
contraction, release of neurotransmitters, and glycogen breakdown. Moreover, Ca�+ is an 
important activator of oxidative metabolism (Voet and Voet, 1990). Cellular Ca'" is a key 
messenger that controls a large number of cellular responses like fertilization, proliferation, 
differentiation, transformation, ceil death, hormone secretion, smooth muscle contraction, 
sensory perception and neuronal signaling (Berridge, 1993; Clapham, 1995). Regulation of 
intracellular Ca!+ concentration ([Ca^ ]^i) plays a central role in the above mentioned actions 
(Studzinski et al., 1999). Numerous studies showed that Ca!+ (especially intracellular Ca"0 
plays an important role in signal transductions in astrocytes (Finkbeiner, 1993; Kostyuk and 
Verkhratsky，1995; Carmignoto etal., 1998), therefore, we focused on the effect ofTNF-a on 
Ca2+ channels in C6 glioma cells in this project. The role ofthe Ca"+ channels in the glial ceils 
and astrocytes will be mentioned later. 
1.6.3.1 Function of Cellular and Nuclear Calcium 
In a cell, there are two major intracellular Ca?+ pools: nuclear and cytoplasmic pools. The 
Ca2+ pools found within a cell is shown in Figure 1.4. Accumulating evidence indicates that 
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Figure 1.4 bitracellular calcium stores in astrocytes. Diagrammatic 
presentation of the nuclear store, and the cytosolic n*3-sensitive and -insensitive 
Ca2+ store (Adapted from Means, 1994). 
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Ca2+ is also involved in the regulation of many nuclear fijnctions such as cell cycle regulation 
(Means, 1994), apoptosis OSficotera and Rossi, 1994), gene transcription (Wegner et al., 1992; 
Peunova and Enikolopov, 1993), DNA synthesis, DNA repair, nuclear envelope breakdown 
(Steinhardt and Alderton, 1998) and nuclear pore assembly (Macaulay and Forbes, 1996). 
More detail information and references regarding the Ca^^-modulated processes in the nucleus, 
information can be found in the review by Santella and Carafoli (1997). 
1.6.3.2 Nuclear Calcium in Cell Proliferation 
Ca2+ and its ubiquitous intracellular receptor calmodulin are required for cell proliferation. 
Studies in a variety of model systems are beginning to identify components of the | 1 
I 
Ca^7calmodulin cascade required for movement of quiescent cells into the cell cycle as well as ！ 
for proliferating cells to move from G1 to S, G2 to M and through mitosis OVLeans, 1994). Two 
Ca2+/calmodulin-dependent enzymes, the multifunctional Ca^7calmodulin-dependent protein j 
kinase and the protein phosphatase 2B (calcineurin) as well as a spindle pole body protein that 
binds calmodulin in the absence of Ca^^have been shown to be essential at specific phases of 
the cell cycle. In addition, the status ofthe intracellular Ca^^pools is critical for normal traverse 
ofthe cell cycle (Means, 1994). 
1.6.3.3 Nuclear Calcium in Gene Transcription 
Studies show that gene expression can be influenced not only by cytoplasmic but also by 
nuclear Ca!+. Moreover, Ca^^-binding proteins have been identified in the nucleus such as 
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calmodulin, calreticulin, calbindin-Djgk and nucleolin OVlalviya and Rogue, 1998). One ofthe 
targets ofthe Ca^^-activated calmodulin is Ca^7 calmodulin-dependent protein kinase (CaM 
kinase) (Srinivasan et al., 1994). Specific isoforms, including type II and type IV of CaM 
kinase have been localized in the nucleus. Both nuclear isoforms of CaM kinase were 
mediators of CREB [cyclic adenosine monophosphate (cAMP) response element binding 
protein] phosphorylation OVlalviya and Rogue, 1998). In the CNS, nuclear calmodulin appears 
essential in the rapid synaptic control of CaM kinase-dependent CREB phosphorylation 
O)eisseroth et al., 1996). 
The most convincing evidence for a direct role of nuclear Ca^ln the regulation ofgene 
expression was demonstrated by Hardingham et al. (1997). They found that increases in 
nuclear level Ca^^level in neuronal cells controlled the transcription of immediate early gene 
c-fos by CRE, whereas increases in cytosolic Ca^^-activated transcription mediated by serum 
response element (SRE). 
The involvement ofCa^^ in the initiation of proliferation of endothelial cells after injury j 
was demonstrated by the findings that a transient [Ca^ ]^i increase was induced in cells at the 
wound edge (Schilling and Elliott, 1992; Villereal and Byron, 1992; Tran et al., 1998; 1999). 
These same cells proliferated 18-24 hours post wounding, as measured by bromodeoxyuridine 
incorporation. The localized Ca^ ^ signal was required specifically during wounding since 
blocking Ca?+ influx reduced proliferation by 40-50%. Proliferation also required serum since 
starvation reduced proliferation by 80% (Tran et al., 1998). These authors further found that 
the signals derived from semm and [Ca^ ]^i combined at least additively to induce proliferation 
(Tran et a/.，1998). Therefore, serum priming followed by a single, transient Ca^ ^ signal 
induced by mechanical injury must occur in a temporally and spatially regulated manner for 
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normal proliferation. They suggest that co-ordination between signalling cascades induced by 
growth factors and release from contact inhibition might be obligatory for localized re-
endotheIialization after injury (Tran et al., 1998; 1999). 
1.6.3.4 Nuclear Calcium in Apoptosis 
The role ofcytosolic Ca^ i^n triggering programmed cell death is well establised (Orrenius 
et a/., 1992). More recently, nuclear Ca^ ^ has also been implicated in apoptosis (Shen et al., 
1991). Ca2+-dependent endonucleases were activated in several experimental systems (Wyllie 
et al., 1981; Kyprianou et al., 1988; Jones et al., 1989). Ca^^-dependent proteases were also 
involved. For example, apoptotic lamin proteolysis was seen when nuclei from untreated cells 
were incubated in the absence of cytosol but in the presence of Ca!+ and Mg2+ (Jones et al., 
.丨 
1989). It was suggested that Ca^^-dependent serine protease associated with the nucleus 
scaffold and capase family of enzymes may be responsible for this effect . 
Another indication of the role of nuclear Ca!+ in apoptosis invloves an anti-apoptosis 
protein, bcl-2, which are located on the outer nuclear membrane. Martin et al. (1995) have 
shown that apoptosis supression by bcl-2 was correlated with exclusion of Ca^+from the 
nucleus. Conversely, an increase in [Ca^^]iWas observed in control cells undergoing apoptosis. 
However, Ca^ + is not the only messenger for apoptosis despite its general involvement. 
Several Ca^^-dependent proteases and endonucleases were suggested to play roles in apoptosis 
(Kyprianou etal., 1988; Gaido and Cidlowski, 1991). 
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1.6.3.5 Spatial and Temporal Changes of Calcium- Calcium Oscillation 
Almost a decade ago，it was shown that Ca^ ^ signals that mediated the effects of 
extracellular stimuli occurred in a form of frequency modulated and spatially organized 
oscillations in individual cells (Jacob，1991). 
The [Ca2+]i oscillations may be of different fiindamental types, involving different 
mechanisms. The two major kinds of [Ca^ ]^i oscillations are baseline spikes and sinusoidal 
oscillations. The mechanism of [Ca^ ]^j oscillations induced by physiological stimuli is not 
clearly defined. Several models have been proposed for the generation of [Ca^ ]^i oscillations by 
receptor agonists in non-excitable cells. In one model, receptor activation may induce a 
pulsatile production ofinositol 1,4,5-triphosphate (EP3) which causes oscillatory mobilization 
ofCa2+from n>3-sensitive pools OMeyer and Stryer, 1988). Berridge and his colleagues first 
proposed a two-pool model in which [Ca^ ]^i oscillations can occur in the presence ofa constant 
level 0fn>3 (Berridge and Irvine, 1989). Jn this model，the [Ca^ ]^i oscillations are generated by 
Ca2+-induced-Ca2+ release (CICR) (Endo, 1977) triggered by the mobilization of Ca'^ by ff3. 
' � 
This two-pool model has been revised recently, in that both Ca!+ pools are EP3-sensitive 
^erridge, 1992). 
» 
‘ 1.6.3.6 Calcium Signalling in Glial Cells 
Traditionally, glial cells were regarded as a passive non-excitable element of the nervous 
system which mainly serve as structural and nutritional units (Kuffler and Potter, 1964; 
Orkand et al, 1966). However, an extensive investigation of glial cell electrophysiology, 
started at the beginning of 1980s after the introduction ofthe patch-clamp technique, finally 
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demonstrated that glia expresses the same complex variety of ionic channels and 
neurotransmitter receptors as neurons do; moreover, the expression of these signalling 
molecules is highly liable and undergoes substantial changes during ontogenesis (Barres etal., 
1988; 1990; Bevan, 1990; Ritchie, 1992; Sontheimer, 1994). 
The investigation of Ca:+ handling in the glial cells clearly demonstrated that glia 
possesses the ability to generate quite complex and organized [Ca^^]j signals (Finkbeiner, 1993; 
Pasti et al., 1997). These [Ca^^]j signals together with electrical membrane responses might be 
an important determinant for glial-neuronal interactions, allowing a two-directional 
information exchange (Finkbeiner, 1993; Pasti et al., 1997). Moreover, studies showed that 
stimulation of neuronal afFerents was found to triggered periodic [Ca^ ]^i oscillations in 
astrocytes, and the frequency of these oscillations was under a dynamic control by neuronal 
activity as it changed according to the pattem of stimulation. These results reveal that [Ca^ ]^i 
oscillations in astrocytes represent a highly plastic signaling system that underlies the 
reciprocal communication between neurons and astrocytes OPasti etal., 1997). 
Glial cells have recently been found to exhibit electrophysiological and metabolic 
responses to many neurotransmitters and neuromodulators, and the attention on the possibility 
that active signaling between neurons and glia could represent an important form of 
intercellular communication within the brain was focused (Charles, 1994; 1998; Cooper，1995; 
Verkhratsky and Kettenmann, 1996; Deitmer et al., 1998). For example, both [Ca'^]i 
oscillations and intercellular Ca�+ waves are generated in neurotransmitter-stimulated glial 
cells. In addition, it has been proposed that rhythmic glial cell contractions and shape changes, 
which have been observed for many decades, are linked to Ca^+-induced secretion of ions, 
1 water, and neuroactive compounds (Charles, 1994; 1998; Cooper, 1995; Verkhratsky and 
I 
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Kettenmann, 1996; Deitmer etal., 1998; Scemes and Spray, 1998). These activities represent 
mechanisms by which Ca^^-induced changes in glial cell physiology could potentially alter the 
excitabflity of neuronal networks (Cooper, 1995; Verkhratsky et al., 1998). 
In contrast to neurons, where electrical excitation plays a key role in [Ca^ ]^i signal 
generation, in glial cells this function is achieved mainly by plasmalemmal receptors 
^Iassinger et al., 1995). Glial cells, astrocytes in particular, express a wide selection ofboth 
ionotropic and metabotropic receptors, the activation of which brings to the game a number of 
different mechanisms, finally altering [Ca^ ]^j ^Iassinger et al., 1995). Recently, it has been 
discovered that the neurotransmitter glutamate induced a variety of [Ca^ ]^i changes in 
astrocytes (Torday et al., 1997; Shelton and McCarthy, 1999). Glutamatergic regulation of 
astrocytic [Ca^ ]^i may be involved in synapse modeling, long-term potentiation, excitotoxicity 
and other events dependent on glutamatergic transmission (Shelton and McCarthy, 1999). 
In astrocytes, there are at least two different intracellular Ca^ ^ stores, the rP3-sensitive 
endoplasmic reticulum ^ R ) Ca^ ^ store and mitochondria Ca^ ^ store (Golovina et al., 1996; 
Boitier et a/.，1999). The Ca^ ^ signal in astrocytes is inhibited in their cellular processes and 
then spreads inside the cell, generating [Ca^ ]^i waves (Giaume and Venance, 1998). In 
astrocytes, Ca^ ^ waves may travel between cells over long distances (Comell-Bell, et a/.’ 1990; 
Giaume and Venance, 1998). 
1.6.3.7 Calcium Channels in Astrocytes 
In addition to the intracellular stores mentioned above，which may act as Ca�+ sources, the 
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of voltage-gated Ca^^channels in glial cells is of particular importance given the ubiquitous 
role of [Ca2+]i as a second messenger. Thus, stimuli that depolarize astroglia sufficiently to 
evoke Ca^ ^ influx and concomitant increase in [Ca^ ]^j may exert widespread effects on 
astroglial physiology (Dufify and MacVicar, 1993). There are many different types of Ca�+ 
channels found in cells, including N-, T-，L-，P/Q-type Ca^ ^ channels OVlacVicar and Tse, 1988; 
Corvalane/a/., 1990;Fern, 1998; Westenbroek etal, 1998;Holden^a/., 1999). Amongthem， 
L-type Ca2+ channels appear to be the major channel type in cultured astroglia, because the 
predominant current measured in cultured cortical astrocytes (MacVicar and Tse, 1988; 
Corvalan et al., 1990)，however, the Ca?+ channels being activated during brain injury is not 
clearly known. Recent studies showed that immunostaining of the a2 subunit ofL-type Ca!+ 
channels by a specific antibody was increased in reactive astrocytes in brain injury 
OVestenbroek etal., 1998). Moreover, the a l C subunits of class C L-type Ca^ ^ channels were 
also upregulated in reactive astrocytes located in the affected regions of brain injury 
(Westenbroek et al., 1998). It was suggested that the upregulation ofL-type Ca^ ^ channels in 
reactive astrocytes may contribute to the maintenance of ionic homeostasis in injured brain 
regions, enhance the release of neurotrophic agents to promote neuronal survival and 
differentiation, and/or enhance signalling in astrocytic networks in response to injury 
OVestenbroeke/a/., 1998). 
In addition, the L-type Ca^^channels have been shown to be responsible for astrocytes 
proliferation (Florio et al., 1996). This study showed that a prion protein fragement, PrP106-
126, which found to directly stimulate the proliferation of astrocytes, caused a rapid increase in 
the [Ca2+]i, and this effect was prevented by nicardipine, a L-type voltage-sensitive Ca^^channel 
blocker or by Ca^^-free conditions OFlorio et al, 1996). Therefore, it suggests that a prion 
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protein fragment directly stimulates the proliferation of astrocytes via an increase in [Ca^ ]^j 
through the L-type voltage-sensitive Ca^^channels. � 
1.6.3.8 Relationship Between [Ca^ ]^j and Brain Injury 
The transduction pathways activated during cell swelling exert inhibitory effects on 
astrocytic gap junctions (Giaume and McCarthy, 1996), and it is proposed that the increased 
junctional conductance during hyposmotic shock is due to increased number of channels, 
possibly triggered by the initial Ca^ ^ signals Polmetsch et al., 1997). The increased 
intercellular communication between mouse astrocytes in response to hyposmotic challenge 
thus occurs via both gap junction-dependent and -independent mechanisms and presumably 
provides neuroprotective effects following nervous system injury (Scemes and Spray, 1998). 
Thus, it has been proposed that Ca^ ^ signals are very important in the transduction pathways in 
astrocytes after brain injury. In support of this thought, it was found that reactive functional 
changes of glial cells seem to be controlled by an altered balance of the second messengers 
Ca2+ and cAMP and can be counter-regulated by the endogenous cell modulator adenosine 
which strengthens the cAMP-dependent signalling chain (Schubert et al., 1998). Moreover, it 
was found that an elevated [Ca^ ]^j observed following traumatic brain injury (TBI) could result 
in mitochondrial dysfunction, increased production of free radicals, and activation of 
degradative processes controlled by Ca^^-activated protease and phospholipases O^igalinski 
et oA，1997). Thus, it is possible that a massive trauma-induced influx of Ca^ ^ into the cells of 
CNS is a primary mediator offunctional changes in astrocytes as well as other cellular damage 
associated with TBI. htterestingly, these authors also found that decreasing the extracellular 
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Ca2+ resulted in consistently higher average levels of injury compared with cells exposed to 
normal concentration of Ca�+ in CSF. However, elevation of [Ca^ ]^i before injury decreases 
stretch4nduced astrocyte injury. Addition of A23187 (which shuttles Ca?+ down its 
concentration gradient into the intracellular environment and directly elevates [Ca�+]!) and 
thapsigargin (which inhibits the Ca^^-ATPase of intracellular Ca^ ^ stores by slow leakage, 
activating the capacitative Ca:+ influx pathway, and thus elevates [Ca^^]i) immediately before 
TBI significantly decreased astrocyte injury. Therefore，these authors suggest that there is a 
dual role for Ca^^in CNS injury. Elevation of [Ca^ ]^i by over-activation of receptor-mediated 
Ca2+ influx certainly contributes to excitotoxic injury in the neuron, while extracellular Ca�+ 
influx may also be necessary for cell repair in the initial stages after injury. Additionally, they 
further hypothesized that changes in Ca^^-mediated signaling pathways, rather than an absolute 
elevation in [Ca^ ]^i, is responsible for some of the pathological consequences of traumatic 
brain injury (Rzigalinski et cd., 1998). 
hi support ofthe role played by Ca!+ homeostasis in brain injury, it was recently reported 
that the increase expression of calbindin-D2gK in calbindin-transfected C6 glial cells stablized 
[Ca2+]i levels and this offered protection againist apoptosis induced by Ca^ ^ ionophore (Wemyj 
et aL, 1999). This finding again emphasizes the role played by Ca^ ^ and astrocytes in brain 
injury. 
Furthermore, it has previously been reported that glutamate receptors activate Ca!+ 
mobilization and Ca^^influx into astrocytes, and it has been suggested that changes in [Ca^ ]^i 
are as important in the regulation of astrocyte function as they are in neurons O^ernyj et al., 
1999). In addition, glutamate receptor agonists, which produce changes in [Ca^^]iin glial cells， 
stimulate active gliosis in the CNS ^Iolzwarth et al., 1994), suggesting that a rise in [Ca^^jin 
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glia may play a role in neuropathological events. Again, these findings support the important 
role of astrocytes in excitotoxic insults, and that in these cases, [Ca^ ]^j is an crucial messengers. 
- � 
1.3.6.9 TNFKX and Astrocyte [Ca^ ]^i 
As TNF-a has been shown to be elevated in brain injury, and in view of the above 
findings, it is quite possible that TNF-a influences [Ca^ ]^^  concentrations. Indeed, various 
reports showed that TNF^x also affected the [Ca^^\ homeostasis and basic 
electrophysiological properties such as the membrane potential in astrocytes. Using the Ca!+ 
indicator dye fura-2 in a cell culture model, it was found that TNF-a (10-1000U/ml), but not 
TL-l, induced a slow but more than two-fold increase of [Ca^ ]^i (Koller et al, 1996). The 
increase in [Ca^ ]^i could be blocked by Co!+ (l.OmM), verapamil (lOO^M) or omission of 
extemal Ca?+. This [Ca^ ]^j increase was accompanied by a marked decrease of the membrane 
potential by 35 mV. The action of TNF-a was confirmed by studies with CSF of patients 
suffering from bacterial meningitis, which is known to contain a large amount ofTNF-a, also 
induced a similar depolarization of astrocytes, and this effect was markedly reduced by a 
neutralizing TNF-a antiserum (Koller et al., 1996). These findings suggest that the TNF-a-
induced [Ca^ ]^i increase and depolarization in astrocytes may result in disturbing voltage-
dependent glial functions such as regulation oflocal ion concentrations and in tum transmitter 
uptake. 
In addition, some studies showed that TNF-a and regulation of [Ca^ ]^i might play a 
cytoprotective role in astrocytes in the injured brain (Mattson et al., 1995a, 1995b). These 
authors found that when the astrocyte cultures were exposed to lOOng/ml TNF-a for 24-72 
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hours, there was a marked 6- to 12-fold increase in the number of calbindin immunoreactive 
astrocytes compared to 2% of the neocortical astrocytes in untreated control (Mattson et al, 
1995a; 1995b). Calbindin is a 28kDa Ca^^-binding protein which regulate [Ca^ ]^j. Jn addition, 
these investigators reported that exposure of cultured astrocytes to medium at pH 6.5 resulted 
in 50% ofcell death, while astrocytes pretreated with TNF-a for 24 hours were relatively more 
resistant to acidosis injury and the survival rate increased to 75-85%. Taken together, the data 
indicate that TNF-a increased in [Ca^ ]^j which in tum induced the expression of calbindin in 
astrocytes and this may explain their resistant to acidosis injury. Again, these findings support 
the thought that Ca^ ^ is a very important factor in the signalling pathway in astrocytes after 
brain injury. 
1.3.6.10 Calcium-Sensing Receptor (CaSR) 
It is becoming increasingly clear that astrocytes play very dynamic and interactive roles 
that are important for the normal functioning of the central nervous system. In culture, 
astrocytes express many receptors coupled to increases in [Ca^ ]^j. In vivo, it is likely that these 
receptors are important for the modulation of astrocytic functions such as the uptake of 
neurotransmitters and ions (Porter and McCarthy, 1995). 
Recently, a G protein-coupled, cell surface extracellular Ca2+([Ca2+L)-sensing receptor 
(CaSR) has been cloned from parathyroid, kidney, and brain, and it plays crucial roles in 
systemic Ca^ ^ metabolism (Mailland et al., 1997; Chattopadhyay et al., 1998). Studies on 
several different tissues in several species demonstrates that this receptor can directly 
recognize and respond to small changes in their ambient level of [Ca�+]�This fmding directly 
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documents that [Ca�+]�can act as an extracellular, first messenger in addition to subserving its 
better known role as an intracellular second messenger (Chattopadhyay et al,, 1996). 
Results obtained with the parathyroid, kidney, and brain CaSRs are predicted to be 
glycosylated proteins of approximately 140kDa with an unusually large extracellular domain 
and the seven membrane spanning region characteristic of other G-protein-coupled receptors. 
CaSRs share limited homology with only one other subfamily of G-protein-coupled receptors, 
the metabotropic glutamate receptors (Rogers et cd., 1997). The relationship between CaSR 
and Ca2+ metabolism is best demonstrated by finding that heterozygous and homozygous 
CaSR knockout mice display mild and severe derangement in Ca^ ^ homeostasis (Rogers et al, 
1997), suggesting a crucial role for CaSR in organismal Ca!+ homeostasis. Moreover, 
mutations in human CaSR cause several diseases of Ca�+ handling (Rogers et al, 1997; Brown, 
1999). CaSR are also expressed in cell types that do not play a direct role in organismal Ca!+ 
homeostasis but utilize extracellular Ca�+ signals for a variety of tasks, including triggering of 
differentiation or feedback regulation of cellular function in response to changes in 
extracellular Ca^ ^ (Gama et al., 1997). It was also found that CaSR could couple to the release 
of [Ca2+]i from the intracellular Ca^ ^ stores (Shorte et al., 1996). For example, in parathyroid 
cells, dermal fibroblasts, and brain cells, increasing the expression of CaSR evokes [Ca^ ]^j 
increases which ^>pear to involve mobilization of intracellular Ca^ ^ stores (Shorte et al，1996). 
These findings suggest that CaSR may play a role in regulation of [Ca^ ]^i. Recent studies also 
found that CaSR transduce extracellular Ca�+ binding into a variety of intracellular responses, 
including inhibition of adenyl cyclase, stimulation of T>-myo- H^ production, and release of 
[Ca2+]i (Shorte et al., 1996). Therefore, it is possible that increase in CaSR expression is related 
to [Ca2+]i changes. The possible actions ofCaSR after sensing [Ca!+]�was shown in Figure 1.5 
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Figure 1.5 Role ofCaSR. Ca!+ binding to CaSR extracellularly can finally 
affect the change in intracellular Ca^^level though a sequence of reactions. 
PKC and n^ 3 are the factors involved. (Adapted from Masiero et al.，1999) 
48 
i 
Chapter 1 Tntroduction 
OVIasieroera/., 1999). 
Li the brain, the highest regional expression of the CaSR RNA in brain occurs in the 
hypothalamus and the corpus striatum (Chattopadhyay et al., 1996; 1997), however, its role(s) 
in the brain is not clearly known. Immunohistochemistry reveals discrete localizations 
throughout the brain that appear to be associated with nerve terminals where CaSR may 
regulate neurotransmitter disposition in response to Ca^ ^ levels in the synaptic space (Ruai et 
a/.，1995). 
As described before, the CaSR in brain is located in nerve terminals as well as in fiber 
tracts, where it may be expressed in glia (Chattopadhyay et al, 1997; 1998). CaSR in 
immature oligodendrocytes may be functionally linked to cellular proliferation and an outward 
K+ channel potentially contributing to local ionic homeostasis in the vicinity of 
oligodendroglia (Chattopadhyay et al., 1998). However, the presence and role of CaSR in 
astrocytes remain to be established. 
1.7 Protein Kinase C (PKC) Pathways 
Besides Ca!+，PKC is another important signalling pathway in brain functions. PKC is a 
heterogeneous family often or more isoforms which plays an important role in neuronal signal 
transduction. At present, at least 12 PKC isozymes have been found which have different 
tissue expressions, and that cDNAs for these isoforms have been cloned (Stabel and Parker, 
1991; Nishizuka, 1992). For example, in brain, the PKC family of serine/threonine protein 
kinases is thought to regulate both neuronal development and synaptic transmission (Jiang et al, 
1994). Isoforms from all subclasses are prominently expressed in the rat hippocampus, as 
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demonstrated by immunoblot with isozyme-specific antisera: Ca^^-dependent PKCs (a, pi, pn 
and y), Ca'^-independent PKCs (5’ s, r\, G), and "atypical" PKCs ( � , X ) (Selbie et al., 1993; -� 
Johannes et al., 1994; Krizbai et al., 1995; Gangeswaran and Jones, 1997). Li addition, two 
atypical members ofthe PKC family，PKCl and PKC-|x, have been reported recently in the 
brain (Selbie et al., 1993; Johannes et a/.，1994). Ca^Mependent PKCs possess a region (C2), 
which binds Ca2+in the presence oflipid. The Ca^^-independent PKCs lack C2, do not require 
Ca2+ for activation and share with the Ca^^-dependent PKCs a diacylglycero_orbol ester 
binding site (C1), containing two cysteine-rich regions. These PKC isozymes are differentially 
expressed at different stages, suggesting they play different and/or specific functions (Jiang et 
aL, 1994). 
Jn addition, the distribution ofPKC mRNAs in the CNS is also specific: PKC-a, pI and 
pn mRNAs were found at low levels throughout the CNS, with higher levels in cerebral cortex 
and in hippocampal pyramidal cells; PKC-s mRNA was found at low levels in the 
hippocampal pyramidal cells; PKC-y mRNA at high levels in many brain regions, including 
the cerebral cortex, hippocampal granule and pyramidal cells and also in thalamic neurons 
(Shimohama et al, 1993; Wilson et al, 1994); and PKC-6 mRNA only in thalamic neurons 
OVilson^a/.’ 1994). 
1.7.1 PKC and Brain Injury 
Recent studies showed that PKC-y plays an important role in brain injury. Electrophoresis of 
the polymerase chain reaction (PCR) products showed that the PKC-y message transiently 
increased to 145%, then declined to 60-65% of control at 6 hours after ischemic insult and 
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remained down-regulated for the next 24 hours; while the amounts of mRNA encoding for a 
and pi PKC isoforms were not significantly altered by ischemia (Zablocka et al., 1998). The 
•v 
selective transient elevation ofPKC-y may be due to the fact that PKC-y message and protein 
are located mainly postsynaptically in the dendrites of cerebellar Purkinje cells (Zablocka et al, 
1998). Di concert with the above observation is the finding that hippocampal cellular 
compartment expressing PKC-y were particularly sensitive to ischemic insult (Krupinski et al., 
1998; Zablocka et al., 1998). 
1.7.2 Role ofProtein Kinase C Activity in TNF-a Gene Expression in Astrocytes 
As discussed above, certain PKC isozymes and TNF-a were activated or elevated in brain 
injury, it is not surprising that there is a relationship between these two parameters, hi this 
connection, it has been reported that primary rat astrocytes express TNF-a protein in response 
to various stimuli including a combined treatment with y-mST and lipopolysaccharides (LPS), 
or y-ffN and JL-l^. It was also found that y-JFNfLPS, and y-ffKyOL-ip induced TNF-a 
mRNA in a time-dependent manner (Chung et al., 1992). Jn these studies, the involvement of 
PKC activity in TNF-a expression was assessed by using various protein kinase inhibitors. 
The two PKC inhibitors, H7 and staurosporine, inhibited the y-ffMLPS-, and y-ffNyOL-ip-
induced TNF-a mRNA and protein expression in a dose-dependent manner, while HA1004, 
relatively a poor PKC inhibitor, did not inhibit TNF-a expression (Chung et al, 1992). The 
participation of PKC in the TNF-a signalling pathway was further proved by other 
experiments. It was reported that the TNF-a-induced intercellular adhesion molecule-1 
(ICAM-1) expression was inhibited by PKC inhibitors such as H7, H8 and calphostin C in rat 
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astrocytes (Ballestas and Benveniste, 1995). In addition, it was found that the expression of 
TNF-a mRNA after infection of astrocytes was significantly decreased in the presence ofPKC 
"V 
inhibitors H7 and stauroporine, but not in the presence of a relatively poor inhibitor HA1004 
^Jeberman et al., 1990). Therefore, it is suggested that PKC may play an important role in 
TNF-a signalling pathway in astrocytes. Although PKC is such an important mediator of 
TNF-a action, the role of PKC in TNF-a-mediated proliferation remains to be elucidated. 
Some ofthe well-known roles ofPKC in the cellular signal transduction pathways were shown 
in Figure 1.6. 
1.7.3 PKC and Calcium in Astrocytes 
As mentioned before，some ofthe PKC isoforms are Ca^^-dependent (Selbie et al., 1993; 
Johannes et al.，1994), suggesting that PKC and Ca:+ have close relationship. Moreover, it was ；| ( 1 
reported recently that activation ofPKC resulted in an increase in capacitative Ca!+ entry (one [ 
/ 
of the most important [Ca^ ]^i regulatory mechanisms) in astrocytes (Wu et al., 1999). In 
addition, it was recently shown that Ca^ ^ influx stimulates a Ca^^-dependent phospholipase D 
(PLD)，an enzyme regulated by PKC in astrocytes (Sun etaL, 1999). Furthermore, it was found 
that phorbol 12-myristate 13-acetate (PMA), a potential stimulator ofPKC, inhibited taurine 
uptake in rat astrocytes, and this effect was potentiated by cotreatment of the cells with 
thapsigargin orthe Ca^^ionophore A23187 (Tchoumkeu-Nzouessa and Rebel, 1996). Taurine 
is an amino acid which is believed to regulate cell volume in astrocytes ^Iuxtable, 1992). 
These findings indicate that both Ca^ ^ and PKC are important in regulating metabolic processes 
and closely-related in transducing signals in astrocytes. 
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Figure 1.6 Schematic overview of the signal transduction pathway. Extracellular 
ligands bind to their cellular receptors. Hydrophobic ligands such as steroid hormones 
diffiise through membranes and bind to intracellular receptors that directly activate 
transcription. Activated receptors consisting of structure with seven transmembrane 
domains (7TM receptors) interact with a transducer with in tum stimulates an effector. 
Activated receptors with Tyr kinase activity can directly activate several effector 
systems. The activated effectors generate second messengers which activate a target 
cascade leading to gene expression in many cases PKC is the first target (Adapted 
from Selbie etal., 1993). 
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1.8 bitermediate Early Genes (ffiGs) 
There are several families of the ffiGs which also participate in many signalling pathways 
in cells (Curran and Morgan, 1987; Ainbinder et al., 1997; Matsumura et al, 1999). ffiGs 
include the fosJun, and zinc finger genes that encode transcription factors. Products of th&fos 
family {c-fos,fra-J,fra-2, and fos E) bind to members of the jun family (c-junJun BJun D) 
via leucine zippers, and this dimer then binds to the AP-1 site (consensus sequence -
TGACTCA-) in the promoter oftarget genes，which in tum regulate the expression of late 
response genes that produce long-term changes in cells. For example, in the brain, c-fos may 
regulate the long-term expression of preproenkephalin, nerve growth factor, dynorphin, 
vasoactive intestinal polypeptide, tyrosine hydroxylase and other genes with AP-1 sites in their 
promoters (Curran and Morgan, 1987; Sheng and Greenberg, 1990). 
1.8.1 ffiGs Expression and Brain Injury 
It was found that astrocytes in vitro readily responded to a wide variety ofneuronal and 
systemic signals by inducing a complex pattern offfiGs. In vivo, the ability of glial cells in 
expressing ffiGs was reported to be highly restricted, however, one important exception was 
the category ofglial response to injury. Long-term expression of multiple JEG proteins in glial 
cells stimulated by neuropathological conditions might play an important role in the outcome 
ofbrain injury and neurodegenerative disease (Arenander and de Vellis, 1992). 
bivolvement of the ffiGs in brain injury and ischemia is under intensive investigation 
(Gubits et al., 1993). The ffiGs, c-fos, c-jun were observed to be induced in the cortex and 
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hippocampus as early as 5 minutes following lateral fluid-percussion (FP) brain injury in the 
rat. The levels of c-fos mRNA returned to control levels by 2 hours, while the c-jun mRNA 
'V 
remained elevated up to 6 hours post-injury (Raghupathi et aL, 1995,1996). 
Injury induced by saline infusion into the hippocampus also produced a time-dependent 
expression of intermediate early proteins (ffiPs). Fos, Jun and Krox 24, but not Fos B and Krox 
20 were expressed in non-nerve cells around the wound margin, whereas the proteins Fos and 
Jun are the products oic-fos and c-jun (Gass et al., 1995). Thus, brain injury is associated with 
a differential expression of ffiPs in non-nerve cells around the wound. The fiinctional 
implications ofthis JEP expression after brain injury are presently unclear, but may be related 
to cellular proliferation after brain injury ^ )ragunow and Hughes, 1993). 
Li astrocytes, ffiGs can be induced within minutes by extracellular stimuli including , 
\ 
transmitters, peptides, and growth factors. It has been found that the c-fos gene was up- ； 
.i 
• j. 
regulated in ischemic astrocytes, and that c-fos induction by ischemia was rapid and transient 
(Yu et al., 1995). Moreover, under oxidative stress, it was found that the elevation of c-fos or 
c-jun mRNAs was still pronounced 6 hours after H2O2 treatment in astrocytes OSfaveilhan et al, 
1994). Therefore, both c-fos and c-jun play important roles in astrocytes after brain injury is 
likely related to cell proliferation ^)ragunous and Hughes, 1993). 
1.8.2 ffiGs Expression and Calcium 
It was found that mechanical wounding induced an increase in the concentration of [Ca^ ]^j 
in endothelial cells at the wound edge. The [Ca^^i signal was required for the transcriptional 
activation oftwo ffiGs, c-fos and c-jun, since blocking Ca!+ influx with Gd^ ^ or EGTA reduced 
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ffiGtranscription, while augmenting Ca!+ influx increased ffiGtranscription (Tran etal., 1999). 
Moreover, it was reported that in inflammatory cells the selective induction of c-fos expression 
by H2O2 was markedly decreased by ethylene glycol-bis(P_aminoethyl ether)-N, N, N', N'-
tetraacetic acid OEGTA) ^VIaki et al., 1992). These results support that the [Ca^ ]^i rise and 
transcriptional activation offfiGs are highly dependent. 
The transcriptional activation of the ffiGs also depended on protein kinase C and 
calmodulin-dependent protein kinase since treatment with the PKC inhibitors calphostin C and 
KN-62 significantly reduced JEG expression (Tran et al.’ 1999). 
ffiGs and Ca!+ are found to be important factors in CNS fonctions. Depolarization of 
neurons either in culture or in vivo resulted in the rapid, Ca^^-dependent induction of several 
ffiGs, including c-fos and c-jun. Thus it is proposed that neuronal stimulation, via elevated , 
\ 
[Ca^ ]^i, leads to the induction of a series of genes, some of which encode proteins involved in ； 
I 
transcriptional regulation, that contribute to long-term adaptive and plastic responses (Morgan : 
and Curran, 1989). Moreover, changes in the levels ofNGF transcripts were associated with 
corresponding modifications of the levels of c-jun transcripts, which suggests that the c-jun 
protein exerts a regulatory role on the expression of the NGF gene (Jehan et al., 1995). In 
conclusion, both c-fos and c-jun expression in astrocytes are Ca^^-dependent, and PKC may 
also have close relationship with Ca^^and ffiGs. 
1.9 The Rat C6 Glioma Cells 
The term glioma describes the group of glial neoplasms including astrocytoma, 
glioblastoma, ependynoma, oligodendroglioma and mixed gliomas, such as oligoastrocytoma. 
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Astrocytic gliomas, which contain fibrillary neoplastic cells, are the most common gliomas. 
Glioma cells are particularly easy to grow in tissue culture, thus in unselected material about 
20% of glioblastoma multiform cells can be grown as continuous cell lines OVestermark etaL, 
1973). Although they may not represent in all aspects of glioma or glial cells in vivo, the 
relative ease with which such cell lines can be established has made them widely used as model 
system for studies on the biology of glioma or glial cells. A number of rat brain tumours 
induced by N-nitrosomethylurea and consisting of more or less differentiated astrocyte-like 
cells are found to contain S-100 protein, a characterisitc protein of glial cells. It was shown that 
injection of newbom rats with these cultured tumour cells resulted in a high efficiency of 
tumour formation (Benda et al., 1968). Five morphologically distinct clonal cell strains were 
'! 
established from these tumours, only one contains appreciable amounts of S-100, is the C6 丨 
\ 
glioma cell line (Benda et al., 1968). { 
C6 glioma cells have provided a usefiil model to study glial cell properties, glial factors : 
and sensitivity ofglial cells to various substances and conditions. As a kind of transformed ceU 
line, the growth characteristics of C6 cells are immortal, anchorage independent, loss of 
contact inhibition, high plating efficiency and shorter population doubling time. In addition to 
its homogeneous genetic properties, C6 cells are tumourigenic and angiogenic ^"reshney, 
1984). Moreover, C6 cells express several astrocyte-specific markers such as S-100 protein, 
GFAP and glutamate synthetase (GS). They also express ciliary neurotrophic factor (CNF), an 
enzyme marker for oligodendrocytes (Kempski et al 1992; Vemadakis et al., 1992). 
Additionally, the expression or activity of the above markers in C6 cells could be induced. For 
instance, CNF is induced by neuron-derived factors, whereas GFAP and GS are induced by 
insulin, cAMP, platelet-activating factor, muscle-derived factors, chronic P-receptor activation 
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and R.-4 ^Parker etal, 1980; Brodie and Vernadakis, 1991; Vernadakis etal., 1991;Brodie and 
Goldreich, 1994). Interesting, cytokines are known to be involved in the expression of 
astrocytic and oligodendrocytic prperties expression in C6 cells early passages (Brodie and 
Goldreich, 1994). 
C6 glioma cells have been found to respond to several cytokines like astrocytes. They 
include TNF-a, E^-6, JL-l and y-TFN. The growth and proliferation of C6 glioma cells is 
stimulated by the cytokines mentioned above (Munoz-Femandez et al., 1991; Munoz-
Fernandez and Fresno, 1993). Therefore, C6 glioma cell line represents a good cell model for 
the study ofthe TNF-a-and other cytokines-induced proliferation in astrocytes in vitro. 
1.10 The Aim of This Project 
Cytokines, a group ofregulatory proteins which was found to be mainly secreted by the 
immune system, have been shown to induce immune responses on the cells in the CNS 
OVlorganti-Kossmann et al., 1992). Now, cytokines including TNF-a, JL-l, JL-6 and y-BFN are 
synthesized and secreted by glial cells ofthe CNS, and they initiate their action by binding to 
specific cell-surface receptors (Morganti-Kossmann and Kossmann, 1995). 
Astrocytes, the major glial cells in the CNS, in addition to their well-known fijnctions 
ofcontrolling the environment surrounding nerve cells and supporting the neuronal network, 
have been found to proliferate following brain injury and subsequently to form scars 
(Kimelberg and Norenberg, 1989). Recently, it was found that TNF-a mRNA was 
significantly elevates in injured brain and that anti-TNF-a substances improved the outcome 
ofinjury (Feuerstein et al, 1994;Fane/a/., 1996; Shohamie/a/., 1996; 1997). These, together 
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with the finding that TNF-a was produced largely by astrocytes, suggest a connection between 
the increase ofTNF-a and astrocytes proliferation and possibly scar formation. Additionally, � 
TNF-a was reported to be harmful in the acute phase of brain injury which resulted in 
astrogliosis and then neurodegeneration (Scherbel et al., 1999), therefore, it is important to 
investigate the signal transduction pathways mediating the proliferative effects of TNF-a in 
C6 cells, so as to find out the possible methods to reduce the outcome ofbrain injury. 
As diverse intracellular signalling pathways were found to regulate the expression of 
cytokines by glial cells and the second messenger systems were reported to mediate 
cytokine-induced responses in the CNS, therefore, the intracellular signalling pathways in 
TNF-induced C6 cell proliferation was studied. Ca!+ is a very important second messenger of 
many metabolic processes (Voet and Voet, 1990), such as cell proliferation and gene [ 
.1 
transcription ^Vleans, 1994; Malviya and Rogue, 1998), and that TNF-a was found to induce � 
,!»< 
/« 
an increase in [Ca^^i and depolarized astrocytes (Koller, et al., 1996), together that there was a 3 
> 
massive influx ofCa^^ into the astrocytic cells after brain injury ^lzigalinski et aL, 1997), the 
role ofCa2+in TNF-a-induced C6 cell proliferation was mainly focused. 
Besides Ca�+, PKC was found to be another important signal transduction pathway in 
brain injury. Recent studies showed that PKC-y plays an important role in brain injury 
(Zablocka et al., 1998). Besides brain injury, it was found that some of the PKC isoforms are 
Ca2+-dependent (Selbie et al., 1993; Johannes et cd,, 1994) and both Ca^ ^ and PKC are 
important in regulating metabolic processes and closely-related in transducing signals in 
astrocytes (Sun et a/., 1999; Wu et al, 1999). Therefore, the role ofPKC and its relationship 
with [Ca2+]i in TNF-a-induced C6 cell proliferation were investigated. 
Jn addition, it was found that astrocytes in vitro readily responded to a wide variety of 
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neuronal and systemic signals by inducing a complex pattem offfiGs (Arenander and de Vellis, 
1992). Long-term expression of DEGs, including c-fos and c-jun in glial cells stimulated by 
neuropathological conditions suggested that they might play an important role in the outcome 
ofbrain injury (Arenander and de Vellis, 1992; Dragunow and Hughes, 1993; Raghupathi et 
al., 1995; 1996). Moreover, it was reported that both c-fos and c-jun expression in astrocytes 
are Ca^^-dependent OVlcNaughton and Hunt, 1992)，and PKC may also have close relationship 
with Ca2+and ffiGs (Tran et al., 1999). Therefore, role of c-fos and c-jun the TNF-induced 
signalling pathway and their relationship with Ca!+ and PKC were also examined. 
Jn sum, the aim of my research project is to study the role of Ca!+and PKC in the TNF-
a-inducedC6 cell proliferation. Additionally, the relationship between TNFKX, Ca^^and PKC 
is also investigated with the aim of elucidating and therefore we can trace out the preliminary ! 
\ 
signal transduction pathways mediating the effects of TNF-a in C6 glioma cells. As :i 
'f '/ 
astrogliosis and scar formation is usually preceded by astrocyte proliferation, results obtained ：! 'J .> 
from this study should provide valuable information on the mechanisms mediating scar 
formation which in tum should lead to more effective treatment for brain injury. 
bi this study, rat C6 glioma cells were used because they have many properties similar to 
those ofprimary cultured astrocytes (refer to Section 1.9 for details). 
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CHAPTER 2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Sources of the Chemicals 
The sources of the chemicals used in this study were as shown in the Table 2.1: 
Chemicals Source 
(a) Cell culture 
Rat C6 glioma cells American Type Culture Collection, 
U.S.A. 
— — .丨 
Dulbecco's Modified Eagle medium (DMEM) GibcoBRL, Life Technologies Inc., , 
U.S.A. 丨 
Penicillin, streptomycin and fungizone (PSF) GibcoBRL, Life Technologies Inc., : 
,^  
U.S.A. : / 
Fetal bovine serum (FBS) GibcoBRL, Life Technologies Inc., 
U.S.A. 
Trypsin — GibcoBRL, Life Technologies Inc., 
U.S.A. 
Dulbecco's phosphate-buffered saline GibcoBRL, Life Technologies Inc., 
U.S.A. 
Sodium hydrogen carbonate (NaHCO3) Riedel-de Haen, AG, Germany 
Dimethyl sulfoxide (DMSO) Sigma Chemical Co.，St Louis, MO, 
U.S.A. 
(b) Proliferation assays 
pH]-thymidine (specific activity = 2Ci/mmol) Amersham, U.K. 
Scintillant: 
2,5-diphenyloxazole (P¥0) Sigma Chemical Co., St. Louis，MO, 
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|U.S.A. 
l,4-bis[5-phenyl-2-oxazolyl]-benzene;2,2-p- Sigma Chemical Co.，St. Louis, MO， 
phenylene-bis[5-phenyoxazole] (POPOP) U.S.A. 
� 
Tohiene AnalaR, England 
Triton X-100 Sigma Chemical Co., St. Louis, MO, 
U.S.A. 
3-amino-7-dimethylamino-2-methyl-phenazine Sigma Chemical Co.，St. Louis, MO, 
hydrochloride (neutral red) U.S.A. 
Sodium dodecylsulfate (SDS) Sigma Chemical Co., St. Louis, MO, 
U.S.A. 
Sodium chloride ONaCl) Riedel-de Haen, AG, Germany 
3_[4,5-dimethylthiazol-2-yl]-2,5- Sigma Chemical Co.，St. Louis, MO， 
diphenyltetrazolium bromide; thiazolyl blue U.S.A. 
(MTT) 
i 
Isopropanol BDH Chemicals Ltd., Poole, England ； 
/ 
Hydrochloric acid (HC1) BDH Chemicals Ltd., Poole, England : 
,1 
Sodium carbonate CNa2CO3) Riedei-de Haen, AG，Germany ； ) 
Sodium hydroxide O^aOH) Riedel-de Haen, AG, Germany ‘ 
Sodium-postassium tartrate Riedel-de Haen, AG, Germany 
Folin “ MERCK, Germany 
Bovine serum albumin Sigma Chemical Co.，St. Louis, MO, 
U.S.A. 
(c) Calcium level measurement 
Normal Buffer: 
Sodium chloride QSTaCl) Riedel-de Haen, AG, Germany 
Potassium chloride (KC1) Riedel-de Haen, AG, Germany 
Calcium chloride (CaCl2) Riedel-de Haen, AG, Germany 
Magnesium chloride (MgSO4) Riedel-de Haen, AG, Germany 
Bi-sodium hydrogen phosphate QSTajMPO.) Riedel-de Haen, AG, Germany 
Glucose Riedel-de Haen, AG，Germany 
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Tris Sigma Chemical Co., St. Louis, MO, 
U.S.A. 
"V 
N-[2-hydroxyethyl]piperazine-N-[2- Sigma Chemical Co., St. Louis, MO, 
ethanesulfonic acid] (HEPES) U.S.A. 
Ionomycin Sigma Chemical Co., St. Louis, MO, 
U.S.A. 
Acridine orange Sigma Chemical Co., St. Louis, MO, 
U.S.A. 
Fluo-3, acetoxymethyl ester (Fluo-3/AM) Molecular probes, Eugene, Oregon, 
U.S.A. 丨 
(d) RNA extraction, RT, and PCR 
TRIZOL GibcoBRL, Life Technologies bic., 
U.S.A. 
I' 
Chloroform AnalaR, England ) 
I. 
Isopropanol Promega, U.S.A : 
y 
j 
Ethanol AnalaR, England ; 
Nuclease-free water Promega, U.S.A : 
I. 
lx reaction buffer (lOmM Tris, 50mM KC1, pH Boehringer Mannheim, Germany 
8.3) 
Random primers Boehringer Mannheim, Germany 
dNTP “ Boehringer Mannheim, Germany 
RNase inhibitor Boehringer Mannheim, Germany 
AMV reverse transcriptase Boehringer Mannheim, Germany 
10x PCR buffer (9mM Tris-HCl, 1.35mM Boehringer Mannheim, Germany 
MgCl2, 45mMKCl,pH8.3) 
Magnesium chloride (MgCl2) Boehringer Mannheim, Germany 
Taq polymerase Boehringer Mannheim, Germany 
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Agarose Sigma Chemical Co., St. Louis，MO， 
U.S.A. 
Loading dye: ethidium bromide Bio-Rad, U.S.A. 
bromophenol blue MERCK, Germany 
ethylenediaminetetraacetic acid Sigma Chemical Co., St. Louis, MO， 
(EDTA) U.S.A. 
glycerol Sigma Chemical Co., St. Louis, MO， 
U.S.A. 1 
AmpliSize™ molecular ruler 50-2000bp ladder~"Bio-Rad, U.S.A. 
Tris-borate EDTA (TBE) buffer: 
Boric acid Sigma Chemical Co., St. Louis, MO, 
U.S.A. 




Tris Sigma Chemical Co., St. Louis, MO, ； 
U.S.A. ” 
(e) Drugs treatment : 
？ 
Tumour necrosis factor-a (TNF-a) Boehringer Mannheim, Germany ； 
toerleukin-la (BL-la) Boehringer Mannheim, Germany / 
Interleukin-lp (化-lp) Boehringer Mannheim, Germany 
Interleukin 6 (D^-6) 一 Boehringer Mannheim, Germany 
y-interferon (y-IFN) “ Boehringer Mannheim, Germany 
A23187 Sigma Chemical Co., St. Louis, MO, 
U.S.A. 
Verapamil ~ Sigma Chemical Co., St. Louis, MO, 
U.S.A. 
Thapsigargin — Molecular probes, Eugene, Oregon, 
U.S.A. 
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Phorbol 12-myristate 13-acetate (PMA) |Sigma Chemical Co., St. Louis, MO， 
U.S.A. 
3- {l-[3-(amidinothio)propyl]-3-indolyl)-4-( 1 - Roche Products Ltd.，U.K. 
methyl-3-indolyl)-lH-pyrrole-2,5-dione 
methanesulfonate (Ro31-8220) 
Anti-TNF-Rl antibody (goat polyclonal IgG) Santa-Cruz Biotechnology, U.S.A. 




Table 2.1 The chemicals used in this study and their sources ：| 
2.1.2 Materials Preparation 
I 




Rat C6 glioma cells were obtained from the American Type Culture Collection GJ.S.A.) ) 
> 
/ 
as mentioned in Table 2.1. They were originally cloned from a rat glial tumour induced by N-
nitrosomethylurea by Benda et al (1968) after a series of alternate culture and animal 
passages. 
2.1.2.2 C6 Glioma Cell Culture 
2.1.2.2.1 Complete Dulbecco's Modified Eagle Medium (CDMEM) 
Dulbecco's Modified Eagle medium ODMEM) with high glucose and L-glutamine was 
purchased from Gibco Lab. (U.S.A.) as mentioned in Table 2.1. The powdered DMEM, 
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together with 3.7g sodium bicarbonate O^aHCO3) and 4.76g HEPES were dissolved in 1 liter 
of NANOpure™ water. The medium was adjusted to pH 7.2 and filtered through a 
presterilized vacuum 0.22^im filter (Millipore, Massachusetts) immediately under suction. 
Then, fetal bovine serum (FBS, Gibco, U.S.A.) and antibiotics (penicillin 10,000U/ml; 
streptomycin 10,000^ig/ml; fungizone 25M.g/ml, Gibco, U.S.A.) were added, the complete 
DMEM (CDMEM) obtained contains 10% (v/v) FBS and lOOU/ml penicillin, lOO i^g/ml 
streptomycin and 0.25^ig/ml fungizone. This medium was stored at 4°C until use. 
2.1.2.2.2 Serum-free Dulbecco's Modified Eagle Medium 
The preparation of serum-free DMEM is the same as that of CDMEM except fetal (. 
,'l 
bovine serum was not added to the medium. Therefore, the serum-free DMEM contains ; •1 ： > 
1: 
DMEM, lOOU/ml penicillin, lOO i^g/ml streptomycin and 0.25^ig/ml fungizone. This medium | 
>1 
i'' 
was also stored at 4®C until use. ''' 
2.1.2.3 Phosphate Buffered Saline (PBS) 
Phosphate-buffered saline (PBS) was prepared by dissolving a pack of powdered 
Dulbecco's PBS (Gibco, U.S.A.) in 1 liter of NANOpure™ water and the pH ofPBS was 
adjusted to 7.4 then autoclaved. The autoclaved PBS was stored at 4�C until use. 
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2.1.2.4 Recombinant Cytokines 
Recombinant mouse tumour necrosis factor-a (TNF-a, specific activity: 6xl0^ U/mg), 
mouse interleukin-la (D^-loc，specific activity: 5xlO^ U/mg), mouse interleukin-ip (DL-ip, 
specific activity: 5xlO^U/mg), mouse interleukin-6 (TL-6, specific activity: lxlO^U/mg) and 
mouse y-interferon (y-ffN, specific activity: lxlO^ U/ml) were all produced in E. coli and 
purchased from Boehringer Mannheim Biochemica (Germany) as mentioned in Table 2.1. 













Antibody against TNF-receptor 1 (TNF-R1) (200^ig/ml, Santa Cmz Biotechnology, Inc., j 
,f 
U.S.A.) was affinity-purified goat polyclonal antibody raised against a peptide corresponding 
to amino acids 26 to 45 mapping at the amino terminus of the TNF-R1 precursor of mouse 
origin. According to the manufacturer, this antibody only reacts with TNF-R1 of mouse and 
rat origin by Westem blotting and immunohistochemistry and is non-reactive with TNF-R2. 
This antibody was stored at 4°C until use. 
2.1.2.5.2 Anti-TNF-Receptor 2 (TNF-R2) Antibody 
Antibody against TNF-receptor 2 (TNF-R2) (200 i^gAnl，Santa Cruz Biotechnology, Inc., 
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U.S.A.) was affinity-purified goat polyclonal antibody raised against a peptide corresponding 
to amino acids 442 to 461 mapping at the carboxy terminus of the TNF-R2 precursor of 
mouse origin. According to the manufacturer, this antibody only reacts with TNF-R2 of 
mouse and rat origin by Westem blotting and immunohistochemistry and is non-reactive with 
TNF-R1. This antibody was stored at 4°C until use. 
2.1.2.6 Chemicals for Signal Transduction Study 
, 
2.1.2.6.1 Calcium Ionophore and Calcium Channel Blocker 
t 
Calcium L-channel blocker, verapamil (Sigma，U.S.A.) was dissolved in 75% ethanol at 丨 
\ 
40mM and stored at -20�C before use, while calcium ionophore, A23187 (Sigma, U.S.A.) J 
•'] 
was dissolved in 75% ethanol at lmg/ml and stored at -20°C before use. Since both of them f 
'^1 / 
are light sensitive, experiments were carried out in the dark and the culture plates were \: 
wrapped with aluminum foil 
2.1.2.6.2 Calcium-Inducing Agents 
Thapsigargin (Molecular Probes, U.S.A.) is a sesquiterpene lactone originally isolated 
from the umbrelliferous plant Thapsia gargancia (Christensen and Nomp, 1985). It acts as an 
irreversible inhibitor of the Ca^-ATPase in the endoplasmic reticulum (ER Ca^^-ATPase) 
(Lytton et a/.，1991; Thastrup et al., 1990) and therefore，Ca^^can no longer be retumed from 
the cytosol to the ER which led to a prolonged rise in [Ca^ ]^i (Vercesi et aL，1996). For 
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preparation, thapsigargin was dissolved in DMSO at 5mM and stored at -20�C until use. 
Another Ca^^-inducing agent, thimerosal (sodium ethylmercurithio-salicylate; mercury-
[(o-carboxyphenyl)thio]ethyl sodium salt) (Sigma, U.S.A.), was also used. Thimerosal, a 
thiol-reactive reagent, has been shown to increase the cytosolic Ca^^concentration in a variety 
of cells (Michelangeli etal., 1995) by sensitizing TP^ receptors (Berridge, 1991). Thimerosal 
was dissolved in CDMEM at 500^M and stored at room temperature. 
2.1.2.6.3 Modulators ofProtein Kinase C OPKC) 
Protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate ^PMA, Sigma, 
U.S.A.) was dissolved in 75% ethanol at 5mg/ml and stored at -20°C until use. On the other 
hand, PKC inhibitor, 3 - {l-[3 -(Amidinothio)propyl]-3 -indolyl} -4-( 1 -methyl-3 -indolyl)-1H-
pyrrole-2,5-dione methanesulfonate (Ro31-8220, Roche Products Ltd., U.K.), was dissolved 
in DMSO at concentration 100|jM and it was stored at -20°C before use. 
2.1.2.7 Reagents for Cell Proliferation Assays 
Scintillant was prepared by dissolving 20g 2,5-diphenyloxazole (PPO) and 2g l,4-bis[5-
K 
phenyl-2-oxazolyl]-benzene;2,2-p-phenylene-bis[5-phenyoxazole] (POPOP) in 3.77L 
toluene and 1.33L triton X-100 and the mixture was stirred ovemight for pH]-thymidine 
incorporation assay. Normal saline was made by dissolving sodium chloride in double-
distilled water at 0.9% (w/v) and neutral red solution was obtained by dissolving neutral red 
in normal saline at 0.5% (w/v) for neutral red assay. For MTT assay, 3-[4,5-dimethylthiazol-
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2-yl]-2,5-diphenyltetrazolium bromide (MTT) solution prepared by dissolving MTT (Sigma, 
U.S.A.) in PBS at 5mg/ml, the solution was then filtered and stored in dark. Acidified 
-� 
isopropanol was made by adding 0.83ml hydrochloric acid into 200ml isopropanol. For 
protein assay，buffer A was prepared by mixing lOmM Tris (pR 7.5, Sigma，U.S.A.) and 
0.lmM EDTA (Sigma, U.S.A.) with Triton X-100 (Sigma, U.S.A.). Reagent A was prepared 
by mixing 190mM Na^COg (Riedel-deHaen, Germany), 100mM NaOH ORiedel-deHaen, 
Germany), 6mM sodium-potassium tartrate (Riedel-deHaen, Germany) in 3L H2O, while 
reagent B was made by mixing 50% folin (MERCK, Germany) with 50% distilled water. Jn 
addition, bovine serum albumin (BSA) was dissolved in distilled water at lmg/ml and stored 
at 4 T until use. 
2.1.2.8 Reagents for Calcium Level Measurement 
The content of the Na+-HEPES normal bathing buffer is as follow: NaCl (130mM, 
Riedel-deHaen, Germany), KC1 (5mM, Riedel-deHaen, Germany)，CaCl2 (lmM, Riedel-
s 
deHaen, Germany), MgS04 (lmM, Riedel-deHaen, Germany), Na2HPO4 (1.2mM, Riedel-
deHaen, Germany), 0.6% glucose (Riedel-deHaen, Germany), and Tris-HEPES (lOmM, pH 
7.4). The stock of Tris-HEPES was prepared by titrating 200mM HEPES (Sigma, U.S.A.) 
with lM Tris-base (Sigma，U.S.A.) to pH 7.4. For fluo-3/AM, it was dissolved in dehydrated 
DMSO [molecular sieves (Sigma, U.S.A.) were used to absorb water in DMSO] at 5mM and 
stored at 4�C. Acridine orange (Sigma，U.S.A.) was dissolved in dehydrated DMSO at 
250nM and stored at 4�C. Additionally, ionomycin (Sigma, U.S.A.) was dissolved in distilled 
^ 
I water at 4mg/ml and stored at -70°C until use. 
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2.1.2.9 Reagents for RNA Extraction and Reverse Transcription-Polymerase Chain Reaction 
�ORT-PCR) 
Reagents used in RNA extraction were mentioned in Table 2.1. TRIZOL (Gibco, U.S.A.) 
and isopropenol (Promega, U.S.A.) were stored at 4�C, while chloroform (AnalaR, England) 
and ethanol (AnalaR, England) were stored at room temperature For RT-PCR, 
Deoxynucleotide mix (dNTP) was made by mixing lOmM ofdATP, dCTP, dGTP, and dTTP 
together, forming lOmM of dNTP. lx reaction buffer for RT contained lOmM Tris and 
50mM KC1 with pH 8.3, while 10x PCR buffer for PCR contained 9mM Tris-HCl, 1.35mM 
MgCl2 and 45mM KCl with pH 8.3. Other reagents for RT-PCR include AMV reverse 
transcriptase (25U/^il), RNase inhibitor (50U/^il), random primer p(dN)g (2^ig/ml), Taq DNA 
polymerase (produced in E. coIi, 5U/M<1) and magnesium cholride (25mM), they were all 
purchased from Boehringer Mannheim (Germany) as mentioned in Table 2.1. Sense and 
antisense used in PCR were obtained from Gibco (Hong Kong) as mentioned in 1.1.2.10. 
2.1.2.10 Sense and Antisense Used 
PCR amplification of cDNA was performed using specific primers. Sense and antisense 
ofthe primers were designed using information obtained from GenBank Sequence Database， 
or searched from relevant papers. All primers were synthesized by Gibco, Hong Kong. Table 
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cDNA Primer sequences (5-3') Nucleotide AmpUed Sources 
amplified position PCR 
fragment size 
m 
p-actin Sense strand: 2166-2185 
TGAGACCTTCAACACCCCAG 201 Nudel et al., 1983 
Antisense strand 2343-2366 
TTCATGAGGTAGTCTGTCAGGTCC 
CaSR Sense strand: 1909-1933 
TTCCGCAACACACCCATTGTCAAGG 816 MasiQioetal, 1999 
Antisense strand: 2700-2724 
GGATCCCGTGGAGCCTCCAAGGCTG 
PKC x^ Sense strand: 875-895 
TGAAACCCTCAGTGCAATGAAGT 325 Krizbaie/a/., 1995 
Antisense strand 1179-1199 
GGCTGCTTCCTGTCrrCTGAA 
PBX"5 Sense strand: 1013-1033 
CACCATCTTCCAAGAAAGAACG 352 Krizbai et al, 1995 
Antisense strand: 1343-1364 
CTTGCCATAGGTCGCGTTGTrG 
PKC^ Sense strand: 577-598 732 
CATCGATCTCTCGGGATCATCG Krizbaie/^/., 1995 
Antisense strand 1288-1308 
CGGTTGTCAAATGACAAGGCC ^ 
PKC-y Sense strand: 1805-1825 
TTGATGGGGAAGATGAGGAGG 347 Davidson et al., 1995 
Antisense strand: 2130-2151 
GAAATCAGCTTGGTCGATGCTG 
PKC-T] Sense strand: 831-851 
GGATAATGCGACAAGGACrrC 238 Knzhaietal., 1995 
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PKC< Sense strand: 617-639 
CGATGGGGTGGATGGGATCAAAA 681 Krizbai et al., 1995 
Antisense strand: 1276-1297 
、 CTATTCATGTCAGGGTTGTCTG 
c-fos Sense strand: 743-762 
CTGCAAGATCCCCAATGACC 273 Schafereta/., 1996 
Antisense strand 996-1015 
AGGTCCACATCTGGCACAGA 
c-jun Sense strand: 1248-1260 
GCTTCTCTCTAGTGCTCCGTAA 427 SchafereM/.，1996 
Antisense strand: 1653-1674 
CAACCAGACGGGAGGGACTA 
TNF-R1 Sense strand: 415435 
ACCAAGTGCCACAAAGGAACC 322 ffimmere/a/., 1990 
Antisense strand: 714-736 
TACACACGGTGTTCTGTTTCTCC 
TNF-R2 Sense strand: 2-22 
ATGAGAAATCCCAGGATGCAGTAGGC 252 BaderandNettesheim, 
Antisense strand: 232-253 1996 
ACAGACGTTCACGATGCAGGTG 
TNF"Ot Sense strand: 171-192 
TCCCAACAAGGAGGAGAAATT 411 Kwon et al., 1993 
Antisense strand 560-581 
TCATACCAGGGCTTGAGCTCAG 
m-la Sense strand: 759-783 
CTAAGAACTACTTCACATCCGCAGC 632 Rohde et al, 1997 
Antisense strand: 1357-1381 
CTGGAATAAAACCCACTGAGGTAGG 
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2.1.2.11 Reagents for Electrophoresis 
rOx DNA loading buffer contained 30% (v/v) glycerol, 0.25% (w/v) bromophenol blue 
and 60mM EDTA (pH 8.5). 10x Tris-boric-EDTA (TBE) buffer was prepared by dissolving 
108g Tris base，55g boric acid and 7.44g EDTA in lL double-distilled water, and the pH was 
adjusted to 8.3. DNA ladder was from Bio Rad QJ S A.). 
2.2 Methods 
2.2.1 Maintenance of the C6 Cell Line 
Rat C6 glioma cells were obtained from American Type Culture Collection (U.S.A.). 
They were cultured, under aseptic conditions, in CDMEM at 37�C in a humidified incubator 
(Shel-Lab, Model 2400，Sheldon Manufacturing，Inc.) under an atmosphere of 5% COJ 95% 
air. 
The cells were subcultured for 3-4 days in culture, at which time they had reached 
confluence. For the subculture procedure, the medium was discarded in the culture flask 
(Coming Laboratory Sciences Company, U.S.A.), and cells were washed with sterilized 
phosphate buffer saline (pH 7.4, Gibco). The cells were treated with 1ml of 0.25% trypsin 
(Gibco) at 3TC for 3-4 minutes. Then lOmI ofCDMEM was added to the culture flask and 
then the medium and cell mixture was transferred to a 50ml tube ^"alcon), and the cells were 
spinned down in a desktop centrifiige (Beckman) at 1000rpm for 3 minutes. Then, the 
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by repeated pipetting. Then，the cells were resuspended with CDMEM, they were adjusted to 
a cell density of 10^  cell/ml and fixrther cultured in a 75cm^ culture flask (Coming Laboratory 
Sciendes Company，U.S.A.) containing 20ml DMEM. 
For long-term storage, 1ml of cells (10^ cells) was suspended in 10% FBS containing 5% 
dimethyl sulfoxide (DMSO, Sigma，U.S.A.) and stored in liquid nitrogen in plastic ampoules 
^Sfunc., Denmark). When required，aliquots were thawed rapidly in CDMEM at 37�C, 
subcultured and cells of passages 6-28 were used in this study. To ensure the purity of the 
cell line, cells were checked regularly for contamination under a microscope. 
2.2.2 Cell Preparation for Assays 
Cells of passages 6-28 were trypsinized, centrifuged and resuspended in CDMEM 
medium or other media depending on the assay procedures and counted using a 
hemacytometer under a light microscope. For assays using 96-well microtiter plates (Coming 
Laboratory Sciences Company, U.S.A.), 5xlO^ cells/well were seeded in DMEM ovemight, 
followed by the addition ofFBS on the day after, and appropriate concentrations of dmg(s) 
was (were) added at various times as indicated in the text. For assays using 6-well plates 
(Coming Laboratory Sciences Company, U.S.A.) or 35mm culture dishes (Coming 
Laboratory Sciences Company, U.S.A.)，lxlO^ cells/well (dish) were seeded in CDMEM 
ovemight, and then appropriate drug(s) was (were) added after the cells have been adhered to 
the bottom of the well. For assays using 60mm culture dishes (Coming Laboratory Sciences 
Company, U.S.A.), 5xlO^ cells/dish were seeded in DMEM overnight, followed by the 
I addition ofFBS on the day after，and appropriate concentrations of drug(s) was (were) added 
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at various times as indicated. For assays using 100mm dishes (Coming Laboratory Sciences 
Company, U.S.A.), 6xl0^ cell/dish were seeded with CDMEM overnight，and then 
appropriate drug(s) was (were) added after the cells have been adhered to the bottom of the 
dish. 
2.2.3 Determination of Cell Proliferation 
All cell proliferation procedures were performed under aseptic conditions in a cell 
culture hood (Biograd hood. Baker Company, Inc.). 
2.2.3.1 Determination ofCell Proliferation by [^-Thymidine Incorporation 
Rat C6 glioma cells were seeded in 96 well-plate, as described in Section 2.2.2. To study 
the effects of TNF-a and/or other drugs on C6 cell proliferation, cells were incubated in the 
presence，or absence ofTNF-oAirugs for various times, then，0.5^Ci [3H]-thymidine (specific 
activity: 2Ci/mmol; Amersham, U.K.) was added to each well and further incubated for 6 
hours to estimate the incorporation of [3H]-thymidine into DNA. At the end of incubation, 
plates were put in a freezer (-20�C) ovemight then thawed and cell debris and DNA were 
harvested with a semi-automatic cell harvester (Flow Lab, U.K.). The radioactivity trapped 
by glass-fiber filters (GF/B, Whatman, U.S.A.) were then dissolved in scintillant. The 
radioactivity of each filter was determined with a liquid scintillation counter OBeckman, 
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2.2.3.2 Measurement of Cell Viability Using Neutral Red Assay 
•� 
To test for the viability of cells following TNF-a and/or drug treatment, cells were 
plated in a 96-well microtiter plate as described in section 2.2.2. After 48 hours of incubation 
with or without drug(s) treatment, the medium was removed, and the wells were washed with 
150 i^l normal saline (0.9%NaCl) followed by the addition of 50 i^l neutral red solution (0.5% 
neutral red in normal saline). Then, the cells were incubated with 0.5% neutral red solution 
(lOO i^l per well) at 37�C, 5% CO2 for one hour. After washing six times with normal saline, 
lOOpil of 1% sodium dodecylsulfate (SDS, Sigma) was added to each well to solublize the 
cells and to release the neutral red. The plate was shaken in a plate shaker (Lab-Line 
Instruments Inc., U.S.A.) for 2 hours and the optical density (OD) at wavelength (入）540nm 
was determined with a microplate reader (Bio-Rad, Model 3550, U.S.A.). 
2.2.3.3 Measurement ofCell Proliferation by MTT Assay 
The procedure of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; 
thiazolyl blue (MTT) assay is similar to that of neutral red assay. Briefly, C6 cells seeded in a 
96-well plate (O.lml cells per well) were treated with various concentrations of TNF-a with 
or without other drugs for various times. After 48 hours incubation, 30 i^l MTT (Sigma, 
U.S.A.) was added per well. Cells were further incubated at for 2 hours, then the MTT 
solution was discarded by suction, and 0.04N HC1 acidified isopropanol (lOO^il/well) was 
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15 minutes to release the dye from cells and the absorbance at A,=540nm was determined 
with a microplate reader (Bio-Rad，Model 3550, U.S.A.). Acidified isopropanol was used as 
a blan3c. 
2.2.3.4 Protein Assay 
C6 cells were seeded and cultured on 100ml tissue culture dishes in CDMEM medium 
ovemight and then treated with different dosages of TNF-a for 48 hours，and cells were 
harvested. The medium was removed by suction, and cells were washed twice with 5ml PBS 
(Gibco. U.S.A.). After that, 0.8 ml PBS was added to each dish, and cells were scrapped 
using a cell scraper (Costar, U.S.A.). The above step was repeated once to scrap the cells 
from the dish completely. The cell suspension was pipetted to 15ml Falcon tube (Falcon), 
and then they were centrifuged at 2500rpm for 10 minutes at 4°C. The supernatant was 
removed, and 500^1 buffer A was added to each tube. The cells were then sonicated with a 
sonicator (Heat Systems-Uhrasonic) at a setting 5 thrice each for 10 seconds, and they were 
stored at -80�C ovemight. To measure the protein content in each sample, to 50 i^l diluted 
sample (15 .^1 sample + 35[il dH2O) or 50 i^l BSA, 2.5ml of Reagent A were added. The 
mixture was mixed and left at room temperature for 10 minutes, then 0.25 ml Reagent B was 
added to each tube. The tubes were left at room temperature for 0.5 hour and the absorbance 
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2.2.3.5 Data Analysis 
2.2.3.5.1 The Measurement of Cell Proliferation by [^]-Thymidine Incorporation 
The cytokine- or drug-induced C6 cell proliferation was expressed as % stimulation of 
the control and calculated according to the equation below: 
% Stimulation = 100 x (CPM a^ted_ CPM ,o^oi)/CPM��_! 
*where GPMt^^d is the radioactivity in CPM (counts per minute) in the cytokine- or drug-
treated samples and CPM ⑶咖！ in the untreated samples. 
2.2.3.5.2 The Measurement ofCell growth in Neutral Red and MTT Assays 
The measurement of cell growth in Neutral Red and MTT assays were expressed as % 
stimulation of the control according to the formula below: 
% Stimulation = 100 x (OD _ 秘 - O D contn>i)/OD ⑵ 血 。 ！ 
2.2.3.5.3 The Measurement ofCell Proliferation in Protein Assay 
The yield of protein was obtained by measuring the corresponding OD from the 
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to the formula below: 
� % Stimulation = 100 x ([protein] ^^ eatef [protein] controi)/[protein]咖加！ 
All results were expressed as the arithmetic mean 土 standard error of 
triplicate/quadruplicate determinations. The data shown were representative of at least 2-3 
separate experiments with similar results. The Students "t" test was used to determine the 
confidence limits and a value of p < 0.05 was regarded as a significantly difference. 
2.2.4 Determination of Intracellular Calcium Changes 
Calcium is a very important intracellular ion. It plays a vital role in the transduction of 
signals from the cell membrane to the cell cytoplasm and a change in intracellular calcium 
levels is a good indication that the cell is responding to a stimulus (Finkbeiner, 1993; 
Kostyuk and Verkhratsky, 1995; Carmignoto et al., 1998). Many stimuli can cause 
mobilization of calcium either as an influx from the extracellular medium or release of 
intracellular stores (Means, 1994). By using fluorescent dyes this mobilization can be 
monitored. 
2.2.4.1 Confocal Microscopy 
Confocal laser scanning microscopy (CLSM) allows 3-D measurement of biological 
structures 碰 little blur and high spatial contrast (Schild, 1996, Lichtman, 1994). 
80 
5 





Chapter 2 Materials and Methods 
2.2.4.1.1 Procedures for Detecting Cell Activity by CLSM 
� 
C6 Cells were seeded on a round cover slip inside 35mm culture dish. The cell density 
used was mentioned in 2.2.2. The cells were seeded in the culture dishes with round cover 
slips in CDMEM medium and incubated at 37®C under an atmosphere of 5% CO2 and air for 
2 days. For confocal microscopic studies, the cover slip was removed from the culture dish 
and mounted on a home-made holder and washed twice with Na+-HEPES buffer before 
loaded with fluo-3/AM (final concentration: lO[xM, Molecular Probes, USA) at room 
temperature for 1 hour. After loading, cells were washed twice with Na+-HEPES bufFer and 
incubated in the same buffer with or without TNF-a and/or drugs as described by Lui et al 
(1997). At various time intervals, x-y images of cells were acquired on a system of CLSM 
(Multiprobe 2001, Molecular Dynamics, U.S.A.)，or InSight Plus，^Vleridian, Miss.，USA) 
that fitted with an argon laser (6mW at excitation for CLSM-MD, 5mW at excitation for 
Meridian) and Nikon diaphot inverted microscope. For fluorescence determination by 
CLSM-MD, an excitation with 488nm wavelength and a long-pass emission filter of510nm 
were used. For CLSM-Meridian, an excitation filter with 488nm wavelength and a clear filter 
were used. C6 Cells were scanned by using a 60X O J^ikon, PlanApo) or 100X (Nikon，Fluor) 
oil objectives with low-fluorescence immersion oil (r\ ^"^1.515, Stephens Scientifics, USA). 
The voltage of the photomultiplier tube was set at optimum. Images and fluorescence 
intensities were processed and averaged by an image analysis software (Imagespace 3.1 for 
CLSM-MD, or Insight IQ Master Program ver. 1.12 for CLSM-Meridian). In the pseudo-
color images, cool and warm colors indicate lower and higher fluorescence intensity 
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respectively. At the end of the experiment, ionomycin (Sigma，U.S.A.) was added to monitor 
the viability of cells while acridine orange (Sigma, U.S.A.) was used to locate the nuclear. 
• � 
2.2.4.1.2 Precautions ofCLSM 
It is better to perform dye loading at room temperature although higher temperature 
during dye loading can enhance the conversion of acetoxymethylester (AM) form of the dye 
to the non-AM form as this has been reported to enhance indicator compartmentation, 
especially in the mitochondria (Di Virgilio et aL, 1990). Alternatively, cells under study 
should be placed for 20-30 minutes at room temperature to allow sufficient time for the 
conversion to occur. Moreover, the cells should first be illuminated until fluorescence has 
reached a stable level, indicating that the unhydrolyzed dye has been exhausted，before 
beginning the experiment. Care should also be taken to prevent photobleaching caused by 
overstrong excitation. 
It is also necessary to make sure that the DMSO for the preparation of fluorescent probe 
is dry. This has significant bearing on experimental accuracy as typically DMSO can absorb 
as much as 30% (v/v) H2O in a very humid environment. Water-contained DMSO has been 
reported to decrease the solubility of the fluorescence indicator. These insoluble dyes, after 
endocytosed, would give rise to bright spots with overall diminished fluorescence inside the 
cell. The hot spots could saturate the detector and the wide range of fluorescence intensity 
created difficulties in data acquisition and image analysis including, for example，background 
subtraction. Moreover, the artifact hot spots might be misintetpreted and masked genuine 
local responses (Lee et al., 1996). To prepare by DMSO as indicator solvent，molecular 
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sieves (Sigma, U.S.A.) were first prepared by leaving the particles in an oven at 150�C 
ovemight. DMSO from the supplier was then incubated with the dry molecular sieve in air-
tight bbttle for at least 2 hours. 
2.2.5 Determination of Gene Expression by RT-PCR 
2.2.5.1 RNAPreparation 
2.2.5.1.1 RNAExtraction 
C6 Cells were seeded on 60mm culture dishes and cultured with or without TNF-
a and/or drugs as mentioned in 2.2.2. All RNA extraction procedures were done at 4�C. Cells 
were washed twice with 3ml ice-cold PBS and 1ml of TR][zoL reagent was added to each 
dish. After 5 minutes，cells were scrapped off using a cell scrapper and transferred to an 
Eppendorf tube, then pipetted up and down several times to ensure the release of RNA. 
Afterwards, 0.2ml of chloroform was added to each tube and followed by vortexing for 15 
seconds. The tubes were allowed to stand at room temperature for 3 minutes，and then 
centrifiiged at ll,900xg for 15 minutes at 4°C. The supernatant was removed and 0.5ml 
isopropanol was added，the solution was then vortexed thoroughly. The tubes were put into a 
freezer (-20T) ovemight to allow the RNA to precipitate. Then, the tubes were centrifiiged 
at 1 l,900xg for 15 minutes at 4°C, and the pellet in each tube was washed with 1ml 75% 
ethanol and centrifuged at 7,500xg at 4�C for 5 minutes. The RNA pellet was resuspended in 
30^il nuclease-free water and kept at -70°C until use. 
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2.2.5.1.2 Measurement ofRNA Yield 
� 
An aliquot of 4^il RNA was mixed with 996|il H2O, and the absorbance at wavelength 
260nm (Ajgo) was measured to determine the concentration ofRNA. The purity is determined 
by calculating the ratio of the absorbance at wavelength 260nm to that at wavelength 280nm 
(A260/A280). The yield and purity ofRNA were calculated by the following equations: 
Yield =A^^n X 40 i^g/^ il Purity = PhJki%u 
(4/1000)Xl0^ 
All RNA samples were adjusted to 0.5pig/^il, and this RNA concentration was used for 
the reverse transcription (RT) reaction. 
2.2.5.2 Reverse Transcription (RT) 
For RT reaction, 0.5(_ig RNA in nuclease-free water was added to a solution, pH 8.3 
containing lOmM Tris, 50mM KC1, 5mM MgCl2, 3.2[ig random primers, lmM dNTP, 
RNase inhibitor (50U) and AMV reverse transcriptase (20U) in a final volume of lO i^l. After 
thorough mixing, RT reaction was performed with a thermocycle polymerase chain reaction 
(PCR) machine (GeneAmp PCR System 9700, Perkin Elmer，U.S.A.). The conditions were 
25�C for 10 minutes, 42�C for 1 hour, afterwards, the temperature was risen to 99�C for 5 
minutes, and then kept in 4�C for 5 minutes. At the end of the RT reaction, the cDNA formed 
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was either stored in a freezer until use or PCR reaction was carried out immediately. 
2.2.5.3�Pdymerase Chain Reaction (PCR) 
The cDNA obtained from RT reaction was first undergone 2-fold dilution before the 
PCR. For PCR, 2.5^il cDNA was mixed with 1.375^il PCR buffer, 1.375mM MgC^，200^lM 
dNTP, Besides, 250nM of the corresponding sense and antisense primers (Section 2.1.2.10)， 
and 0.625U Taq polymerase in a final volume of 25|iL After thorough mixing with a vortex, 
reaction was carried out in a PCR machine (GeneAmp PCR System 9700，Perkin Elmer, 
U.S.A.). The conditions were 94�C for 5 minutes, which was followed by 30 cycles (35 
cycles for endogenous TNF-a) o f94�C for 30 seconds，59�C for 1 minute 15 seconds (6VC 
for 1 minute for endogenous TNF-a), and 72�C for 1 minute. After the above steps, the tubes 
were maintained at 72°C for 5 more minutes, and the products were stored in a freezer until 
agarose gel electrophoresis. 
2.2.5.4 Separation ofPCR Products by Agarose Gel Electrophoresis 
2% Agarose gel was used to separate the PCR products. The electrophoretic procedures 
were the same as described by Gangeswaran and Jones (1997). Briefly, 50 i^l PCR product 
together with 1.3 i^l DNA loading buffer were added to each well and electrophoresis was 
carried out at 100V for 30 minutes. At the end of electrophoresis, the gel was stained with 
ethidium bromide (Bio Rad, U.S.A.), washed and transferred to a UV box to visualize the 
cDNA bands and photographed with using a GelCam camera ^>olaroid, U.K.). 
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2.2.5.5 Quantification ofBand Density 
Band density of the PCR product was quantified by densitometry using the program 
ImageQuant by Molecular Dynamics. Density of the band from the target gene being 
analyzed was first normalized by the corresponding band from P-actin gene, then the 
normalized value of the treated sample was divided by the normalized value of the control in 
the same set of treatment to obtain a relative density value. The higher the densitometry value 
suggested the higher the expression of gene was. 
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CHAPTER 3 RESULTS 
3.1 Effects of Different Drugs on C6 Cell Proliferation 
� 
Evidence accumulated shows that after brain injury, astrocytes proliferate and 
astrogliosis often occurs. Since many studies showed that TNF-a and other cytokines like 
n^-l, y-BFN, n_,-6 were found in glial scars O^an et al., 1991; Feuerstein et al., 1994; 
Rostworowski etaL, 1997; Hans etal., 1999), Ca^ +, a divalent cationthat knownto mediate 
many cellular processes, including proliferation and cell death (Means，1994); and PKC, 
which has been shown to mediate astrocyte proliferation (Wilson et al‘, 1994), therefore, 
the effects of TNF-a, Ca】+，PKC and also other cytokines on C6 proliferation were first 
examined. C6 Cells were chosen as a model as they behave very much like astrocytes. Five 
different types of methods were used to measure the C6 cell proliferation after cytokines 
treatment, and they included pH] thymidine incorporation assay, neutral red assay, MTT 
assay, protein assay, and cell cycle measurement. 
3.1.1 Effects ofCytokines on C6 Cell Proliferation 
Since cytokines play an important role in the communication between cells of the 
immune and nervous systems and among cells of the nervous system, it is of interest to 
study their effects on astrocytes, the most abundant cell type found in the CNS (Benveniste, 
1992; Martin et aL, 1992; Martin & Tracey, 1992). hi addition, astrocytes have been 
reported to express a number of cytokines and their respective receptors which are known 
to be important in regulating the proliferation and differentiation of astrocytes (Benveniste, 
1992). Like astrocytes, C6 glioma cells also respond to a large number of cytokines, 
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including TNF-a, y-HT I^, D -^1 and D^-6 fMunoz-Femandez & Fresno，1993; Simmons & 
Murphy, 1992; 1993). Thus, they represent a good model system for studying the 
conditions and factors which regulate the development and differentiation of glial cells and 
•� 
the signalling pathways that might be involved in these processes (Mangoura et “/., 1989). 
In this thesis project, the effects of various cytokines in triggering C6 cells proliferation 
were first examined, since many studies showed that cytokines are closely related to 
astrogliosis (Giulian and Lachman, 1985; Hertz etal., 1990; Selmaj etaL，1990). Inthe first 
set of experiments, C6 glioma cells were treated with different dosages of TNF-a for 
various times to investigate the optimal proliferative effect ofTNF-a on C6 glioma cells. Jn 
the second part of the experiments, C6 cells were treated with different cytokines, such as 
TNF-a, DL-la, D^-lp, EL-6 and y-WN to examine the selectivity, if any，of these cytokines. 
These cytokines were chosen because most of them are found in the injury site. 
3.1.1.1 Effects of TNF-a on C6 Cells Proliferation 
Li this study, C6 glioma cells were treated with various concentrations ofTNF-a for 
different time intervals, and [^B] thymidine incorporation assay as well as protein assay 
were used to determine cell proliferation. Figures 3.1 and 3.2 demonstrate that C6 cell 
proliferation is TNF-a dosage-dependent. C6 cells were treated with various 
concentrations ofTNF-a for 48 hours. The C6 cell proliferation increased when the TNF-
a concentration increased and the proliferation reached a maximal with lOOU/ml TNF-a. 
The C6 cell proliferation reduced when the TNF-a concentration increased to higher than 
500U/ml. Neutral red assay was used to determine the C6 cell proliferation upon exposure 
to lOOU/ml TNF-a for various times. lOOU/ml TNF-a was chosen as it showed the highest 
proliferative effect in the thymidine incorporation assay. Figure 3.3 shows that C6 
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Figure 3.1 Effect ofvarious concentrations ofTNF-a on C6 glioma cell proliferation. C6 
Cells (density: 5^10^ cells/well) were treated with various concentrations of TNF-a (10, 50, 
100 or 500U/ml) at 37°C under the atmosphere of 5% CO2for 48 hours. Cell proliferation was 
measured by 阳]thymidine incorporation assay as described in Section 2.2.3.1. Results were 
expressed as percentage ofstimulation and point represents the mean 土 standard deviation of8 
separate experiments each in quadruplicate. 
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Figure 3.2 Effect ofvarious concentrations ofTNF-a on protein content in C6 glioma cell. 
C6 Cells (density: 6xl0^ cell/dish) were incubated with different concentrations ofTNF-a (50, 
100, 500, lOOOU/ml) at 37�C under the atmosphere of 5% CO2for 48 hours. Cell proliferation 
was measured by means of increase in protein level as described in Section 2.2.3.4. Results 
were expressed as percentage of stimulation and each point represents the mean 士 standard 
deviation of3 experiments each in triplicate. 
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Figure 3.3 Effect of TNF-a on the proliferation of C6 glioma cells at different time 
intervals. C6 Cells (density: 5xlO^ cells/well) were cultured with lOOU/ml TNF-a for 
different times (4, 18, 24 or 48 hours) at 37�C under an atmosphere of 5% CO2. C6 cell 
proliferation was measured by neutral red assay as described in Section 2.2.3.2. Results were 
expressed as percentage ofstimulation and each point represents the mean 土 standard deviation 




proliferation also increased in a time-dependent manner, about 25% increase was observed 
after incubation with TNF-a for 48 hours. These proliferation studies showthat C6 cell is a 
good model cell type to study the proliferative effects and signalling pathways mediated by 
'V 
TNF-a. 
3.1.1.2 Effects ofOther Cytokines on C6 Cell Proliferation 
Jn this experiment, cells were treated with EL-la (lng/ml), n,-ip (lng/ml), JL-6 
(lng/ml) and y-JFN (lOOU/ml) for 48 hours，and cell proliferation were measured by MTT 
assay. Figure 3.4a shows that D^-la and E^-ip induced C6 cell proliferation, while H>-6 
and y-WN did not. The effects of different dosages of H -^6 and y-JFN on C6 cell 
proliferation were also studied to further prove that both cytokines did not show any 
proliferative effect on C6 cells (Figures 3.4b and c). These findings suggest that only 
certain cytokines are capable of inducing cell proliferation and indicating the specificity of 
TNF-a, n , - l a and E^-ip. 
3.1.2 The Signalling Pathway ofTNF-a-induced C6 Cell Proliferation 
Results described in Section 3.1.1.2 showed that several cytokines could induce C6 
glioma cell proliferation; however, the underlying mechanism remains unclear and very 
little is known about the signal transduction pathways mediating the action of various 
cytokines. Since TNF-a and EL-ls have been reported to stimulate various second 
messengers in primary glial cell cultures O^orris et al., 1994), and TNF-a have been 
reported to play an important role in brain injury and then astrogliosis (Giulian and 
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Figure 3.4 Effects of IL-la, H^ip，n^6 and y-JFf^ on C6 cell proliferation, (a) C6 cells 
(density: 5xlO^ cells/well) were cultured with TNF-a (lOOU/ml), n.-la(lng/ml), H.-
ip (IngAnl)，JL-6 (lngAnl) or y-WN (lOOU/ml) at 37�C under an atmosphere of 5% CO2for 48 
hours. C6 cells (density: 5xlO^ cells/well) were also treated with D -^6 (10，100，1000or 
lOOOOpg/ml) alone (b) ory-ffN (10, 100，1000, 10000U/ml) alone (c). Cell proliferation was 
measured by MTT assay as described in Section 2.2.3.3. Results were expressed as percentage 
of stimulation and each point represents the mean 土 standard deviation of 3 separate 




various signalling pathways in TNF-a-induced proliferation in C6 cells were studied. The 
second messenger systems studied included Ca!+ and protein kinase C (PKC), since both of 
them are important second messenger which play roles in brain injury and TNF-a � 
production. 
3.1.2.1 The Livolvement ofCalcium Ions in TNF-a-induced C6 Cell Proliferation 
Ca2+ serves as a second messenger to trigger intracellular responses 0-ehniger, et al., 
1993). Normally the cytosolic [Ca�+] is kept low (<lO'^M) by the action of Ca�+ pumps in 
the endoplasmic reticulum, mitochondria, plasma membrane, and the Ca^^-binding proteins. 
Hormonal, neural, or other stimuli can cause influx of Ca^ ^ into the cell through specific 
Ca2+ channels in the plasma membrane or release of sequestered Ca^ ^ from the endoplasmic 
reticulum or mitochondria, raising the cytosolic [Ca^ ]^ and triggering the cellular response 
(Wegner et al., 1992; Means et al., 1994; Nicotera and Rossi，1994). One way in which 
Ca2+ triggers cellular responses is by activating a variety of Ca^^-dependent enzymes, 
including the Ca^7calmodulin-dependent protein kinase (Lehniger, etal, 1993). Moreover, 
it was found thatjust like TNF-a elevated Ca^ ^ level also plays an important role in brain 
injury (Rzigalinski et al’ 1997), and that TNF-a could trigger [Ca^^i rise in astrocytes 
pColler et al., 1996)，therefore Ca?+ may be an important factor involved in the TNF-a-
mediated proliferation and subsequent astrogliosis. Thus, the main focus of this thesis 
project is to study the role ofCa^^ in the TNF-a-triggered proliferation in C6 cells. In this 
study, the actions of A23187, a calcium ionophore, and a Ca^ ^ L-channel blocker, 
verapamil on TNF-a-induced proliferation were tested. A23187 itself is a pore-forming 
molecule for Ca^^fluxes. It creates many Ca^ ^ channels to increase the [Ca^^ilevel sharply 




was found that L-type Ca^ ^ channels are responsible for astrocytes proliferation (Florio et 
al., 1996; Westenbroek et al., 1998), therefore, verapamil was chosen as the Ca^ ^ channel 
blocker for investigation. 
in this experiment, cells were treated with different doses of Ca!+ ionophore, A23187 
(12.5ng/ml to lOOng/ml) and calcium channel blocker, verapamil (0.3jxM to lO^iM), and 
cell proliferation was determined by MTT assay. Figure 3.5 shows the effects of A23187 
and TNF-a on C6 cell proliferation. C6 cells were cultured for 48 hours in control medium， 
in the presence or absence of lOOU/ml TNF-a with various concentrations of A23187. It 
was found that the effect of A23187 was dose-dependent, and optimal effect was observed 
with 25ng/ml A23187. The C6 cell proliferation was enhanced by the combined treatment 
of TNF-a and A23187, and the maximum proliferative effect observed with 25ng/ml 
A23187. Figure 3.6 showsthe effects ofverapamil and TNF-a on C6 cell proliferation. C6 
cells were treated for 48 hours in control medium, in the presence or absence of lOOU/ml 
I 
TNF-a with various concentrations of verapamil. Verapamil alone had no significant effect, 
but the TNF-a-induced C6 proliferation was inhibited by the addition of verapamil. In the 
presence of lOpM verapamil, the TNF-a induced C6 cell proliferation was almost 
completely abolished. Therefore，these findings suggestthat Ca^^play an important role in 
TNF-a-induced proliferation in C6 cells and that this cytokines induced the opening ofL-
type Ca2+-channels. However, as the combined A23187 and TNF^x treatment resulted in 
higher proliferative effect, it is possible that TNF-a induces cell proliferation also by a 
mechanism in addition to [Ca^^jchanges ^"igure 3.5). 
3.1.2.2 The Involvement ofProtein Kinase C in TNF-a-induced C6 Cell Proliferation 
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Figure 3.5 Effects ofA23187 alone and on TNF-a-induced C6 cell proliferation. C6 Cells 
(density: 5xlO^ cells/well) were treated with medium alone or with TNF-a (lOOU/ml) in the 
presence or absence of A23187 (12.5, 25, 50 or lOOOng/ml) for 48 hours at 37�C under an 
atmosphere of5% CO2. Cell proliferation was measured by MTT assay as described in Section 
2.2.3.3. Results were expressed as percentage of stimulation and each point represents the 
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Figure 3.6 Effect ofverapamil on TNF-a-induced C6 cell proliferation. C6 Cells (density: 
5x104 cells/well) were treated with medium alone or with TNF-a (lOOU/ml) in the presence or 
absence ofverapamil (0.3, 2 or lOpM) for 48 hours at 37�C under an atmosphere of 5% CO2. 
Cell proliferation was measured by MTT assay as described in Section 2.2.3.3. Results were 
expressed as percentage ofstimulation and each point represents the mean 士 standard error of5 
separate experiments each in quadruplicate. 
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an important role in signal transduction in many cell types. Recent studies show that one of 
the PKC isoforms, PKC-y, plays an important role in brain injury. Li addition, since certain 
cytokines have been shown to induce phosphatidycholine hydrolysis (Cataldi et al., 1990) � 
and activate certain PKC isozymes (Pfeffer et al, 1990), it is of interest to see ifPKC is 
involved in mediating the proliferative effect of cytokines in C6 cells. In the present study, 
PMA and PDA, which are potent PKC activators (Hug & Sarre, 1993)，were used to 
investigate the role ofPKC in C6 cell proliferation. 
To test ifPKC mediated the proliferative effect ofTNF-a, the effect of a potent PKC 
inhibitor, Ro31-8220 on TNF-a-induced C6 cell proliferation was investigated (Tamaoki 
et al., 1986). Ro31-8220 was chosen because it has been found to be a more potent PKC 
inhibitor in C6 cells (Tsang et al., 1997). 
Jn this experiment, cells were treated with different concentrations of a PKC activator, 
PMA (lOpM to lOnM) and a PKC inhibitor, Ro31-8220 (4nM to 200nM), and proliferation 
measured by MTT assay. C6 Glioma cells were treated with various concentrations of 
PMA for 48 hours. Figure 3.7 illustrates that PMA alone elicited a proliferative effect on 
C6 cells and optimal effect was observed with 100nM ofPMA. Figure 3.8 shows the effects 
ofvarious concentrations ofRo31-8220 on TNF-a-induced proliferation of C6 cells. C6 
Cells were cultured for 48 hours with TNF-a (lOOU/ml) in the presence or absence of 
various concentrations ofRo31-8220. Ro31-8220 alone had no significant proliferative 
effect, while the TNF-a-induced C6 cell proliferation was inhibited by the added Ro31-
8220, and this inhibition was concentration-dependent. Near complete inhibition was 
observed with 200nM Ro31-8220. Thus, PKC activation is also another important step 
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Figure 3.7 Effect of PMA on C6 cell proliferation. C6 Glioma cells (density: 5xlO^ 
cells/well) were treated with various concentrations ofPMA (10，100，1000，lOOOOpg/ml) for 
48 hours at 37�C under an atmosphere of 5% CO2. Cell proliferation was measured by MTT 
assay as described in Section 2.2.3.3. Results were expressed as percentage of stimulation and 
each point represents the mean 士 standard error of 4 separate experiment each in quadruplicate. 
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Figure 3.8 Effect of various concentrations of Ro31-8220 on TNF-a-induced 
proliferation of C6 cells. C6 Cells (density: 5xlO^ cells/well) were treated with various 
concentrations ofRo31-8220 (4, 20, 100 or 200nM) in the presence or absence of TNF-a 
(lOOU/ml) for 48 hours at 37�C under an atmosphere of5% CO2 for 48 hours. Cell proliferation 
was measured by MTT assay as described in Section 2.2.3.3. Results were expressed as 
percentage of stimulation and each point represents the mean 土 standard error of 3 separate 
experiments each in quadruplicate. 
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3.1.3 Effects ofAnti-TNF Receptor Subtype Antibodies on C6 Cell Proliferation 
It is believed that TNF-a mediates its action by binding to TNF receptors. There are 
two types of TNF-R, TNF-R1 and TNF-R2 (Smith et al., 1990). Many studies 
demonstrated that binding ofTNF-a to TNF-R1 resulted in cell apoptosis, while, binding 
ofTNF-a to TNF-R2 resulted in cell proliferation (Shen et al, 1992; Huang et al., 1998). 
In order to investigate the TNF-R subtype that is responsible for the TNF-a-triggered cell 
proliferation, cells were treated with lOOU/ml TNF-a, O.OSM-g/ml anti-TNF-Rl or 
0.08M,g/ml anti-TNF-R2 antibodies alone for 48 hours, or they were treated with anti-
TNF-Rl or anti-TNF-R2 antibodies for 2 hours, then followed by lOOU/ml TNF-a for 48 
hours. The concentration ofthe anti-TNF-Rs antibodies (0.08 i^gy^ml) used has been proved 
high effective enough to block the corresponding TNF-a receptors. The data will be shown 
in the later part of the thesis (Figure 3.18). | 
鲁 '^ 
Figure 3 .9 shows that no significant changes in cell proliferation were observed with ； 
！ 
anti-TNF-Rl or anti-TNF-R2 antibodies alone. In the presence ofTNF-a and anti-TNF-Rl 
or TNF-a alone, cell proliferation was unaffected, but in the presence of anti-TNF-R2, the 
TNF-a-induced cell proliferation was almost completely blocked. Therefore, it suggests 
that TNF-a may carry out its proliferative action in C6 cells proliferation by binding to 
TNF-R2. 
3.2 The Effect of in Tumour Necrosis Factor-a on Changes in bitracellular Calcium 
Concentration 
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Figure 3.9 Effects of anti-TNF-R antibodies on C6 cell proliferation. C6 Glioma cells 
(density: 5><10^  cells/well) were treated with TNF-a (lOOU/ml), anti-TNF-Rl antibody 
(0.08^ig/ml) or TNFR-2 antibody (0.08^lg/ml) or pre-treated with anti-TNF-Rl or anti-TNF-
R2 antibody (0.08^ig/ml) for 2 hours and then with TNF-a (lOOU/ml) for another 48 hours at 
37°C under an atmosphere of 5% CO2. Cell proliferation was measured by MTT assay as 
described in Section 2.2.3.3. Results were expressed as percentage of stimulation and each 




pathways, this, together with that both A23187 (Figures 3.5 and 3.6) and TNF-a (Figures 
3.1-3.3) play significant roles in C6 glioma cell proliferation, the role of Ca!+ in mediating 
the effects ofTNF-a in C6 glioma cells was examined in more detail in this project. In my 
' V 
study, [Ca2+]iChanges upon the addition ofTNF-a and other drugs were studied by confocal 
microscopy. 
A fluorescent dye, fiuo-3/AM was used for monitoring [Ca^ ]^j levels in this study. 
Fluo-3/AM is a commonly used fluorescence indicator for Ca�+ (Merritt et al., 1990). 
Fluo-3 contains five negative charges and it cannot pass through the plasma membrane. 
Hence, the uncharged acetoxymethyl (AM) ester form of fluo-3 was employed. The 
advantage in using fluo-3/AM is that it is distributed rather homogeneously within the 








Figure 3.10 shows the confocal images in which [Ca^ ]^i was detected by a CLSM 
OVLeridian). It was found that when C6 glioma cells were suspended in Na+-HEPES normal 
buffer (pH 7.4) alone’ no release of Ca^^was observed throughout the time course (2500 
seconds) studied. However, it was obviously that addition of ionomycin to cells induced a 
sharp rise in [Ca2+][ The increase in [Ca^^jby ionomycin (8^ig/ml), a strong Ca^ ^ ionophore, 
confirmed that the Ca^ ^ system was not impair under the experimental conditions and the 
Ca2+ released by ionomycin were from both intra- and extracellular sources. 
Figure 3.11 also illustrates that the addition of lOOU/ml TNF-a caused a slow rise in 
[Ca2+]iin Na+-HEPES buffer. Initially, lOOU/ml TNF-a did not cause [Ca^^iincrease in a 
short incubation time. When the incubation time of TNF-a increased to 300 seconds, 
[Ca2+]i started to increase, and a 3-fold of increment was observed after 2500 seconds. The 
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Figure 3.10 Confocal images showing the effect ofTNF-a on [Csi^% level. C6 Cells lxlO^ 
(cells/well) grown on a cover slip were loaded with fluo-3/AM (lO^iM) for one hour at room 
temperature. To initiate the experiment, either normal buffer (control) (a) or TNF-a (lOOU/ml) 
(b) was added and the changes in fluorescence intensity were monitored by confocal 
microscopy as described in Section 2.2.4. At the end of the experiment (1800 seconds), 
ionomycin (8^ig/ml) was added to the control to monitor the viability of cells and the cell 
nucleus was located with a nucleic acid stain, acridine orange (0.5pM). The fluorescence was 
presented as pseudocolour as indicated by the colour palette, and the scale bar represents the 
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Figure 3.11 Effect ofTNF-a on [Ca^^j level change in C6 ceUs. C6 cells (lxlO^ cells/well) 
were loaded with fluo-3/AM (lO^iM) for one hour at room temperature To initiate the 
experiment, either normal buffer (control) (a) or TNF-a (lOOU/ml) (b) was added and the 
changes in fluorescence intensity were monitored by confocal microscopy as described in 
Figure 3.10. At the end ofthe experiment (1800 seconds), ionomycin (8^ig/ml) was added to 
the control to monitor the viability of cells，and the cell nucleus was located with acridine 
orange (0.5^iM). The fluorescence intensities in the cytosol and the nucleus were calculated 
and the changes in Ca^ ^ concentration at each time point were normalized by dividing the 
fluorescence intensity at a particular time point with the one at time zero (F/Fo). The trace 




results suggest that TNF-a could increase the [Ca^ ]^i. 
3.2.2 Effects of Calcium Ionophore and Calcium Channel Blocker on TNF-a-induced 
[Ca2+]i Release 
、 
Since both TNF-a and A23187 can trigger C6 glioma cell proliferation, and that 
TNF-a was found to induce [Ca^ ]^i rise in C6 cells, thus, the role of Ca^^in the TNF-a-
induced C6 cell proliferation was further investigated. For the rise in Ca�+, two components 
can be found: release of Ca^ ^ from internal stores or influx of Ca^^from extemal source. 
A23187 and verapamil were used again to investigate the relationship between TNF-a and 
[Ca2+]i release in C6 glioma cells. A23187 is a potent calcium ionophore which can create 
many Ca!+ channels to facilitate Ca!+ fluxes in the cells, therefore, the [Ca^ ]^i level will be 
drastically increased with the addition of A23187. On the other hand, verapamil is a L-type ( 
I 
Ca2+ channel blocker which blocks the L-type Ca^ ^ channel in the cells, therefore, Ca^ ^ � 
*t 
entering the cells via the L channel is blocked. Figure 3.12 illustrated that the TNF-a- 3 
• 1 
triggered [Ca^ ]^i increase was enhanced when C6 cells were pre-treated with a small dose of 
A23187 (25ng/ml) after 2000 seconds oftreatment (normalized value: 3), when compared 
with that ofTNF-a alone (normalized value: 2.2). However, the TNF-a-triggered [Ca^ ]^i 
increase was partly inhibited when the C6 cells were pre-treated with verapamil (lO^iM) 
(normalized value: 1.4) after 1500 seconds of treatment, when compared with the TNF-
a-treated case (normalized value: 2). This is a typical example from 10 identical 
experiments. Therefore, it shows that changes in [Ca^ ]^i is a factor involved in the TNF<t-
mediated proliferation in C6 cells. To determine the specificity of the action ofTNF-a on 
[Ca2+]i changes，the effects ofdifferent cytokines on [Ca^^i changes were investigated. 
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Figure 3.12 Effects ofcalcium ionophore A23187 and calcium channel blockerverapamil 
on the TNF-a-induced [Ca^^i rise. C6 cells (lxlO^cells/well) grown on a cover slip were 
loaded with fluo-3/AM (lO^iM) for one hour at room temperature. Cells were pre-treated with 
A23187 (25ng/nl) priorto the addition ofTNF-a (lOOU/ml) (a) or pre-treated with verapamil 
(10M.M) before the addition ofTNF-a (lOOU/ml) (b), and the changes in fluorescence intensity 
were monitored by confocal microscopy as described in Figure 3.10. At the end of the 
experiment, the cell nucleus was located by acridine orange staining (0.5^iM). The 
fluorescence intensities in the cytosol and the nucleus were calculated and the changes in Ca^ ^ 
concentration were normalized by dividing the fluorescence intensity at a particular time point 





3.2.3 Effects ofOther Cytokines on the Change in [Ca^ ]^j 
• v 
It was found that other cytokines, such as DL-la (lng/ml) and JL-ip (lng/ml), like 
TNF"tt, can also stimulate C6 glioma cell proliferation (Section 3.1.1.2), therefore, the 
effects ofother cytokines on the [Ca^^jlevel also studied to determine the specificity of the 
action ofTNF-a on [Ca^ ]^i changes. Figures 3.13 and 3.14 demonstrated that both n . - l a ] 
(lng/ml) and n,- ip (lng/ml) were able to trigger the [Ca^^j rise in C6 cells in both nucleus 
and cytosol, but they were less effective than TNF-a (Figures 3.13 and 3.14). On the other 
hand,正-6 (lng/ml) and y-JFN (lOOU/ml) which did not induce C6 cell proliferation 
^7igure 3.4) had no significant effect on [Ca^]i ^"igures 3.13-3.14). Result shown a typical 
_ / 
example from 10 identical experiments with similar results. Therefore，these observations � 
/ 
showed that the action ofcytokines on the rise of [Ca^ ]^i in C6 cells is specific. However, it 
1," 
is still unclear regarding the mechanism ofTNF-a stimulates [Ca^ +L rise in C6 cells, thus, | 
i 
! • i 
the effects of the messenger substances involved in cell signalling, such as PKC, was 
investigated. 
3.2.4 The Role ofPKC in [Ca^^j release in C6 Glioma Cells 
Since PKC plays an important role in the TNF-a induced cell proliferation (Figures 
3.7 and 3.8) and TNF-a has been shown to activate PKC during brain injury (Zablocka et 
al., 1998), we examined the effects ofPKC activator and inhibitor on [Ca^ ]^j change. In 
addition, it was found that PKC could induce TNF-a expression. Studies showed that two 
PKC inhibitors, H7 and staurosporine, inhibited the y>ffMLPS-, and y-ffWD^-ip-induced 
TNF-a mRNA and protein expression in a dose-dependent manner, while HA1004, a 
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Figure 3.13 Confocal images showing the effects of other cytokines on the [Ca^^i changes. 
C6 cells (lxlO^cells/well) were loaded with fluo-3/AM (lO^dVl) for one hour at room 
temperature. Cells were treated with BL-la (lngy^ml) (a), JL-l^ (lng/ml) (b), DL-6 (lng>^ml) (c) 
or y-WN (lOOU/ml) (d), and the changes in fluorescence intensity were monitored by confocal 
microscopy as described in Figure 3.10. At the end of the experiment (1620 seconds), 
ionomycin (8^ig/ml) was added to the E>-6-treated and y-m^J-treated cells to monitor the 
viability ofthe cells, and the cell nucleus was located with acridine orange (0.5[iM). The 
fluorescence was presented as pseudocolour as indicated by the colour palette, and the scale 
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Figure 3.14 Effects of other cytokines on the�CVI^ change. C6 cells (lxlO^ cells/well) 
grown on a cover slip were loaded with fluo-3/AM (lO^iM) for one hour at room temperature. 
Cells were treated with D^-lot (ln^ml) (a)，IL-lp (lng/ml) (b), n,-6 (lng/ml) (c) or y-WN 
(lOOU/ml) (d), and the changes in fluorescence intensities were monitored by confocal 
microscopy as described in Figure 3.10. At the end of the experiment, ionomycin (8 i^gAnl) was 
added to the tt>-6-treated and y-mST-treated cells to monitor the viability of the cells, and the 
cell nucleus was located with acridine orange (0 5pM). The fluorescence intensity in the 
cytosol and the nucleus were calculated and the changes in Ca^ ^ concentration at each time 
point were normalized by dividing the fluorescence intensity at a particular time point by that 





compound structurally similar to H7, but a poor PKC inhibitor, did not inhibit TNF-
a expression. Moreover, TNF-a expression in other cell types, including human 
astroglioma cells, is also mediated by a PKC-dependent pathway (Chung et al., 1992). '• 
3.2.4.1 Effects ofPKC Activators and Inhibitors on the Changes in [Ca^ ]^j 
Figure 3.15 illustrated the role ofPKC in [Ca^^i changes in C6 cells. When the cells 
were treated with Ro31-8220 (200nM), a PKC inhibitor in C6 cells (Tsang et al, 1997) for 
1200s, no significant change in the resting [Ca^ ]^j was observed, but the addition ofthe 
same concentration ofRo31-8220 to TNF-a (lOOU/ml)-treated cells, a decrease in [Ca^ ]^i 
was observed immediately (Figure 3.15). On the contrary, the PKC activator, PMA 
i 
(lng/ml), increased the [Ca^ ]^i in the cytosol and the nucleus of C6 cells. Result shown a / 
\ 
typical example from 10 identical experiments with similar results. From the above � 
I 1 j,! 
findings, it showed that PKC is a mediator for the TNF-a-induced [Ca^ ]^i rise in C6 cells. 丨 
r: 
3.3 Determination of Gene Expressions by RT-PCR 
Besides confocal microscopy, the importance of [Ca^ ]^i rise in relationship to C6 
proliferation was also examined at the molecular level by RT-PCR. In this part，the effects 
of [Ca2+]i rise and TNF-a on the expression ofdifFerent genes was focused. Since PKC also 
plays roles in proliferation and changes in [Ca^^i, and that other cytokines also stimulate 
C6 cell proliferation, the actions ofPKC and other cytokines on the expression ofcertain 
genes related to TNF-a-induced proliferation were also studied. 
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Figure 3.15 Effects of PKC activator and inhibitor on [Ca^^j changes. C6 cells 
(lxlO^ells/well) were loaded with fluo-3/AM (lO^iM) for one hour at room temperature. 
During the experiment，cells were treated with Ro31-8220 (200nM) (a)，pre-treated with 
TNF-a (lOOU/ml) prior to the addition ofRo31-8220 (200nM) (b), or treated with PMA 
(lng/ml) (c), and the changes in fluorescence intensities were monitored by confocal 
microscopy as described in Figure 3.10. Atthe end of the experiment, ionomycin (8pig/ml) was 
added to the Ro31-8220-treated and the TNF-a and Ro31-8220-treated cells to monitor the 
viability of the cells, and the cell nucleus was located with acridine orange (0.5pM). The 
fluorescence intensity in the cytosol and the nucleus were calculated and the changes in Ca!+ 
concentration at each time point were normalized by dividing the fluorescence intensity at a 
particular time point by that at time zero (¥fFo). Traces are typical examples of 10 separate 




3.3.1 Studies on TNF Receptors Gene Expression 
� 
In orderto exert its actions，TNF-a must bind to its specific receptor on the target cells. 
The effects ofTNF-a are mediated through two distinct, high-affinity receptors: TNF-R1 
and TNF-R2 (Smith et al.，1990). As previous studies showed that binding of TNF-a to 
TNF-R1 mediated cell apoptosis, while binding of TNF-a to TNF-R2 mediated cell 
proliferation ^iuang et al, 1998), the expression of TNF-R1 and TNF-R2 were first 
studied in this project. Another obvious reason is our finding that TNF-R2 antiserum 
blocks the TNF-a-induced C6 cell proliferation (Figure 3.9). 
, ; i 
'I 




The effect ofTNF-a on the TNF receptors gene expressions was first examined. C6 !丨 
1 
Glioma cells were cultured with 100 U/ml TNF-a for various times. After TNF-a I 
treatment, RNA of C6 glioma cells was extracted by TRJZOL reagent, and the extracted 
RNA was then reverse transcribed to the corresponding cDNA by RT. Three different sets 
ofprimers were used to carry out three different sets ofPCR to amplify the following target 
genes: TNF-R1, TNF-R2 and P-actin; the latter is for normalization. After PCR reaction, 
the amplified cDNA were separated by electrophoresis as described in Chapter 2. 
Figure 3.16 demonstrates the expression of TNF-R1, TNF-R2 and P-actin after 
treating the C6 glioma cells with TNF-a for different time intervals. It was found that there 
were no significant changes for the expression ofTNF-Rl and P-actin at all the time points 
studied. However，the expression of TNF-R2 was increased and the TNF-R2 expression 
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Figure 3.16 Expression of TNF receptors (TNF-Rs) after treating with TNF-a. C6 Glioma 
cells (density: 5xlO^ cell/dish) were cultured with 100 U/ml TNF-a treatment for various times 
(5, 10, 20, 30 minutes, or 1, 2，4 24, 48 hour(s)). Untreated cells were acted as the control 
(CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. 
Expression of TNF-R1, TNF-R2 and P-actin were measured. Densitometry was used to 
quantify the density ofbands. The result shown is a typical electrophoretic pattem of 5 separate 
experiments with similar results. The DNA markers (left) were mn on the same gel and the 




reached its maximum at 2 hours. When the C6 glioma cells were treated with TNF-a for 
longer than 2 hours，down-regulation occurred, and the TNF-R2 expression dropped 
gradually from 4 hours to 48 hours. Since the expression of TNF-R2 increases upon the � 
addition ofTNF-a, this observation suggests that TNF-a mediates C6 cell proliferation by 
increasing the expression ofTNF-R2 (Figure 3.16) through the binding to TNF-R2 (Figure 
3.9). 
3.3.1.2 Effects of Other Cytokines on the TNF Receptors Expression 
Since both YL-la and IL-P, like TNF-a, can stimulate C6 cell proliferation, the effects 
of R^-la and JL-^ on the TNF receptors gene expressions were also studied. In this 
experiment, TNF-a was also added to cells for comparison. C6 Glioma cells were cultured :；, 
I 
with lOOU/ml TNF-a, lng/ml IL-la and lng/ml JL-ip for 2 hours, respectively. After the � 
i 
cytokines treatment, RNA was extracted, RT-PCR was performed and cDNA was 
separated by electrophoresis as mentioned in 2.2.5.4. 
Figure 3.17 demonstrates the expression of TNF-Rl, TNF-R2 and P-actin after 
treatment with different cytokines. Similar to the findings with TNF-a (Figure 3.17), it was 
found that there were no significant changes in the expression ofTNF-Rl and P-actin after 
cytokines treatment. However, the expression TNF-R2 was increased upon cytokines 
(lOOU/ml TNF-a, lngAnl D^-la and lngAnl H>-ip) treatment. This finding suggests that 
both n , - l a and R,-lp, like TNF-a, can increase the production of TNF-R2. As Lung 
(1999) in our laboratory showed that both E.-1 s could stimulate the expression ofTNF-a in 
C6 cells, it is likely that these two cytokines stimulate cell proliferation via the TNF-a 
mechanism. 
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Figure 3.17 Effects of different cytokines treatment on the expression of TNF-Rs and P_ 
actin. C6 Glioma cells (density: 5xlO^ celVdish) were cultured with lOOU/ml TNF-a or 
lng/ml n . - l a or lng/ml IL-ip for 2 hours, respectively. Untreated cells served as the control 
(CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. 
Expression of TNF-R1, TNF-R2 and P-actin were measured and densitometry was used to 
quantify the density of bands. The result shown is a typical electrophoretic pattem of 5 
separate experiments with similar results. The DNA markers (left) were run on the same gel 
and the sizes of the PCR bands were indicated on the right (bp). 
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3.3.1.3 Effects of Anti-TNF Receptor Subtype Antibodies on the TNF-a-induced 
Receptors Expression 
、 
The role of TNF-Rs in mediating TNF-a-induced C6 cells proliferation was further 
studied by using anti-TNF-Rl and anti-TNF-R2 antibodies. In this experiment，cells were 
treated with various concentrations of anti-TNF-Rl (2 i^gy'ml to 0.016^ig/ml) or anti-TNF-
R2 (2fxg/ml to 0.016 i^gy'ml) alone for 2 hours or challenged with TNF-a (lOOU/ml) for 
1 
another 2 hours after 2 hours of anti-TNF-Rs antibodies treatment. After RNA extraction, 
expression ofTNF-Rs and P-actin were then measured by RT-PCR as mentioned before. 
Figure 3.18a demonstrates the expression ofTNF-Rs and P-actin after treating with 1 j 
antibodies alone. It was found that there were no significant changes in the expression of 
TNF-R1, TNF-R2 and P-actin in all treated cells, showing that no initiation of gene 
, f ' »' 
expression upon antibodies treatment alone. Figure 3.18b shows the expression of TNF-Rs � 
':i, 
and P-actin after TNF-a with and without anti-TNF-Rs antibodies treatment. It was found j| 
. . ：) 
that there were no significant changes in the expression of TNF-R1 and P-actin in all I 
treated cells. However, the TNF-a-induced TNF-R2 expression was decreased with the 
addition of anti-TNF-R2 antibody, while addition of anti-TNF-Rl antibody cannot block 
the effect ofTNF-a on TNF-R2 expression, and an increase was still evident (Figure 3.18b). 
Jn the case ofanti-TNF-R2 treatment, the addition of this antibody effectively blocked the 
induction at 0.08mg/ml. These findings suggest that TNF-a stimulates C6 cell proliferation 
by binding to TNF-R2 and by inducing the expression ofTNF-R2. 
3.3.1.4 Effect ofCalcium Ions on TNF Receptors Expression 
As mentioned earlier, Ca^ ^ serves as a second messenger in trigger intracellular 
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Figure 3.18 EfTects of anti-TNF receptor antibodies on the TNF-Rs and P-actin 
expression. C6 Cells (density: 5xlO^ celVdish) were treated with different concentrations 
(2^ig/ml, 0.4^ig/ml, 0.08|agAnl, 0.016^ig/ml) of anti-TNF-Rl or anti-TNF-R2 (2^ig/ml, 
0.4^ igy^ nd, 0.08^ig/ml, 0.016^ig/ml) antibodies for 2 hours alone (a) or treated with different 
concentrations (2^ig/ml, 0.4^igAnl, 0.08p,g/ml, 0.016^ig/ml) of anti-TNF-Rlor anti-TNF-R2 
(2^ig/ml, 0.4^ig/ml, 0.08^igAnl, 0.016^ig/ml) antibodies for 2 hours alone before the 
incubation with TNF-a (lOOU/ml) for another 2 hours. Untreated cells without the addition 
of antibody and TNF-a were served as the control (CTL). Total RNA was isolated and 
subjected to RT-PCR as described in Chapter 2. Expression ofTNF-Rl, TNF-R2 and P-actin 
were measured. Densitometry was used to quantify the density ofbands. The result shown is 
a typical electrophoretic pattem of 5 separate experiments with similar results. The DNA 
markers (left) were run on the same gel and the sizes of the PCR bands were indicated on the 
right (bp). 
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responses 0-ehniger, et al., 1993) and that TNF-a induced a slow but more than two-fold 
increase in [Ca^ ]^i concentration in astrocytes (Koller et al, 1996), we investigated the role 
of Ca2+in TNF-a-induced TNF-Rs expression. Another reason for performing this study is � 
because of our finding that TNF-a selectively induces the expression of TNF-R2 in C6 
cells (Figure 3.16). 
Moreover, as one of the ways in which Ca�+ triggers cellular responses is by activating 
a variety of Ca^7calmodulin-dependent protein kinase, including PKC (Selbie etal., 1993; 
Johannes et al., 1994; Wu et al., 1999), the effect ofPKC on TNF-Rs expression was also 
examined. 
3.3.1.4.1 Effect of Calcium Ionophore on TNF Receptors Expression 
A23187 is a pore-inducing agent for the fluxes of Ca:+ in cells. We made use of this 
fact to examine the effects of rise in [Ca^ ]^iOn the expression ofTNF-Rs. 
In this experiment, cells were treated with A23187 (25ng/ml) for various times and the 
RNA extracted and then sujected to RT-PCR as mentioned before. 
Figure 3.19 demonstrates the expression ofTNF-Rs and P-actin after treating the C6 
glioma cells with A23187 for different time. It was found that there were no significant 
changes in the expression of TNF-R1 and P-actin at all time points examined, however, 
significant increase in the expression ofTNF-R2 was observed from 5 to 10 minutes after 
the addition ofA23187. The TNF-R2 expression reached its maximum at 10 minutes and 
then declined possibly because of down-regulation of gene expression. Our finding 
suggests that a fast rise in [Ca^^j can induce TNF-R2 expression, thus it is possible that an 
increase in [Ca^ ]^j plays a role in TNF-a-induced C6 cell growth. 
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Figure 3.19 Effect ofA23187 on TNF-Rs and P-actin expression. C6 Cells (density: 5xlO^ 
cell/dish) were treated with A23187 (25ng/ml) for 5 minutes, 10 minutes, 30 minutes or 1 
hour. Cells were also treated with TNF-a (lOOU/ml) for 2 hours. Untreated cells served as 
the control (CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 
2. Expression ofTNF-Rl, TNF-R2 and P-actin were measured and densitometry was used to 
quantify the density of bands. The result shown is a typical electrophoretic pattem of 5 
separate experiments with similar results. The DNA markers (left) were mn on the same gel 
and the sizes of the PCR bands were indicated on the right (bp). 
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3.3.1.4.2 EfFect ofTNF-a Combination with A23187 on the Expression ofTNF Receptors 
The effects of combined treatment with calcium ionophore and TNF-a on TNF-Rs � 
expression were also studied to see if the addition of A23187 prior the addition of TNF-a 
can enhance the TNF-Rs expression. In this experiment, cells were first treated with 
A23187 (25ng/ml) for various times then with TNF-a for another 2 hours. RNA of C6 
glioma cells was extracted by TRIZOL reagent and the expression of TNF-Rs and P-actin 
were then measured by RT-PCR as mentioned above. 
Figure 3.20 shows the expression ofTNF-Rs and P-actin after different treatments. It 
was found that there were no significant changes in the expression ofTNF-Rl and p-actin 
in all samples studied. However, the expression ofTNF-R2 was increased 5 minutes after 
the addition of A23187 and reached its maximum at 10 minutes then declined. The latter 
observation could be due to the down-regulation of the expression. The TNF-a induction 
was further enhanced in cell previously exposed to A23187, this suggests that TNF-a can 
activate other [Ca^ ]^j stores or other mechanisms. This thought can be further support by the 
treatment of cells with TNF-a in combination with different concentration of A23187 
(Figure 3.21). The expression ofTNF-R2 was the greatest when the cells were treated with 
A23187 (25ngAnl) for 2 hours prior to the addition ofTNF-a (lOOU/ml) while there were 
no significant changes in the expression ofTNF-Rl and p-actin in all samples studied. The 
difference in the expression of TNF-R2 upon the addition of various concentrations of 
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Figure 3.20 Effect of combined TNF-a and A23187 treatment on TNF-Rs and P-actin 
expression. C6 Cells (density: 5xlO^ ceiydish) were first treated with A23187 (25ngAnl) for 
various times (5, 10，30 minutes, 1 or 2 hour(s)) then challenged with lOOU/ml TNF-a for 
another 2 hours. For comparison, some cells were also treated with TNF-a (lOOU/ml) alone. 
Untreated cells acted as the control (CTL). Total RNA was isolated and subjected to RT-PCR 
as described in Chapter 2. Expression ofTNF-Rl, TNF-R2 and P-actin were measured and 
the density of the bands was quantified by densitometry. The result shown is a typical 
electrophoretic pattem of 5 separate experiments with similar results. The DNA markers (left) 
were run on the same gel and the sizes of the PCR bands were indicated on the right (bp). 
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3.3.1.4.3 Effects of Calcium Ionophore and Channel Blocker on TNF Receptors 
Expression 
、 
In this experiment，cells were treated with TNF-a (lOOU/ml), calcium ionophore， 
A23187 (25ngAnl) or calcium channel blocker, verapamil (10|xM) alone for 2 hours, or 
with A23187 or verapamil for 2 hours then with TNF-a for another 2 hours. Expression of 
TNF-R1 and TNF-R2 were measured by RT-PCR. Figure 3.22 shows the results of the 
TNF-Rs gene expression after RT-PCR. No significant changes of in the expression of 
TNF-R1 and p-actin were observed upon different treatments. However，either TNF-a or 
A23187 alone increased the TNF-R2 expression, and the TNF-R2 expression was ftirther 
augmented by the A23187 and TNF-a combined treatment. With the addition of verapamil 
(lO^iM), the effect of TNF-a on the expression of TNF-R2 was partially inhibited. These 
suggest that increase in [Ca^^]iis important for the TNF-R2 expression. As verapamil can 
partially inhibit the TNF-a-induced TNF-R2 expression, it is suggested that TNF-a can 
induce Ca!+ influx possibly through the L-type Ca?+ channel. As the binding of TNF-a to 
TNF-R2 has been shown to elicit cell proliferation, the effect ofTNF-a and A23187 on the 
C6 cells proliferation may be mediated, at least in part, by inducing TNF-R2 expression. 
3.3.1.4.4 Effects of Calcium-Inducing Agents on TNF Receptors Gene Expressions 
Results shown in Sections 3.3.1.4.1-3 showed that A23187 which induced the influx 
of Ca2+ could stimulate TNF-R2 expression, we therefore tested the effects of thapsigargin 
and thimerosal on TNF-R expression. Thapsigargin is a sesquiterpene lactone originally 
isolated from the umbrelliferous plant Thapsia gargancia (Christensen and Norup, 1986) 
which acts as an irreversible inhibitor of the Ca^^-ATPase in the endoplasmic reticulum 
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Figure 3.21 Effect ofvarious concentrations ofA23187 on TNF-a-induced TNF-Rs and 
P-actin expression. C6 Cells (density: 5xl0^ cellAlish) were first treated with various 
concentrations of A23187 (2.5^ig/ml, 250ng/ml, 25ng/ml or 2.5ng/ml) for 10 minutes, then 
challenged with lOOU/ml TNF-a for another 2 hours. For comparison，some cells were also 
treated with TNF-a (lOOU/ml) alone. Untreated cells acted as the control (CTL). Total RNA 
was isolated and subjected to RT-PCR as described in Chapter 2. Expression of TNF-R1, 
TNF-R2 and P_actin were measured and the density of the bands was quantified by 
densitometry. The result shown is a typical electrophoretic pattem of 5 separate experiments 
with similar results. The DNA markers (left) were run on the same gel and the sizes of the 
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Figure 3.22 Effects of A23187 and verapamil on TNF-Rs and P-actin expression. C6 
Cells (density: 5x10' ceUAiish) were treated with TNF-a (lOOU/ml), A23187 (25ng/ml) or 
verapamil (lO^iM) for 2 hours, or with A23187 or verapamil for 2 hours first followed by 
TNF-a for another 2 hours. Untreated cells were served as the control (CTL). Total RNA 
was isolated and subjected to RT-PCR as described in Chapter 2. Expression ofTNF-Rl, 
TNF-R2 and P-actin were measured and densitometry was used to quantify the density of 
bands. The result shown is a typical electrophoretic pattem of 5 separate experiments with 
similar results. The DNA markers (left) were run on the same gel and the sizes of the PCR 
bands were indicated on the right (bp). 
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OER) O^ytton et al., 1991; Thastrup et al., 1990). When the ER pump is inhibited Ca'^ can 
no longer returned from the cytosol to the ER for storage which leads to a prolonged rise in 
[Ca2+]i (Vercesi et al., 1996). Besides, thimerosai, a thiol-reactive reagent, has been shown � 
to increase the cytosolic Ca^^concentration in a variety of cells (Michelangeli et al., 1995) 
by sensitizing W^ receptors (Benidge, 1991) was also examined to complement the 
thapsigargin study. 
C6 Cells were treated with thapsigargin (2^M) or thimerosal (20^iM) alone for 30 
minutes or with either thapsigargin (2pM) or thimerosal (20p,M) for 30 minutes then with 
lOOU/ml TNF-a for another 2 hours, and gene expressions were measured by RT-PCR. 
Figure 3.23 shows the results of the TNF receptors gene expression after RT-PCR. No 
significant differences of TNF-R1 and P-actin genes were observed upon different 
treatments. On the other hand, TNF-R2 expression was increased upon treatments with 
either thapsigargin or thimerosal. The TNF-R2 expression was further augmented by the 
combined treatments of thapsigargin and TNF-a orthimerosal and TNF-a. These findings 
suggest that a prolong rise in [Ca^ ]^j selectively induced TNF-R2 expression. Therefore, 
increase in [Ca^ ]^j can augment the expression of TNF-R2, and that rise in [Ca^ ]^i is 
involved in C6 cell proliferation. Moreover, the expression of TNF-R2 was further 
increased by TNF-a, by the presence of thapsigargin or thimerosal (Figure 3.23). The 
findings that thapsigargin or thimerosal which increases [Ca^ ]^i independent of extemal 
Ca2+, suggest that changes in [Ca^ ]^j concentration is an important signal which triggers 
TNF-R2 expression. 
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Figure 3.23 Effects of calcium-inducing agents on TNF-Rs and P-actin gene expression. 
C6 Cells (density: 5xlO^ ceUAiish) were treated with thapsigargin (2^M) or thimerosal 
(20^iM) for 30 minutes or TNF-a (lOOU/ml) for 2 hours. For the combined treatment, cells 
were treated with thapsigargin (2^iM) or thimerosal (20^iM) for 30 minutes first followed by 
lOOU/ml TNF-a for another 2 hours. Untreated cells were served as the control (CTL). Total 
RNA was isolated and subjected to RT-PCR as described in Chapter 2. Expression of TNF-
R1, TNF-R2 and P-actin were measured and densitometry was used to quantify the density of 
bands. The result shown is a typical electrophoretic pattem of 5 separate experiments with 
similar results. The DNA markers (left) were run on the same gel and the sizes of the PCR 
bands were indicated on the right (bp). 
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3.3.1.5 Effects of PKC Activator and Inhibitor on TNF-a-induced TNF Receptors 
Expressions 
、 
Since PKC has been shown to regulate both neuronal development and synaptic 
transmission (Jiang et al, 1994) and our previous finding that PMA is involved in C6 cell 
proliferation, we examined the role ofPKC in mediating TNF-Rs expression. 
Jn the first set of experiment, cells were treated with TNF-a (lOOU/ml) or a potent 
PKC activator, PMA (lng/ml) for 2 hours, or with PMA for 2 hours followed by TNF-a for 
another 2 hours. Then, the TNF-Rs expressions were measured by RT-PCR. No significant 
differences in TNF-R1 and P—actin expressions were observed upon the addition ofPMA, 
TNF-a or both agents. However, TNF-R2 expression was increased upon the addition of 
either TNF-a or PMA and the TNF-R2 expression was much higher in the presence ofboth 
TNF-a and PMA (T"igure 3.24). Therefore，it suggests that TNF-a stimulates cell 
proliferation by inducing the expression TNF-R2, and this induction is through the 
activation of PKC. However，the TNF-R2 expression was higher in cells treated with 
TNF-a and PMA, therefore it is possible that another mechanism may be involved in the 
TNF-a-induced TNF-R2 expression, e.g. PKC. 
To obtain fiirther support of the involvement of PKC, in the second part of the 
experiment, cells were treated with TNF-a (lOOU/ml) or PMA (lng/ml) in the presence or 
absence o f a strong PKC inhibitor, Ro31-8220 (200nM) (Tsang et al., 1997) for 2 hours. 
For the combined treatment, cells were challenged with Ro31-8220 for 2 hours and 
followed by TNF-a or PMA for another 2 hours. No significant changes in TNF-R1 and 
p-actin expressions were observed upon the addition of any one of these agents. However， 
the TNF-R2 expression was increased upon the addition of TNF-a or PMA, and both 
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Figure 3.24 Effect ofPMA on TNF^-induced TNF-Rs and p-actin expression. C6 Cells 
(density: 5xlO^ cell/dish) were treated with TNF-a (lOOU/ml) or PMA (lng/ml) for 2 hours, 
or with PMA for 2 hours followed by TNF-a for another 2 hours. Untreated cells were 
served as the control (CTL). Total RNA was isolated and subjected to RT-PCR as described 
in Chapter 2. Expression ofTNF-Rl, TNF-R2 and P-actin were measured. Densitometry was 
used to quantify the density ofbands. The result shown is a typical electrophoretic pattem of 
5 separate experiments with similar results. The DNA markers (left) were run on the same 
gel and the sizes of the PCR bands were indicated on the right (bp). 
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Figure 3.25 Effects of PKC activator and inhibitor on TNF-a-induced TNF-Rs and p-
actin expression. C6 Cells (density: 5xlO^ cell/dish) were treated with TNF^x (lOOU/mI), 
PMA (lng/ml) or Ro31-8220 (200nM) for 2 hours. For the combined treatment, cells were 
exposed to Ro31-8220 for 2 hours and followed by TNF or PMA for another 2 hours. 
Untreated cells acted as the control (CTL). Total RNA was isolated and subjected to RT-PCR 
as described in Chapter 2. Expression ofTNF-Rl，TNF-R2 and p-actin were measured and 
the density of the bands was quantified by densitometry. The result shown is a typical 
electrophoretic pattem of 5 separate experiments with similar results. The DNA markers (left) 
were run on the same gel and the sizes of the PCR bands were indicated on the right (bp). 
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increases were significantly reduced with the pre-treatment ofRo31-8220 (Figure 3.25). 
Therefore, it is very likely that PKC is a factor involved in the TNF-a-mediated TNF-R2 
expression. � 
3.3.1.6 Effects ofPKC and Ro31-8220 on E.-1-induced TNF Receptors Expressions 
As both n,-ls stimulate proliferation and TNF-R2 expression, it is of interest to see if 
the action ofboth D^-ls is mediated by PKC. In this study, C6 Cells were treated with E.-
l a (lng/ml) or JL-l^ (lng/ml) and with or without Ro31-8220 (200nM) pre-treatment as 
described above. TNF-Rs expressions were measured by RT-PCR. No significant changes 
in TNF-R1 and P-actin expression were observed upon the addition of different agents 
either alone or in combination. However, the TNF-R2 expression was increased upon the 
addition of IL-la or D^-lp. Ro31-8220, which had been shown to be very potent in 
reducing the TNF-a-stimulated TNF-R2 expression, did not decrease the TNF-R2 
expression ^Figure 3.26). Also, Ro31-8220 alone had no effect. Thus, PKC may not be an 
important factor in mediating the D^-l-induced TNF-R2 expression and the pathways 
involved in JL-l- and TNF-a-mediated C6 cell proliferation are not the same. 
3.3.2 Expression of Calcium-sensing Receptor upon Different Drug Treatments 
Calcium-sensing receptor (CaSR) has been shown to couple with the release of 
intracellular Ca^ ^ fromthe intracellular Ca^ ^ stores (Shorte etal., 1996). In parathyroid cells, 
dermal fibroblasts, and brain cells, increased the expression of CaSR has been shown to 
evoke [Ca^^i increases and thus the mobilization of [Ca^ ]^i stores (Shorte et al, 1996). 
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Figure 3.26 Effect of Ro31-8220 on n^l-induced TNF-Rs and P-actin expression. C6 
Cells (density: 5xlO^ celVdish) were treated with n , - l a (lng/ml) or n,-ip (lng/ml) for 2 
hours with or without the pre-treatment of various dosages (2nM, 20nM, 200nM, 2^iM) of 
Ro31-8220 for 2 hours. Untreated cells acted as the control (CTL). Total RNA was isolated 
and subjected to RT-PCR as described in Chapter 2. Expression ofTNF-Rl, TNF-R2 and 3-
actin were measured and the density of the bands was quantified by densitometry. The result 
shown is a typical electrophoretic pattem of 5 separate experiments with similar results. The 
DNA markers (left) were run on the same gel and the sizes of the PCR bands were indicated 
on the right (bp). 
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in situ hybridization (Rogers et al., 1997). Of interest is that they were located in nerve 
terminals as well as fiber tracts, where it may be expressed in glia (Chattopadhyay et al., 
1998). Therefore, CaSR may play a role in mediating the TNF-a-triggered increases in � 
astrocytes after exposure to this cytokine. 
3.3.2.1 Effect ofTNF-a on the Calcium-sensing Receptor Expression 
Results presented earlier illustrated that increase in intracellular Ca!+ by calcium 
ionophore or calcium-inducing agents increased the expression of TNF-R2 and triggered 丨 
.i ； 
C6 cell proliferation similar to that of TNF-a. These, together with the result that TNF-a 丨 
could induce [Ca^ ]^i rise in C6 cells, thus it is important to examine the expression of CaSR 
after TNF-a treatment. This study should provide valuable information about the 
mechanism mediating the TNF-a-induced [Ca^ ]^i increase. 
C6 Glioma cells were cultured with 100 U/ml TNF-a for various times as shown in 
Figure 3.27. After TNF-a treatment, RNA of C6 glioma cells was extracted by TRIZOL 
reagent, and then the extracted RNA was reverse transcribed to the corresponding cDNA 
by RT as mentioned above. Expression of CaSR and p-actin were then measured by RT-
PCR mentioned before. 
Figure 3.27 demonstrates the time course expression of CaSR and P-actin after TNF-
a treatment. It was found that there were no significant changes in the expression ofP-actin 
at all the time points studied. However, the expression CaSR was changed in a time-
dependent manner upon TNF-a treatment (Figure 3.27). The expression of CaSR reached 
its maximal at 5 minutes ofTNF-a treatment，then a decline was observed after prolonged 
treatment. The latter observation may be due to a down-regulation of gene expression. As 
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Figure 3.27 Effect of TNF-a on the calcium-sensing receptor (CaSR) expression. C6 
Glioma cells (density: 5xlO^ cell/dish) were cultured with 100 U/ml TNF-a for various times 
(5, 10, 20, 30 minutes or 1, 2, 4，24, 48 hour(s)). Untreated cells served as the control (CTL). 
Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. Expression of 
CaSR and P-actin were measured. Densitometry was used to quantify the density ofbands. The 
result shown is a typical electrophoretic pattem of 5 separate experiments with similar results. 
The DNA markers (left) were run on the same gel and the sizes of the PCR bands were 
indicated on the right (bp). 
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TNF-a can induce a very rapid increase in CaSR expression which is comparable to that of 
rise in [Ca^]j after TNF-a treatment, it is quite possible that TNF-a changes by [Ca^ ]^j, at 
least in part, activating the expression of CaSR. � 
3.3.2.2 Effects of Other Cytokines on CaSR Expression 
The interesting results obtained with TNF-a prompted us to examine the effects of 
TNF-a, tt>-la and D^-ip and JL-6 onthe CaSR expression, so as to examine the specificity 
of different cytokines. In this experiment, C6 glioma cells were cultured with lOOU/ml 
TNFKX, lng/ml 化-la，lng/ml H>-ip or JL-6 (lOpg/ml-lOOng/ml) for 2 hours, and the 
expression of CaSR and p-actin were studied by RT-PCR. 
Figures 3.28 and 3.29 demonstrate the expression of CaSR and P-actin after treating ： 
the C6 glioma cells with different cytokines. It was found that there was no significant 
change in the expression P-actin after various cytokines treatment. However, it showed that 
；! 
] 
the expression CaSR was increased upon treatment with lOOU/ml TNF-a, lng/ml n^-la i 
and lng/ml D^-ip ^lgure 3.28), but not after DL-6 treatment (Figure 3.29). 
Figure 3.29 demonstrates the expression of CaSR and p-actin after treatment with 
K.-6 ranging from lOpg/ml to lOOng/mL It is clear that there were no significant effects on 
the expression of P-actin and CaSR (Figure 3.29). Thus, the increase in the expression of 
CaSR, and the changes in [Ca^ ]^i rises, are quite specific to certain cytokines, these 
cytokines are also capable of stimulating C6 cell proliferation. 
3.3.2.3 Effect ofA23187on CaSRExpression 
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Figure 3.28 Effects of IL- la and BL-ip on CaSR and p-actin expression. C6 Glioma cells 
(density: 5xlO^ ceUMish) were cultured with lOOU/ml TNF-o, lng/ml E^-la or lng/ml E>-ip 
fbr 2 hours, while untreated cells served as the control (CTL). Total RNA was isolated and 
subjected to RT-PCR as described in Chapter 2. Expression of CaSR and P-actin were 
measured. Densitometry was used to quantify the density of bands. The result shown is a 
typical electrophoretic pattem of 5 separate experiments with similar results. The DNA 
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Figure 3.29 Effect of JL-6 on CaSR and P-actin expression. C6 Cells (density: 5xlO^ 
cell/dish) were treated with different dosages of R.-6 (lOpg/ml, lOOpg/ml, lng/ml, lOngAnl) 
for 2 hours, while untreated cells served as the control (CTL). Total RNA was isolated and 
subjected to RT-PCR as described in Chapter 2. Expression of CaSR and p-actin were 
measured. Densitometry was used to quantify the density of bands. The result shown is a 
typical electrophoretic pattem of 4 separate experiments with similar results. The DNA 
markers (left) were run on the same gel and the sizes of the PCR bands were indicated on the 
right (bp). 
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the [Ca2+]i stores (Shorte et aL, 1996). In brain cells, the increased in the expression of 
CaSR has been shown to evoke [Ca^ ]^i increases then the mobilization of [Ca^ ]^j stores 
(Shorte etal., 1996). Thus, CaSR expression and [Ca^^]iare closely related. Since calcium 
ionophore, A23187 can create Ca^ ^ channels and lead to a sharp increase in [Ca^ ]^j, we, 
therefore, examined the effect of induced rise in [Ca^ ]^j on the expression of CaSR. 
Li this experiment, cells were treated with A23187 (25ng/ml) for various times and the 
expression of CaSR and P-actin were measured by RT-PCR. 
Figure 3.30 shows the expression of CaSR and p-actin after treatment with A23187 
for different time intervals. It was found that there were no significant changes in the 
expression of P-actin, however, the expression of CaSR was increased at 5 minutes. The 
decrease observed after prolong treatment may be because of down-regulation of gene 丨 




induction CaSR expression observed suggests that CaSR expression can be induced by 
increase in [Ca2+][ 
3.3.2.4 Effect ofTNF-a and A23187 Combined Treatments on CaSR Expression 
Since both A23l87 and TNF-a increased CaSR expression, we examined the 
combined effect of A23187 and TNF-a on CaSR expression. In this experiment, cells were 
first treated with A23187 (25ng/ml) for various time intervals then challenged with 
lOOU/ml TNF-a for another 2 hours, and the expression of CaSR and P-actin were 
measured byRT-PCR. 
It was found that there was no significant changes in the expression ofP-actin at all the 
time points studied，however, the expression of CaSR was increased in the presence of 
A23187. In the presence of both A23187 and TNF-a, CaSR expression was further 
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Figure 3.30 Effect of A23187 on CaSR and P-actin expression. C6 Cells (density: 5xlO^ 
cell/dish) were treated with A23187 (25ng/ml) for various times (5, 10, 30 minutes or 1 hour) 
or with TNF-a (lOOU/ml) for 2 hours. Untreated cells served as the control (CTL). Total 
RNA was isolated and subjected to RT-PCR as described in Chapter 2. Expression of CaSR 
and P-actin were measured and the density of the bands was quantified by densitometry. The 
result shown is a typical electrophoretic pattem of 5 separate experiments with similar results. 
The DNA markers (left) were mn on the same gel and the sizes of the PCR bands were 
indicated on the right (bp). 
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Figure 3.31 Effect of combined treatment of calcium ionophore and TNF-a on the 
expression of CaSR and P-actin. C6 Cells (density: 5xlO^ cell/dish) were first treated with 
A23187 (25ng/ml) for various times (5, 10, 30, 60 or 120 minutes) then challenged with 
lOOU/ml TNF-a for another 2 hours. For comparison, some cells were also treated with 
TNF-a (lOOU/ml) alone. Untreated cells were acted as the control (CTL). Total RNA was 
isolated and subjected to RT-PCR as described in Chapter 2. Expression of CaSR and p-actin 
were measured and the density of the bands was quantified by densitometry. The result 
shown is a typical electrophoretic pattem of 5 separate experiments with similar results. The 
DNA markers (left) were run on the same gel and the sizes of the PCR bands were indicated 




enhanced ^"igure 3.31). This finding suggests that TNF-a further increases [Ca^ ]^j which in 
tum enhances CaSR expression. However, the possibility that TNF-a activate another 
mechanism besides the increase in [Ca^ ]^i cannot be discarded. � 
3.3.2.5 Effects of Calcium-inducing Agents on CaSR Expression 
Since the calcium-inducing agents, thapsigargin and thimerosal, as mentioned above， 
can induce the intracellular Ca^ ^ increases, their effects on CaSR expression was also 
examined. In this study, C6 cells were treated with thapsigargin (2^iM) or thimerosal 
(20[xM) each for 30 minutes, or with thapsigargin (2^M) or thimerosal (20^iM) for 30 
minutes followed by TNF-a (lOOU/ml) for another 2 hours. Expression of CaSR was 
measured by RT-PCR. No significant differences in P-actin gene expression were 
observed upon different treatments. On the other hand, CaSR expression was increased 
upon the treatment with thapsigargin or thimerosal ^"igure 3.32). The CaSR expression 
was further augmented by the combined treatments (thapsigargin +TNF-a or thimerosal + 
TNF<x). This finding suggests that Ca^^-inducing agents-induced CaSR expression is 
independent of extemal Ca�+. As TNF-a further enhanced the activation of thapsigargin 
and thimerosal, this finding also support the idea that TNF-a can induce CaSR expression 
by another mechanism unrelated to the increase in [Ca^ ]^i. 
3.3.2.6 Effects ofPKC Activator and PKC Wiibitor on CaSR Expression 
As TNF-a activates PKC, which in tum induces TNF-R2 expression, and [Ca^^i rise， 
we examined the effect ofPKC activator and inhibitor on CaSR expression. 
ln the first set of experiment, cells were treated with PMA (lng/ml) for various times, 
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Figure 3.32 Effects of calcium-inducing agents with or without TNF-a on CaSR and P_ 
actin expression. C6 Cells (density: 5xlO^ celVdish) were treated with thapsigargin (2^iM) 
or thimerosal (20nM) for 30 minutes or with TNF-a (lOOU/ml) for 2 hours. For the 
combined treatment, cells were treated with thapsigargin (2^iM) or thimerosal (20pM) for 30 
minutes first and followed by TNF-a for another 2 hours. Untreated cells were acted as the 
control (CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. 
Expression of CaSR and P-actin were measured and the density of the bands was quantified 
by densitometry. The result shown is a typical electrophoretic pattem of 5 separate 
experiments with similar results. The DNA markers (left) were mn on the same gel and the 
sizes of the PCR bands were indicated on the right (bp). 
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Figure 3.33 Effect of PMA on CaSR and P-actin expression. C6 Glioma cells (density: 
5xlO^ cell/dish) were treated with PMA (lng/ml) for 30 minutes, 1 hour, 2 hours, 2 hours or 
24 hours. Untreated cells acted as the control (CTL). Total RNA was isolated and subjected 
to RT-PCR as described in Chapter 2. Expression of CaSR and P-actin were measured and 
the density of the bands was quantified by densitometry. The result shown is a typical 
electrophoretic pattem of 5 separate experiments with similar results. The DNA markers (left) 
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Figure 3.34 Effects ofPKC activator and inhibitor on CaSR and p-actin expression. C6 
Cells (density: 5xlO' cell/dish) were treated with TNF-a (lOOU/ml) or PMA (lng/ml) or 
Ro31-8220 (200nM) for 2 hours. For the combined treatment, cells were exposed to Ro31-
8220 for 2 hours and then with TNF-a or PMA for another 2 hours. Untreated cells were 
acted as the control (CTL). Total RNA was isolated and subjected to RT-PCR as described in 
Chapter 2. Expression ofCaSR and P-actin were measured and the density of the bands was 
quantified by densitometry. The result shown is a typical electrophoretic pattem of 5 separate 
experiments with similar results. The DNA markers (left) were run on the same gel and the 
sizes ofthe PCR bands were indicated on the right (bp). 
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and CaSR and P-actin expression were then measured by RT-PCR. No significant change 
in p-actin expression were observed all the time points studied, however, the CaSR 
expression was increased upon the addition ofPMA (Figure 3.33). � 
In the second part of the experiment, cells were treated with TNF-a (lOOU/ml) or 
PMA (lng/ml) with or without pre-treatment with Ro31-8220 (200nM) for 2 hours. No 
significant changes in P-actin expression were observed upon the addition of different 
agents. The CaSR expression was increased upon the addition ofTNF-a or PMA; but in the 
presence of Ro31-8220, the expression of CaSR was significantly reduced (Figure 3.34). 
Thus, it is very likely that TNF-a-induced CaSR expression by activating PKC. 
3.3.3 Expression ofPKC Isoforms upon Treatment with Different Drugs 
Results presented in the earlier sections clearly show that PKC plays an important role 
in TNF-R2 and CaSR expression, as well as cell proliferation. Studies also showed that 
PKC isoforms, such as PKC y plays an important role in brain injury O^ilson et al, 1994; 
Zablocka et al, 1998), moreover, another study reported that the addition of two PKC 
inhibitors, H7 and staurosporine, could inhibit the y-mS[/LPS-, and y-HWE^-ip—induced 
TNF-a mRNA and protein expression in a dose-dependent manner. PKC consists of ten or 
more isoforms with different patterns of tissue expression, and the cDNAs for these 
isoforms have been cloned (Stabel and Parker, 1991;Nishizuka, 1992). Recently，the PKC 
isozymes have been classified into the Ca^^-dependent (a, pi^  pn and y), Ca^^-independent 
(6, s, Ti, 9), and "atypical" (C, X)PKCs (Selbie"a/., 1993;Johannes"a/., 1994). Because 
ofthese, it is important to examine the effects of TNF-a, A23187 and calcium-inducing 
agents on the expression ofPKC isoforms in C6 cells. 
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Figure 3.35 Effect of TNF-a on PKC isoforms and P-actin expression. C6 Glioma cells 
(density: 5xlO^ cell/dish) were cultured with 100 U/ml TNF-a for various times (5，10, 20, 
30 minutes, 1, 2, 4, 24 or 48 hour(s)). Untreated cells acted as the control (CTL). Total RNA 
was isolated and subjected to RT-PCR as described in Chapter 2. Expression of PKC-a, 
PKC-s, PKC-y, PKC-r|, PKC-C and P-actin were measured. Densitometry was used to 
quantify the density of bands. The result shown is a typical electrophoretic pattem of 5 
separate experiments with similar results. The DNA markers (left) were run on the same gel 
and the sizes ofthe PCR bands were indicated on the right (bp). 
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3.3.3.1 Effects of TNF-a on the PKC Isoforms expression 
� 
The effects TNF-a on the expression of different PKC isoforms, including PKC-a, 
PKC-s, PKC-y, PKC-r|, and PKC-C were examined in this part. These isoforms were 
chosen as study in our laboratory that they are found in C6 cells O^ung, 1999). 
C6 glioma cells were cultured with 100 U/ml TNF-a for various times. RNA was 
extracted by TRIZOL reagent, then the extracted RNA was reverse transcribed as 
mentioned above. Expression ofPKC isoforms and P-actin were measured by RT-PCR. 
Figure 3.35 demonstrates the time course expression of PKC isoforms and P-actin 
after TNF-a treatment. It was found that there were no significant changes in the 
expression ofPKC-a and P-actin at all the time points studied. However, the expression of 
PKC-s，PKC-y, PKC-T], and PKC-; were increased in a time-dependent manner upon 
TNF-a treatment OFigure 3.35)，though a decline was observed after prolonged treatment. 
The latter observation may be due to a down-regulation of gene expression. Their 
maximum gene expressions ranged from 5 minutes to 60 minutes. As a result，TNF-a 
induced PKC isoforms expression were also fast, but when compared with that CaSR, the 
PKC isoforms expression reached their maximum much later. This suggests that the 
expression of CaSR may come before the expression ofPKC isoforms. Moreover, since not 
all the PKC isoforms expressions were changed during the TNF-a time course treatment, it 
indicates that the induction of certain PKC isoforms is quite specific. 
3.3.3.2 Effect ofA23187 on the PKC Isoforms expression 
Jn order to examine if the increase in [Ca^ ]^j can induce the expression of PKC 
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Figure 3.36 Effect of A23187 on the PKC isoforms and P-actin expression. C6 Cells 
(density: 5xlO' cell/dish) were treated with TNF-a (lOOU/ml) for 2 hours or A23187 
(25ng/ml) for various times (5, 10, 30 minutes or 1 hour). Untreated cells acted as the control 
(CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. 
Expression ofdifferent PKC isoforms, including PKC-a, PKC-s, PKC-y, PKC-T], PKC< and 
P-actin were examined and the density of the bands was quantified by densitometry. The 
result shown is a typical electrophoretic pattem of 5 separate experiments with similar results. 
The DNA markers (left) were run on the same gel and the sizes of the PCR bands were 




isoforms, cells were treated with A23187 (25ng/ml) for various times and the expression of 
the PKC isoforms and p-actin were measured by RT-PCR. 
Figure 3.36 demonstrates the expression of different PKC isoforms and p-actin after 
� 
treatment with A23187 for different time intervals. It was found that there were no 
significant changes in the expression ofp_actin and PKC-a in A23187-treated cells. Figure 
3.36 also indicates that the expression of PKC-e, PKC-y, PKC-”，and PKC< were 
increased when treated with A23187 from 5 to 60 minutes. These findings show that 
A23187 induced a rather rapid expression ofPKC-s, PKC-y, PKC-r|, and PKC< similar to 
the induction by TNF-a. As PKC-y is Ca^^-dependent, it is likely that this isoform may play 
a more major role in mediating the action of TNF-a. Although PKC-s and PKC-r| are 
Ca2+4ndependent, an increase in [Ca^^]j was also found to induce these isoforms expression, 
it is reasonable to speculate that both PKC activation and an increase in [Ca^ ]^j may play 
very important role in TNF-a-mediated C6 cell proliferation. 
3.3.3.3 Effect ofTNF-a and Calcium Ionophore Combined Treatments on PKC Isoforms 
expression 
The effects of combined treatment of calcium ionophore and TNF-a on PKC isoforms 
expression were also studied to see if the addition of A23187 prior to the addition ofTNF-a 
could fiirther enhance the PKC isoforms expression. In this experiment, cells were first 
treated with A23187 (25ng/ml) for various times then challenged with lOOU/ml TNF-a for 
another 2 hours, then the expression ofPKC isoforms and P-actin were measured by RT-
PCR. 
Figure 3.37 shows the expression of PKC isoforms and P-actin after different 
157 
— _ — ^ 
, rhapfer3Results 
PKC"tt 1.00 0.82 1.16 1.14 1.09 1.18 1.11 
i n i i i i i i i i i i i i i i ^ i i i i ^ ^ ^ j i ^ 2 ^ j i i i 2 i i 2 i i i ^ 2 i j i i Q 2 2 u i i i 2 m 
PKC-s 
1.00 1.36 1.63 1.71 2.60 2.99 3.06 
^niiii^ ^^ i^iiiiiiii^ iiiiminiiiiiii^ iiiiiiiiiniiiiiiiiiiiii^ iiii^ i^iii^ ^ji2iii 
PKC-Y 1.00 1.48 1.03 2.05 1.30 1.28 6.25 
H S ^ B H H H I H H H H H H H H B H H H H H R H H H H H H M I 
^^ H|^ H|H||^ ^^ ^^ H^^ ^^ ^^ |^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ H 
^^^^^^^^m^^^Hm^^HH^^BHHI^^ |^^^^^^^^^^^HI^HB B H m ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ l 347bp I^^^E3IHHHII^IHH^IHHIHHHHIHBHII^^IHIHIHHHH 
PKC-Ti 1 .00 0 . 8 6 0 . 6 8 0 .99 1.27 1.42 1.52 
||||||HH||||m||j^ ^^ ||m|m|^ ^^ |||||||||^ |^2m^^ ^^ U|||||2|^ |^^ |||||||j^ j^||||||||||^ |^ j^|^ || 
PKC< 1.00 1.44 1.17 1.18 1.89 2.16 2.39 
^ 5 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ g ^ _ ^ ^ ^ ^ m i g i i i _ i g i g i m i m ^ ^ m ^ g m g ^ ^ m m g i i i g i ^ m m m i 
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^9 681bp 
P-actin J | ^ J | U | ^ | U m U m | ^ | ^ | ^ ^ ^ J | 
^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^¾!^^ ^^^ ^^^ ^^^ ¾^^^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^¾¾ ^^01i3^^ 
^ ^ ^ 3 S S B B 




CTL A23187 2h A23187 A23187 
+ 30m 5m 
TNF"Ot + + 
TNF-a TNF-a 
Figure 3.37 Effect of the combined treatment of calcium ionophore and TNF-a on PKC 
isoforms and P-actin expression. C6 Cells (density: 5xlO^ cell/dish) were first treated with 
A23187 (25ng/ml) for various times (5, 10, 30 minutes, 1 or 2 hour(s)) followed by lOOU/ml 
TNF-a for another 2 hours. Cells were also treated with TNF-a (lOOU/ml) alone for 
comparison. Untreated cells acted as the control (CTL). Total RNA was isolated and 
subjected to RT-PCR as described in Chapter 2. Expression ofPKC-a，PKC-e, PKC-y, PKC-
r|，PKC-C and P-actin were measured and the density of the bands was quantified by 
densitometry. The result shown is a typical electrophoretic pattem of 5 separate experiments 
with similar results. The DNA markers (left) were run on the same gel and the sizes of the 




combined treatment of A23187 and TNF-a. It was found that there were no significant 
changes in the expression ofPKC-a and P-actin exposed to different combined treatments. 
In the presence ofTNF-a (lOOU/ml), the expression ofPKC-e, PKC-y, PKC-ii, and PKC-� 
^were increased at 5 minutes and decreased after 10 minutes of treatment. With the 
addition of A23187, TNF-a-induced PKC isoforms expressions were further enhanced. 
Therefore, it suggests that TNF-a is capable of enhancing these PKC isoforms expression 
by a mechanism besides the increase in [CdL^ % 
3.3.3.4 Effects ofCalcium-inducing Agents on PKC Isoforms expression 
hi order to examine whether the increase in PKC isoforai expression depends on 
external Ca!+，the effects of calcium-inducing agents, thapsigargin and thimerosal, on PKC 
isoforms expression were also examined. C6 Cells were treated with thapsigargin (2^iM) or 
thimerosal (20^iM) for 30 minutes, or with thapsigargin (2MM) or thimerosal (20^ dVO for 30 
minutes first and then with 100 U/ml TNF-a for another 2 hours. The expression of 
different PKC isoforms and P-actin were measured by RT-PCR. No significant changes in 
PKCa and P—actin expressions were observed with either calcium-inducing agent 
treatment. On the other hand, the expression ofPKC-s, PKC-y, PKC-r|, and PKC< were 
increased upon treatment with thapsigargin orthimerosal. The expression ofthese isoforms 
were further augmented by the combined treatment of thapsigargin +TNF-a or thimerosal 
+ TNF-a^"igure 3.38). As both thapsigargin and thimerosal induce a prolong rise in 
[Ca2+l independent of an extemal Ctf+source, therefore，the augmented expression of 
PKC-8, PKC-y, PKC-Ti, and PKC-C suggest that an increase in [Ca^ ]^i is sufficient to induce 
the expression ofthese PKC isoforms . As TNF-a can further enhance the effect of Ca!+-
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Figure 3.38 Effects of calcium-inducing agents on PKC isoforms and P-actin expression. 
C6 Cells (density: 5xlO^ celL^dish) were treated with thapsigargin (2[iM) or thimerosal 
(20^iM) for 30 minutes or with TNF-a (lOOU/ml) for 2 hours. For the combined treatment, 
cells were exposed to thapsigargin (2fiM) or thimerosal (20^iM) for 30 minutes first then 
with lOOU/ml TNF-a for another 2 hours. Untreated cells acted as the control (CTL). Total 
RNA was isolated and subjected to RT-PCR as described in Chapter 2. Expression ofPKC-a, 
PKC-s, PKC-y, PKC-r|, PKC< and P-actin were measured and the density of the bands was 
quantified by densitometry. The result shown is a typical electrophoretic pattem of 5 separate 
experiments with similar results. The DNA markers (left) were run on the same gel and the 
sizes of the PCR bands were indicated on the right (bp). 
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inducing agents, it is likely that TNF-a also augment the expression of these isoform by a 
mechanism unrelated to an increase in [Ca!+]� 
、 
3.3.4 Expression of the Transcription Factors c-fos and c-jun in Drug Treatments 
Besides the expression ofTNF receptors, CaSR and PKC isoforms, the expression of 
two immediate early genes (ffiGs), c-fos and c-jun were also studied in this thesis report. 
These ffiGs were chosen as they have been implicated in brain injury and ischemia (Gubits 
et al., 1993, Yu, et al, 1995, Dutcher, et al, 1999). Products of the fos family {c-fos,fra-
\,fra-l, and /os-B) are thought to bind to members of the jun family (c-jun, Jun-B, jun-D) 
via leucine zippers, and the dimer formed binds to the AP-1 site (consensus sequece -
TGACTCA-) in the promoter of the target genes, and in tum regulates the expression of 
certain late response genes that produce long-term changes in cells (Curran and Morgan, 
1987; Sheng and Greenberg, 1990). Moreover, It was reported that long-term expression of 
multiple ffiG proteins in glial cells stimulated by neuropathological conditions may play an 
important role in the outcome of brain injury and neurodegenerative disease (Arenander 
and Vellis, 1992), and that the products of c-fos and c-jun are rapidly activated in brain 
injury (Raghupathi and McIntosh, 1996; Herrera and Robertson, 1996; Dragunow and 
Hughes, 1993). In addition, it was reported that mechanical wounding induced an increase 
in [Ca2+]i and that the [Ca^ ]^i signal was required for the transcriptional activation oftwo 
ffiGs: c-fos and c-jun, since blocking Ca^ ^ influx with Gd^ ^ or EGTA reduced ffiG 
transcription, while augmenting Ca^ ^ influx increased ffiGs transcription. These results 
demonstrated that the [Ca^ ]^i rise and transcriptional activation ofDBGs in brain injury are 
highly dependent (Tran et al,, 1999). Furthermore, ffiGs and Ca^ ^ are found to be important 
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Figure 3.39 Expression ofc-fos, c-jun and ^-actin after treating with TNF-a. C6 Glioma 
cells (density: 5xlO^ cell/dish) were cultured with 100 U/ml TNF-a treatment for various 
times (5, 10, 20, 30 minutes, or 1, 2, 4 24, 48 hour(s)). Untreated cells were acted as the 
control (CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. 
Expression ofc-fos, c-jun and P-actin were measured. Densitometry was used to quantify the 
density of bands. The result shown is a typical electrophoretic pattem of 5 separate 
experiments with similar results. The DNA markers (left) were mn on the same gel and the 




suggesting that ffiGs and Ca!+ are closely related. Therefore, c-fos and c-jun expression 
were chosen to see if they also play a role TNF-a-mediated C6 cell proliferation. 
� 
3.3.4.1 Effect ofTNF-a on c-fos and c-jun Expression 
C6 Glioma cells were cultured with 100 U/ml TNF-a for various times. After TNF-
a treatment，RNA was extracted by TRLZOL reagent, the extracted RNA and the expression 
ofc-fos, c-jun and P-actin were then measured by RT-PCR as mentioned before. 
Figure 3.39 demonstrates the time course expression of c-fos, c-jun and P-actin after 
TNF-a treatment. It was found that there were no significant changes in the expression of 
P-actin at all the time points studied. However, the expression of c-fos and c-jun were 
increased in a time-dependent manner upon TNF-a treatment (Figure 3.39), though a 
decline was observed after prolonged treatment. The latter observation may be due to a 
down-regulation of gene expression. The expression of c-fos and c-jun reached their 
maximals 1 hour after the addition of TNF-a. The expression of c-fos and c-jun appeared 
much later than the enhanced expression of CaSR and PKC isoforms and then increase in 
[Ca2+L. 
3.3.4.2 Effect of A23187 on c-fos and c-jun Expression 
To examine if an increase in [Ca^^i can induce the expression of these two ffiGs, the 
effect ofTNF~a and A23187 on the expression of c-fos and c-jun were examined in cells 
treated with A23187 (25ng/ml) for various times and the expression of c-fos and c-jun and 
P-actin were measured by RT-PCR. 
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Figure 3.40 Effect of A23187 on the c-fos, c-jun and P-actin expression. C6 Cells (density: 
5xlO^ cellMish) were treated A23187 (25ng/ml) for various times (5, 10, 30 minutes or 1 
hour) or with TNF-a (lOOU/ml) for 2 hours for comparison. Untreated cells acted as the 
control (CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. 
Expression of c-fos, c-jun and P-actin were measured and the density of the bands was 
quantified by densitometry. The result shown is a typical electrophoretic pattem of 5 separate 
experiments with similar results. The DNA markers (left) were run on the same gel and the 
sizes of the PCR bands were indicated on the right (bp). 
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No significant changes in the expression of p-actin were observed after A23187 
treatment (Figure 3.40). The expression of c-fos and c-jtm, however，were increased 
following A23187 treatment, and A23187 caused an increase in both ffiGs at 5 minutes and � 
reached their maximals at 1 hour. As A23187 can increase [Ca^ ]^i, the enhanced expression 
ofc-fos and c-jun observed, it is likely that the TNF-a-induced the expression of these two 
ffiGs, at least in part, by increasing [Ca^ ]^i. 
3.3.4.3 Effect ofTNF-a in Combination with A23187 on c-fos and c-jun Expression 
The effects of combined treatment of calcium ionophore and TNF-a on c-fos and c-
jun expression were also studied to see if the increased expression of these ffiGs by A23187 
could be enhanced by TNF-a. In this experiment，cells were first treated with A23187 
(25ng/ml) for various times then challenged with lOOU/ml TNF-a for another 2 hours and 
the expression of c-fos, c-jun and P-actin were measured by RT-PCR. 
Figure 3.41 shows the expression of c-fos, c-jun and p-actin following various 
treatments. It was found that there were no significant changes in the expression P-actin in 
all treated cells (Figure 3.41). The expression of c-fos and c-jun were increased by A23187 
treatment and significant increases in both ffiGs were observed at 5 minutes and reached 
their maximals at 10 minutes then declined. After the prior exposure to addition of A23187, 
and followed by TNF-a fiirther enhanced c-fos and c-jun expression when compared with 
the cells treated with TNF-a alone. Therefore, it is suggested that TNF-a caused a further 
increase in [Ca^ ]^i which then enhanced the effect of A23187 on c-fos and c-jun expression. 
However, the possibility that TNF-a induce the expression of these ffiGs by a mechanism 
unrelated to the increase in [Ca^ ]^i cannot be excluded. 
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Figure 3.41 Effect of combined treatment of calcium ionophore and TNF-a on c-fos, c-
jun and P-actin expression. C6 Cells (density: 5xlO^ cellAiish) were first treated with 
A23187 (25ngy'ml) for various times (5, 10, 30 minutes，1 or 2 hour(s)) and followed by 
lOOU/ml TNF-a for another 2 hours. Cells were also treated with TNF-a (lOOU/ml) alone 
for comparison. Untreated cells acted as the control (CTL). Total RNA was isolated and 
subjected to RT-PCR as described in Chapter 2. Expression of c-fos, c-jun and P-actin were 
measured and the density of the bands was quantified by densitometry. The result shown is a 
typical electrophoretic pattem of 5 separate experiments with similar results. The DNA 




3.3.4.4 Effect of Calcium-inducing Agents on c-fos and c-jun Expression 
To see ifthe expression of c-fos and c-jun depends on an extemal Ca�+ source，C6 cells 
* x 
were treated with thapsigargin (2\jM) or thimerosal (20^iM) for 30 minutes, or with 
thapsigargin (2^M) or thimerosal (20[iM) for 30 minutes first then with lOOU/ml TNF-a 
for another 2 hours. The expression of c-fos, c-jun and P-actin was measured by RT-PCR. 
No significant changes in P-actin gene expression were observed in all the samples 
examined (pgure 3.42). On the other hand, the expression of c-fos and c-jun was increased 
upon treatment with thapsigargin or thimerosal. The expression of these genes was fiuther 
augmented by the addition of TNF-a (thapsigargin +TNF-a or thimerosal + TNF-
a) f igure 3.42). As thapsigargin or thimerosal caused a prolong rise in [Ca^ ]^j 
independent of an extemal Ca!+ source，therefore, increase in [Ca^ ]^i alone can augment the 
expression of c-fos and c-jun. The enhancement effect ofTNF-a suggests that this cytokine 
can activate other processes, including increased Ca^^entry as well as a mechanism 
unrelated to increased [C2^^\ 
3.3.5 Effects ofDifFerent Drugs on Endogenous TNF-a Expression 
Endogenous TNF-a was found in glioma cells (Maruno et al., 1997), and it was 
reported that TNF-a played an autocrine pathway in astroglial cell lines fNitta et al., 1994). 
Therefore, the expression of the endogenous TNF-a was also examined in the TNF-a-
triggered C6 proliferation to determine if there is any autocrine pathway involved besides 
triggering its actions by binding to its receptors. As described earlier, we observed that 
some of the drugs tested induced C6 proliferation as well as TNF-R2 expression, it should 
be important to clarify if the induced proliferation is mediated by an increase in TW-R2 
167 
c-fos 
1.00 1.29 3.94 






















Figure 3.42 Effects of calcium-inducing agents on c-fos, c-jun and f3-actin expression. C6 
Cells (density: 5xl05 cell/dish) were treated with thapsigargin (2J,JM) or thimerosal (20J,JM) 
for 30 minutes or TNF-a. (IOOU/mt) for 2 hours. For the combined treatment, cells were 
treated with thapsigargin (2J,JM) or thimerosal (20J,JM) for 30 minutes first and then followed 
by 100U/ml TNF-a. for another 2 hours. Untreated cells acted as the control (CTL). Total 
RNA was isolated and subjected to RT-PCR as described in Chapter 2. Expression of c-fos, 
c-jun and f3-actin were measured and the density of the bands was quantified by densitometry. 
The result shown is a typical electrophoretic pattern of 5 separate experiments with similar 
results. The DNA markers (left) were run on the same gel and the sizes of the PCR bands 
were indicated on the right (bp). 
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and TNF"a. This is very important issue as TNF-R2 is believed to mediate the proliferative 
effect ofTNF-a in other cell (Tartaglia etal., 1993; Komi and Lassila, 1998). 
� 
3.3.5.1 Effect ofTNF-a on Endogenous TNF-a Expression 
C6 Glioma cells were cultured with 100 U/ml TNF-a for various times. After TNF-
a treatment, RNA was extracted by TRIZOL reagent，and the expression of endogenous 
TNF-a and P-actin were then measured by RT-PCR as mentioned before. 
Figure 3.43 demonstrates the time course expression of endogenous TNF-a and P_ 
actin after TNF-a treatment. It was found that there were no significant changes in the 
expression ofp_actin at all the time points studied. However，the expression of endogenous 
TNF-a was increased in a time-dependent manner upon TNF-a treatment ^"igure 3.43), 
though a decline was observed after prolonged treatment. The latter observation may be 
due to a down-regulation of gene expression. The expression of endogenous TNF-a 
reached its maximum when treated with TNF-a for 30 minutes. It is suggested that there is 
an autocrine positive feedback，in which TNF-a binding to its receptor, which possibly 
TNF-R2, results in the induction of endogenous TNF-a production. 
3.3.5.2 Effect ofA23187 on Endogenous TNF-a Expression 
The effect of A23187 on the expression endogenous TNF-a was examined in cells 
treated with A23187 (25ng/ml) for various times and the expression of endogenous TNF-
a and P-actin were measured by RT-PCR. 
No significant changes for the expression of P-actin were observed after A23187 
169 
— Chapter 3 Results 
Endogenous TNF-a 
� 1.00 0.64 0.71 0.79 5.75 2.68 2.75 2.36 1.43 1.14 
^ ^ ^ ^ ^ ^ 3 h 
P-actin 
|H|^ j^ ji|^ |^ ^^ |^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ P^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ P^ 
H^^ ^^ ^^ ^^ ,^*^ |^|jp^ ^^ ^^ ^^ ^^ ^^ PWP^^ pWiP^^ ^PWI^ ^^ W^^ ^^ ^B^^ ||^ BiP||ySWiWI)^ |^  
M i M i i i r i f c _ _ _ _ i i f c _ f l i i I I I _ i i i i i i i ？⑴如 
CTL 5m 10m 20m 30m 1h 2h 4h 24h 48h 
Figure 3.43 Effect of TNF-a on endogenous TNF-a and P-actin expression. C6 Glioma 
cells (density: 5xlO^ celVdish) were cultured with 100 U/ml TNF-a for various times (5，10, 
20, 30 minutes, 1, 2, 4, 24, or 48 hour(s)). Untreated cells acted as the control (CTL). Total 
RNA was isolated and subjected to RT-PCR as described in Chapter 2. Expression of 
endogenous TNF-a and P-actin were measured and the density of the bands was quantified 
by densitometry. The result shown is a typical electrophoretic pattem of 4 separate 
experiments with similar results. The DNA markers (left) were run on the same gel and the 
sizes of the PCR bands were indicated on the right (bp). 
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Figure 3.44 Effect of A23187 on the endogenous TNF-a and P-actin expression. C6 Cells 
(density: 5xlO' cellMish) were treated with TNF-a (lOOU/ml) for 2 hours or A23187 
(25ng/ml) for various times (5, 10, 30 minutes or 1 hour). Untreated cells acted as the control 
(CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. 
Expression of endogenous TNF-a and p-actin were measured. Densitometry was used to 
quantify the density of bands. The result shown is a typical electrophoretic pattem of 5 
separate experiments with similar results. The DNA markers (left) were run on the same geI 
and the sizes of the PCR bands were indicated on the right (bp). 
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treatment O i^gure 3.44). The expression of endogenous TNF-a was increased following 
A23187 treatment, and A23187 caused an increase at 5 minutes and reached its maximum 
at 10-30 minutes then declined. Therefore, it suggests that rise in [Ca^ ]^i is involved in the � 
TNF-a autocrine pathway. 
3.3.5.3 Effect of TNF-a in Combination with A23187 on the Expression of Endogenous 
TNF-a 
Figure 3.45 shows the expression of endogenous TNF-a and P-actin following 
various treatments. It was found that there were no significant changes in the expression 
P-actin in all treated cells (Figure 3.45). The expression of endogenous TNF-a enhanced 
after the prior exposure of A23187 (25ngy^ml, with the maximum enhancement when the 
cells were treated with A23187 for 1 hour), and followed by TNF-a (lOOU/ml) when 
compared with the cells treated with TNF-a alone. As A23187 can increase [Ca^ ]^i, the 
enhanced expression of endogenous TNF-a suggested that the TNF-a-induced endogenous 
TNF^ autocrine pathway, at least by part, by increasing [Ca^ ]^j. 
3.3.5.4 Effects of Calcium-inducing Agents on Endogenous TNF-a Expression 
To see if the effect of rise in [Ca^ ]^i on the expression of endogenous TNF-a, depends 
on an external Ca^^source, C6 cells were treated with thapsigargin (2^iM) or thimerosal 
(20pM) for 30 minutes, or with thapsigargin (2^iM) or thimerosal (20|iM) for 30 minutes 
first then with lOOU/ml TNF-a for another 2 hours, and the expression of endogenous 




1.00 9.47 7.37 15.47 10.91 8.23 7.53 
^yj[^^miiiiiiiiiiiiiiiiiiiiiiii[iiiii[iiiiiiiiimiiiiiiiiii[iiiiiimiinimimiiii 
^ H ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 4iibp 
H H H ^ ^ ^ ^ ^ H H H I i ^ ^ ^ H I ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
p-actin 
| ^ j ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 201bp 




CTL A23187 2h A23187 A23187 
+ 30m 5m 
TNF-a + + 
TNF-a TNF-a 
Figure 3.45 Effect of the combined treatment of calcium ionophore and TNF-a on 
endogenous TNF-a and p-actin expression. C6 Cells (density: 5xlO^ ceUMish) were 
first treated with A23187 (25ng/ml) for various times (5, 10, 30 minutes, 1 or 2 hour(s)) 
followed by lOOU/ml TNF-a for another 2 hours. Cells were also treated with TNF-a 
(lOOU/ml) alone for comparison. Untreated cells acted as the control (CTL). Total RNA 
was isolated and subjected to RT-PCR as described in Chapter 2. Expression of 
endogenous TNF-a and P-actin were measured and the density of the bands was 
quantified by densitometry. The result shown is a typical electrophoretic pattem of 4 
separate experiments with similar results. The DNA markers (left) were mn on the same 
gel and the sizes of the PCR bands were indicated on the right (bp). 
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Figure 3.46 Effects of calcium-inducing agents on endogenous TNF-a and P-actin 
expression. C6 Cells (density: 5xlO^ ceUAiish) were treated with thapsigargin (2jjM) or 
thimerosal (20^iM) for 30 minutes or with TNF-a (lOOU/ml) for 2 hours. For the combined 
treatment, cells were exposed to thapsigargin (2^iM) or thimerosal (20j_iM) for 30 minutes 
first then with lOOU/ml TNF-a for another 2 hours. Untreated cells served as the control 
(CTL). Total RNA was isolated and subjected to RT-PCR as described in Chapter 2. 
Expression of endogenous TNF-a and 3-actin were measured. Densitometry was used to 
quantify the density of bands. The result shown is a typical electrophoretic pattem of 5 
separate experiments with similar results. The DNA markers (left) were run on the same gel 
and the sizes of the PCR bands were indicated on the right (bp). 
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expression were observed in all samples studied ^"igure 3.46). On the other hand，the 
expression of endogenous TNF-a was increased upon treatment with thapsigargin or 
thimerosal. Moreover, the expression of endogenous TNF-a was further augmented by the � 
addition of TNF-a (thapsigargin +TNF-a or thimerosal + TNF-a). As thapsigargin or 
thimerosal caused a prolong rise in [Ca^^]j independent ofan external Ca^^source, therefore， 
the increase in TNF^x expression depends mainly on the rise in [Ca^ ]^i. This finding fiirther 
suggests that [Ca^ ]^i play a role in the TNF-a autocrine pathway. As TNF-a also activates 
other pathways，e.g. PKC，the role(s) of this pathway should also be considered. 
3.3.6 Effects of Different Drugs on JL-1 Expression 
It was showed that both D^-la and E>-ip, like TNF-a, can increase the expression of 
TNF-R2 (Figures 3.16 and 3.17) and that both can stimulate the proliferation of C6 cells 
(Figures 3.1-3.4) as well as trigger an increase in [Ca^ ]^j ^^igures 3.10 and 3.14). In addition, 
literature reviewed that mechanical lesion to the hippocampus of adult mice induced a 
neuronal expression of the cytokines D^-la and TNF-a (Tchelingerian et al., 1997, 
Bruccoleri et al., 1998). Besides, a stab injury to the adult mouse brain elicited a prompt 
and marked increase in levels of transcripts for D^-la and TNF-a. Moreover, the elevations 
were occurred concomitantly with the rise in GFAP mRNA, showing an early 
manifestation of astrogliosis fRostworowski et aL, 1997, Bruccoleri et al., 1998). As a 
result, it suggests that both TNF-a and D^-la play an important role in brain injury and 
then astrogliosis, therefore, experiments were done to study if there is any relationship 
between TNF-a, EL-1，as weU as rise in [Ca^^l in C6 cells. In the following studies, the 
expression of DL-la was examined，as both DL-ls are of equal potency in stimulating C6 
cells proliferation. 
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Figure 3.47 Effect of TNF-a on D ^ l a and P-actin expression. C6 Glioma cells (density: 
5xlO^ cellMish) were cultured with 100 U/ml TNF-a for various times (5，10, 20, 30 minutes 
or 1, 2, 4, 24, 48 hour(s)). Untreated acted as the control (CTL). Total RNA was isolated and 
subjected to RT-PCR as described in Chapter 2. Expression of D -^lcc and P-actin were 
measured and the density of the bands was quantified by densitometry. The result shown is a 
typical electrophoretic pattern of 5 separate experiments with similar results. The DNA 
markers (left) were run on the same gel and the sizes of the PCR bands were indicated on the 
right (bp). 
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3.3.6.1 Effect ofTNF-a on JL-la Expression 
The effect ofTNF-a on the EL-la gene expressions was first studied. C6 Glioma cells 
•、 
were cultured with 100 U/ml TNF-a for various times and the expression JL-la and P_ 
actin were monitored by RT-PCR. 
Figure 3.47 demonstrates the expression ofD^-la and p-actin after TNF-a treatment. 
It was found that there were no significant changes in the expression of P-actin, however, 
the expression ofK^-la was increased in a time-dependent manner upon TNF-a treatment 
and maximum response was observed at 24 hours. Prolonged TNF-a treatment appeared to 
down-regulate EL-la expression as it dropped gradually from 4 hours to 48 hours. 
3.3.6.2 Effect ofA23187 on the EL-loc Expression 
The effect of A23187 on the expression ofEL-la was examined. In this study, cells 
were treated with A23187 (25ngy^ ml) for various time, then, the expression of E^-la and 
P-actin were measured by RT-PCR. 
Figure 3.48 demonstrates the expression of E^-la and P-actin after treatment with 
A23187 for various time intervals. It was found that there were no significant changes in 
the expression of P-actin in all samples examined, however，the expression ofEL-lot was 
first increased at 30 minutes then decreased with A23187 treatment, showing down-
regulation may have occurred. Therefore, it seems that [Ca^ ]^j rise may be responsible for 
the induction ofD^-la expression. 
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Figure 3.48 Effect of A23187 on the n ^ l a and P-actin expression. C6 Cells (density: 
5xlO^ celL^dish) were treated with TNF-a (lOOU/ml) for 2 hours or with A23187 (25ng/ml) 
for various times (5, 10, 30 or 60 minutes). Untreated cells acted as the control (CTL). Total 
RNA was isolated and subjected to RT-PCR as described in Chapter 2. Expression ofE^-la 
and P-actin were measured and the density of the bands was quantified by densitometry. The 
result shown is a typical electrophoretic pattem of 5 separate experiments with similar results. 
The DNA markers (left) were run on the same gel and the sizes of the PCR bands were 
indicated on the right (bp). 
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3.3.6.3 Effect of Calcium Ionophore and TNF-a Combined Treatment on D^-la 
Expression 
、 
The effect of combined treatment of A23187 and TNF-a on n , - l a expression were 
also studied to observe if the addition of A23187 prior the addition ofTNF-a can enhance 
EL-la expression. In this experiment, cells were first treated with A23187 (25ng/ml) for 
various times, then challenged with lOOU/ml TNF-a for another 2 hours and the expression 
ofn>-la and P-actin was measured by RT-PCR. 
Figure 3.49 shows the expression ofH^-la and P-actin. It was found that there were no 
significant changes in the expression and P-actin in all the samples studied. The expression 
ofD^-lct was increased in a time-dependent manner after A23187 treatment，and maximum 
response was observed at 2 hours. With the addition of A23187, the TNF-a-induced E^-loc 
expression was further enhanced. It is suggested that [Ca^ ]^i rise is an important factor in 
enhancing D_^ -loc expression and that TNF-a fiirther induced D^-la expression by fiirther 
increasing [Ca^ ]^i^  However, the possibility of a mechanism not directly related to rise in 
[Ca2+]i, e.g. PKC activation, cannot be excluded. 
3.3.6.4 Effects of Calcium-inducing Agents on D^-la Expression 
The effect of calcium-inducing agents，thapsigargin and thimerosal on R.-
l a expression was also examined as to see if increase in [Ca^ ]^i depends on an external 
source. In this study, C6 cells were treated with thapsigargin (2pM) or thimerosal (20|iM) 
for 30 minutes, separately or with thapsigargin (2^iM) orthimerosal (20^iM) for 30 minutes 
first and then with lOOU/ml TNF-a for another 2 hours. Expression ofDL-la and P-actin 
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Figure 3.49 Effect of combined treatment of calcium ionophore and TNF-a on H^la 
and P-actin expression. C6 Cells (density: 5xlO^ ceiydish) were first treated with A23187 
(25ng/ml) for various times (5，10, 30, minutes, 1 or 2 hour(s)) followed by lOOU/ml TNF-a 
for another 2 hours. Cells were also treated with TNF-a (lOOU/ml) alone for comparison. 
Untreated cells acted as the control (CTL). Total RNA was isolated and subjected to RT-PCR 
as described in Chapter 2. Expression ofE^-la and P-actin were measured and the density of 
the bands was quantified by densitometry. The result shown is a typical electrophoretic 
pattem of 5 separate experiments with similar results. The DNA markers (left) were run on 
the same gel and the sizes of the PCR bands were indicated on the right (bp). 
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were measured by RT-PCR, and Figure 3.50 showed the results ofH>-la and p-actin gene 
expression after RT-PCR. No significant changes in p-actin gene expression were 
observed in all the samples studied. On the other hand, the expression of 正 - la was � 
increased upon treatment with thapsigargin or thimerosal. Both inductions were further 
augmented by the addition ofTNF-a (thapsigargin +TNF-a or thimerosal + TNF-a), and 
thimerosal plus TNF-a were more effective. The latter observation was unclear at present 
was due to an rise in [Ca^ ]^i As calcium-inducing agents caused a prolong rise in [Ca^ ]^j 
independent of an external Ca!+ source，it is likely the expression ofD^-la was due to a rise 
in [Ca2+]i The further increase in D^-la expression may be due to the further increase in 
[Ca2+]i induced by TNF-a and/or that TNF-a induced another mechanism not directly 
relatedCa'+，likePKC. 
3.3.6.5 Effect ofPKC Activator on the JL-la Expression 
For this part of the experiment, cells were treated with potent PKC activator，PMA 
(lngAnl) for various times, and gene expression measured by RT-PCR. No significant 
changes in P‘actin were observed in all samples studied. However，D^-la expression was 
increased upon the addition ofPMA, and increase was observed from 30 minutes to 2 hours 
then its expression declined ^lgure 3.51). Therefore, PKC is messenger mediating the 
expression ofH^-la gene in C6 cells. Moreover, this finding suggests that TNF-a induced 
JL-la, and possibly D^-lp, expression by activating this pathway. Equally possible is the 
rise in [Ca^ ]^i. 
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Figure 3.50 EfTects of calcium>inducing agents on D^la and P-actin expression. C6 
Cells (density: 5xlO^ cell/dish) were treated with thapsigargin (2^iM) or thimerosal (20^iM) 
for 30 minutes, or with TNF-a (lOOU/ml) for 2 hours. For the combined treatment, cells 
were exposed to thapsigargin (2nM) or thimerosal (20[\M) for 30 minutes first then with 
lOOU/ml TNF-a for another 2 hours. Untreated cells acted as the control (CTL). Total RNA 
was isolated and subjected to RT-PCR as described in Chapter 2. Expression ofD^-la and P_ 
actin were measured and the density of the bands was quantified by densitometry. The result 
shown is a typical electrophoretic pattem of 5 separate experiments with similar results. The 
DNA markers (left) were run on the same gel and the sizes of the PCR bands were indicated 
ontheright(bp). 
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Figure 3.51 Effect ofPMA on the BL-la and p-actin expression. C6 Cells (density: 5xlO^ 
cell/dish) were treated with PMA (lng/ml)for various times (30 minutes or 1，2, 4，24 
hour(s)). Untreated cells acted as the control (CTL). Total RNA was isolated and subjected to 
RT-PCR as described in Chapter 2. Expression o f n , - l a and P-actin were measured and the 
density of the bands was quantified by densitometry. The result shown is a typical 
electrophoretic pattem of 5 separate experiments with similar results. The DNA markers (left) 
were mn on the same gel and the sizes of the PCR bands were indicated on the right (bp). 
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CHAPTER 4 DISCUSSIONS AND CONCLUSIONS 
4.1 Effects ofCytokines, Ca�+ and PKC and Anti-TNF-a Antibodies on C6 Glioma Cells 
Proliferation 
Astrocytes have been found to proliferate following brain injury and subsequently 
forming glial scars ^Fedoroff，1986; Kimelberg et al., 1989; Miyake et al., 1992). Recently, it 
was found that TNF-a mRNA was significantly elevated in injured brain. Studies found that 
the expression of TNF-a mRNA was elevated in injured site following experimental lateral 
fluid percussion in rats. As the level of TNF-a was increased during the acute reaction and 
hypermetabolic response phases, it has been suggested that the synthesis andA>r release of 
TNF-a was induced following brain injury (Selmaj et al., 1990; Fan et aL, 1996; Feuerstein 
et al, 1998; Knoblach et al, 1999). Moreover, it was shown that anti-TNF-a substances, 
such as HU-211, TBP and PTX, improved the outcome of injury (Shohami et al.，1996; 
Shohami et al., 1997) and that circulating antibody against TNF-a protected brain injury 
0:^avine et al., 1998). These findings suggest that TNF-a plays an important role in brain 
injury. As TNF-a was found to be produced largely by astrocytes after brain injury (Selmaj 
et al, 1990, Kita et al, 1997), and that TNF-a stimulated the proliferation of cultured 
astrocytes in a dose-dependent manner (Selmaj et al., 1990), these suggest a close connection 
between the increase in TNF-a and astrocyte proliferation following brain injury, and 
possibly scar formation. However, the pathways mediating these events are still unclear. 
C6 Glioma cells were chosen as model of astrocytes as they behave and response to 
cytokines like astrocytes OBenda et a/.，1968; Westermark et al., 1973). Moreover, C6 glioma 
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cells are easier to culture and they multiply more rapidly (Benda et al., 1968; Westermark et 
aL, 1973). Therefore, C6 glioma cells were used in the present study to examine the signal 
transduction pathways mediating the proliferative effect ofTNF-a so as to obtain some basic 
information on the possible relationship between elevated TNF-a level, astrocyte 
proliferation and glial scar formation observed following brain injury. 
Results ofthe present study showed that only TNF-a, D^-la, EL-ip, but not EL-6 and y-
JFN stimulated proliferation in C6 glioma cells (Figures 3.1-3.4), suggesting this effect was 
cytokine specific. As only TNF-R2 antibody inhibited the TNF-a-induced C6 cell 
proliferation, while neither TNF-R1 nor -R2 antibody alone had any effect ^ ^igure 3 .9); these 
findings clearly demonstrated that TNF-a induced proliferation by interacting with TNF-R2. 
The latter finding is in line with the general belief that TNF-R1 mediates cytotoxicity, while 
TNF-R2 proliferation (Dopp etal, 1997). 
Besides TNF-a, we found that A23187, a calcium ionophore, induced C6 cell 
proliferation ^"igure 3.5). It is likely that TNF-a induced cell proliferation via a mechanism 
related to Ca^. Indeed, the finding that verapamil, a L-type Ca!+ channel blocker, reduced the 
TNF~a-induced cell proliferation(Figure 3.6) supports that TNF-a induced C6 cell 
proliferation by interacting with L-type Ca!+ channels. These findings are in agreement with 
reports that Ca^ ^ plays an important role in cell proliferation Oceans et al., 1994) and 
astrogUosis (Cortez et al., 1989) via the L-type Ca^ ^ channels (Florio et a/.，1996). The fact 
that astrocyte [Ca^]i was rapidly elevated after stretch injury (Rzigalinski et al., 1998), 
together with this observation support the proposal that both Ca^ ^ and TNF-a play critical 
roles in brain injury (Fan et al., 1996; Shohami et al., 1996; 1997; Rzigalinski et aL, 1997; 
Schubert^a/.，1998). 
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Moreover, we found that C6 cell proliferation was resulted after PMA treatment OFigure 
3.7), while the TNF-a-induced C6 proliferation was inhibited by Ro31-8220, a PKC inhibitor � 
(Figure 3.8). This indicates that TNF-a induced C6 cell proliferation via PKC. In this regard， 
it is worthy of mentioning that PKC has also been shown to play an important role in 
neuronal transduction (Jiang et al, 1994) and brain injury (Wilson et aI., 1994; Zablocka et 
al., 1998). 
The above results indicate that TNF-a induced C6 cell proliferation by binding to TNF-
R2 which in tum activated Ca!+ channels, likely the L-type, and PKC. Furthermore, these 
findings also indicate that Ca!+ and PKC are messengers mediating the proliferative effect of 
TNF-a in C6 cells. 
4.2 The Role ofCalcium in TNF-a-induced Signal Transduction Pathways 
When the changes in [Ca^ ]^j level in C6 cells were monitored by confocal microscopy, 
we found that TNF-a,化-la and E^-lp，but not 正-6 and y-WM (Figures 3.10-3.11，3.13-3.14) 
triggered the rise in [Ca^^iboth in the cytosol and nucleus. The effects of these cytokines 
were similar to their proliferative effects ^"igures 3.1-3.4). TNF-a has been reported to 
induce an increase in [Ca^ ]^j and depolarized astrocytes ^Coller et al., 1996) and these 
findings support the thought that the properties of astrocytes and C6 cells are very similar. 
The nuclear and cytosolic Ca^ ^ stores affected by TNF-a and other effective cytokines are 
not clear at present. But it is likely that the nuclear, nuclear envelop OLui et al., 1997) as well 
as the ff3-senstive and ff3-insenstive Ca�+ stores which are found in C6 glioma (Sabala et al., 
1997) were involved. 
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We also found that the TNF-a-induced [Ca^ ]^j rise was inhibited by the addition of 
Ro31-8220, whereas no significant changes in [Ca^]j level were observed with Ro31-8220 
alone: In addition, PMA could increase [Ca^^i suggesting that PKC may also be an important 
pathway for TNF-a-mediated [Ca^^j changes as well as cell proliferation (Figure 3.15). This 
finding is in line with reports that depletion of the ff3_sensitive [Ca^ ]^j with thapsigargin, 
resulted in cell cycle arrest (Mean et al., 1994) and that traumatic stretch injury caused 
release of calcium from D P 3 - s e n s i t i v e Ca!+ stores in astrocytes (Leybaert et al, 1998; 
Rzigalinski,e^a/., 1998). 
4.3 Gene Expressions in C6 Cells after TNF-a Stimulation 
The role of Ca^ ^ and the signal transduction pathways involved in TNF-a-mediated C6 
glioma cells proliferation were also studied by RT-PCR to examine the changes in the 
expression some relevant genes. The target genes were TNF-Rs, endogenous TNF-a and JL-
la, CaSR, PKC isoforms, c-fos and c-jun., 
4.3.1 Expression ofTNFKX, TNF-Receptors and JL-l 
We found that the expression of TNF-R2 was selectively and significantly increased 5 
minutes after TNF-a treatment and reached its maximum at 2 hours. OFigure 3.16) This, 
together with the observation that only TNF-R2 antiserum inhibited the TNF-a-induced 
TNF-R2 expression ^"igure 3.18), suggest that TNF-a triggered C6 cell proliferation by 
binding to TNF-R2 and inducing the expression of this receptor subtype. This finding is in 
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good agreement with reports that TNF-a has higher affinity for TNF-R2 (Botchkina et al” 
1997) and that this receptor subtype is believed to mediate cell proliferation O)opp et al, 
1997). The expression of endogenous TNF-a was increased after exogenous TNF-a 
treatment and the expression reached its maximum after culturing cells with TNF-a for 30 
minutes (J"igure 3.43). Therefore, it suggests that there exists an autocrine positive feedback 
ps[itta et al.’ 1994; Maruno et al.’ 1997) in C6 cells in which the exogenous TNF-a by 
binding to its receptors, possibly TNF-R2, induced the production of endogenous TNF-a. 
This cascade would result in further C6 cell proliferation. 
The findings that the expression of TNF-a ^.ung, 1999) and TNF-R2 O i^gure 3.17) 
were also increased upon D^-la and/or D^-ip treatment suggest that there could be a close 
connection between different cytokines in C6 cells. In fact, a number of cytokines, including 
TNF-a and D^-ls，were found to be increased at injured sites following brain injury 
OElostworowski etal., 1997; Tchelingerian etal., 1996; Bmccoleri etal., 1998). 
Results obtained with A23187, thapsigargin and thimerosal treatments showed that the 
expression ofTNF-a (Figures 3.44-3.46) and TNF-R2 (Figures 3.19-3.23) were increased. It 
is likely that A23187 stimulated cell proliferation by increasing [Ca^ ]^i which in tum induced 
the expression of both entities. The involvement of elevated [Ca^ ]^j in inducing the 
expression ofTNF-R2 is also supported by the observation that verapamil inhibited the TNF-
a-induced TNF-R2 expression (Figure 3.22). The source of Ca^ ^ could be either external or 
internal as A23187 which induced Ca�+ entry, and thapsigargin and thimerosal which induced 
[Ca2+]i elevation independent ofan external Ca^^supply, all stimulated the expression ofTNF-
a and TNF-R2. In addition to elevated [CaL^\ PKC is another messenger which regulated 
TNF-R2 expression. This is evidenced from observations that PMA induced TNF-R2 
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expression and that Ro-31-8220, a selective PKC inhibitor in C6 cells (Tsang et al, 1997), 
reduced the TNF-a-induced TNF-R2 expression f igure 3.25). On the other hand, the E>-
la- and n.-lp-induced TNF-R2 expression were not inhibited by Ro31-8220 ^'igure 3.26) 
indicated that PKC might not be a messenger in these stimulations. In fact. Lung (1999) in 
our laboratory reported that the messenger mediating these two cytokines was nitric oxide. 
As both PMA and Ca^ ^ induced the expression of TNF-R2 expression at around 5 
minutes, it is difficult to conclude with confidence whether TNF-a activated PKC first and 
followed by elevated [Ca^ ]^i or vice versa. Judging by the confocal microscopic tracing 
^?igure 3.10), it appears that [Ca^^j was slightly elevated shortly after the addition ofTNF-
a. However, it is not clear whether such a slight elevation would be sufficient to explain the 
observed effects. The finding that both PKC activation and [Ca�+]^ elevation were involved in 
the stimulation of TNF-R2 is not surprising as it had been reported that both PKC and Ca^ ^ 
played important roles in astrogliosis and brain injury (Wilson et a/.，1994; Rzigalinski et aL, 
1998;Zablocka^a/., 1998; Wemyj etaL, 1999). 
Although A23187, thapsigargin, thimerosal and PMA all stimulated the expression of 
n . - la in C6 cells (Figures 3.48-3.50)，the time courses were in general longer than those for 
TNF-a and TNF-R2. Moreover, the expression ofE^-la was increased after TNF-a 
treatment (Figure 3.47) and reached its maximum at 24 hours. Therefore, E^-la might not 
play a very important role at the early phase of the induction of TNF-a and TNF-R2 
expression. As both n , - la and TNF-a were elevated following brain injury (Rostworowski 
et al., 1997; Tchelingerian et al., 1997; Bruccoleri et al., 1998), and that both cytokines 
elevated and found to be involved in astrogliosis OBruccoleri et al, 1998), it is quite possibly 
that these two cytokines could play distinct but concerted roles in astrogliosis and brain 
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injury. 
4.3.2CaSR Expression 
Results indicated that expression of CaSR was increased after TNF-a treatment, and 
peaked at 5 minutes (Figure 3.27), showing that the induction of CaSR expression was one of 
early events after challenging the cells with TNF-a. As CaSR could couple to the release of 
[Ca2+]i from the intracellular Ca�+ stores (Shorte et al, 1996), therefore, the rapid induction of 
CaSR expression suggests that the increase in [Ca^^j after TNF-a treatment is an early event 
of TNF^x action in C6 cells. Jn addition to TNF-a, the expression of CaSR was increased 
after D^-la and E^-lp, but not D -^6 treatment ^*igures 3.28-3.29) indicating that the action of 
cytokines is specific. Again，this observation is similar to the cytokine actions on TNF-R2 
expression (Figure 3.17) and proliferation ^"igure 3.4). 
Results also indicated that increase in [Ca^ ]^i level could stimulate the expression of 
CaSR. Studies with A23187, thapsigargin and thimerosal also resulted in the increase in the 
expression ofCaSR (Figures 3.30-3.32) suggesting that an increase in [Ca^^i was sufficient 
in inducing the expression ofthis receptor. Moreover, all these stimulation were augmented 
by the addition of TNF-a suggesting that TNF-a triggered further increase in [Ca^^i or 
activated other mechanisms not directly related to [Ca^^i ,for example PKC. However, the 
maximum expression ofCaSR in the combined treatment was found to be 10 minutes, which 
appeared later than that of treating with TNF~a alone (5 minutes). The result can be 
explained by that TNF-a was added to cells for 2 hours instead of 5 minutes. At 2 hours of 
TNF-a treatment, the CaSR gene was not highly expressed, therefore, it might take a longer 
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time for the action of A23187 to reach maximum. The thought that TNF-a might activate 
other mechanisms besides [Ca^ ]^j could be supported by Figure 3.21, in which the expression 
of TNF-R2 varied when C6 cells were treated with TNF-a in combination with various 
concentrations of A23187. As A23187, thapsigargin and thimerosal all stimulated this 
expression, it is very likely that this Ca^^-induced CaSR expression is independent ofextemal 
or internal Ca!+ source. 
The expression ofCaSR was also stimulated by the PKC activator, PMA, and that PKC 
inhibitor, Ro31-8220, inhibited the TNF-a-induced CaSR expression ^"igures 3.33-3.34). 
This finding suggests that TNF-a also exerted its action by activating PKC. As PKC could 
induce the increase in [Ca^ ]^j (Figures 3.7-3.8), it is possible that PMA induced CaSR 
expression by elevating [Ca?\ However, a direct action ofPKC is equally likely. 
In addition to its presence in parathyroid cells and dermal fibroblasts, CaSRs were also 
found in the CNS by in situ hybridization (Rogers et a/.,1997) and localized in nerve 
terminals as well as fiber tracts where they may be expressed in glial (Chattopadhyay et al” 
1998). Although it is not sure whether this receptor are found in astrocytes, our findings that 
CaSR mRNA was expressed in C6 cells suggests that this receptor is also present in 
astrocytes. 
The effect ofthe CaSR-evoked [Ca^ ]^j increase involving mobilization of intracellular 
Ca2+ stores (Shorte et al, 1996) in C6 cells remains to be elucidated. Recent studies found that 
the CaSR-transduced extracellular Ca�+ facilitated a variety of intracellular responses, 
including inhibition ofadenylate cyclase, stimulation ofJP^ production, and release of [Ca^ ]^i 
(Shorte et al, 1996). Thus, these mechanisms should be fiirther examined in C6 cells. As 
PKC was also involved in mediating the TNF-a-induced CaSR expression, this strengthen 
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the possibility that both PKC and changes [Ca^ ]^i are important factors in the TNF-a-
triggered signal transduction pathways in C6 cells. � 
4.3.3 PKC Isoforms Expressions 
The expression ofPKC-a, PKC-s, PKC-y, PKC-ri and PKC< were examined following 
treatment with TNF-a and other agents (Figures 3.35-3.38). It was found that expressions of 
PKC-8, PKC-y, PKC-T] and PKC< were increased after TNF-a treatment，while that of 
PKC-a unchanged (Figure 3.35) suggesting the effect of TNF-a is specific. The expression 
of different PKC isoforms reached their peaks at different times after TNF-a treatment: 
PKC-8 (30 minutes). PKC-y (20 minutes), PKC-ri (1 hour), PKC< (5 minutes) OFigure 3.35). 
This finding again supports the specificity of this cytokine. Among these isoforms，PKC< 
could be a more important isoform in the TNF-a-mediated signalling pathways as it was 
being induced at a very early time after TNF-a treatment (5 minutes). 
The expression ofPKC-s, PKC-y, PKC-ri and PKC< were also increased after A23187 
(Figures 3.36-3.37), thapsigargin and thimerosal ^"igure 3.38) treatment and that the effects 
ofthese agents were further enhanced by TNF-a. These findings suggest that an increase in 
[Ca2+]i is sufficient to induce the expression of these isoforms. Moreover, these findings also 
support the view that there is a close relationship between activation of PKC and [Ca^ ]^i 
mobilization. The fact that TNF-a further enhanced the expression of these isoforms 
indicates that TNF-a could further increase the [Ca^^i in C6 cells. In this connection, it is 
interesting to note that activation of PKC resulted in an increase in capacitative Ca�+ entry 
(one of the most important [Ca^^j regulatory mechanisms) in astrocytes O^u et al., 1999), 
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thus, it is possible that PKC exerted this action by inducing CaSR expression in C6 cells. In 
addition, PKC was found to be involved in the expression of TNF-a and brain injury 
(Shimohama et a/., 1993; Wilson et al., 1994; Zablocka et al, 1998). 
PKC isoforms have been classified into Ca^^-dependent, Ca^Mndependent and atypical 
forms (Selbie et al., 1993; Johannes et a/., 1994). However the induction of isoforms 
observed with TNF-a, A23187, thapsigargin and thimerosal showed no preferential 
expression with reference to Ca!+ dependence. 
4.3.4 Expression of c-fos and c-jun 
The expressions oic-fos and c-jun were increased after TNF-a treatment and both 
reached their peaks at 1 hour (Figure 3.39). This finding is in line with observations that both 
c-fos and c-jun were found to play roles in brain injury ^laghupathi et al, 1995; 1996) where 
TNF-a was increased, and cell proliferation (Dragunow and Hughes, 1993). Also, the 
expressions of c-fos and c-jun were elevated upon A23187 treatment and peaked at 1 hour 
^7igure 3.40). This observation is in agreement with reports that the expressions oic-fos and 
c-jun were found to be CdL^ dependent (Maki et cd., 1992; Morgan and Curran, 1989; Tran et 
al., 1999). The finding that only the induction of c-fos was increased by the addition ofTNF-
a may be due to the further changes in [Ca^ ]^i induced by TNF-a. The expression of c-fos 
had been shown to be more sensitive to the increase in [Ca^ ]^i levels (Maki et cd., 1992; 
McNaughton & Hunt，1992). Or that，the expression of c-fos is further enhanced by a TNF-
a-induced mechanism not directly related to [Ca^ ]^i, for example PKC. 
Both the expressions ofc-fos and c-jun appeared quite late following TNF-a treatment 
193 
. Chapter 4 Disciissions and Conclusions 
this indicates that these two genes play roles at the late stages of TNF-a-induced 
proliferation in C6 cells. � 
4.4 Conclusion 
In conclusion, this study showed that [Ca^ ]^i plays a central role in the INF^x-mediated 
C6 cell proliferation. This is in line with findings that reduction of [Ca^ ]^i resulted in cell 
cycle arrest (Mean et al., 1994). As elevation of [Ca^ ]^i was observed shortly after the 
addition ofTNF-a, it is believed that the rise in [Ca^ ]^i, possibly via the L-type Ca^ ^ channels, 
was an early event in the TNF-a-induced signal transduction pathways. This is followed by 
induction of a number of genes including further induction of TNF-R2, increase in the 
expression ofCaSR, PKC，c-fos and c-jun, as well as n , - l a and TNF-a which in tum caused 
cell proliferation. At this stage, the induction sequence of these genes can be hypothesized as 
follows: TNF-a mediated its action by binding to and inducing the expression of TNF-R2, 
which in tum triggered the expression of CaSR and PKC isoforms (e, y, r{, Q, followed by 
the expression of endogenous TNF-a, then c-fos and c-jun and finally TL-l. The induction 
sequence ofthese genes cannot be definitely assigned from the present study as some ofthem 
(including CaSR and PKC isoforms) showed significant increase as early as 5 minutes 
following TNF-a treatment. Although the increase in [Ca^^]ifollowing TNF-a was favored，it 
should be noted that Wu et al (1999) recently found that activation ofPKC resulted in an 
increase in Ca!+ in cerebellar astrocytes. Moreover, it has been reported that PMA and 
A23187 increased the intercellular adhesion molecule-1 (ICAM-1) mRNA expression in 
astrocytes (Ballestas and Benveniste, 1995). ICAM-1 is constitutively expressed in neonatal 
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rat astrocytes, and its expression is enhanced by proinflammatory cytokine, like TNF-a. 
Therefore, it is not surprising that activation of PKC could in tum trigger the release of 
[Ca^^i. In general, the actions of both [Ca^ ]^i. and PKC in the signalling pathway may be 
inter-related and they may interact together. In addition, findings that TNF-a induced 
elevation in [Ca^^i and that elevation of [Ca^ ]^i could trigger TNF^x expression in C6 cells 
suggest the presence o f a positive feedback loop in the TNF-a signal transduction pathway. 
In fact, feedback loops involving [Ca^ ]^j have been reported in a number of cell types 
(Bezprozvanny et al, 1991; Finch et al., 1991; Griffin et al, 1998). 
As positive feedback loops exist with TNF-a stimulation, there should be some 
mechanisms to terminate the process. Evidence accumulated in the literature showed that a 
rise in cytosolic Ca�+ ([Ca^ ^^ ytX resulting from mobilization ofER Ca^ ^ stores was followed 
by a rise in mitochondrial Ca'^([Ca'^]J CBoitier et al., 1999). In temporal term, the [Ca'+Ly^  
recovered within approximately 1 minute , while that for [Ca^ ]^„ was approximately 30 
minutes (Boitier et aL’ 1999). These investigators further reported that dissipation the 
mitochondrial membrane potential with uncouplers prevented mitochondrial Ca�+ uptake, and 
slowed the rate ofdecay of[Ca^^,yt. They concluded that [Ca2+]„uptake played a significant 
role in the clearance ofphysiological [Ca^ ]^,yt loads in astrocytes (Boitier et al., 1999). These 
data indicate that cytosolic Ca!+ buffering by mitochondria provides a potent negative 
feedback mechanism to regulate the astrocytic Ca^ ^ signals. Moreover, it was reported that 
sequential positive and negative feedback regulation by calcium of DVinduced calcium 
release may contribute to transients and oscillations of cytosolic-free calcium in vivo ^"inch 
et al, 1991). Thus，Ca^ ^ itselfalso involves in negative as well as positive feedback. 
Besides regulation of[Ca^^i, down regulation ofPKC following prolonged activation is 
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a very common phenomenon in various cell types (Olah et al., 1990; Patrizio et al., 1997). In 
fact, we also found that prolong treatment of cells with PMA resulted in down-regulation of 
CaSR expression ^"igures 3.34) and BL-la expression (Figure 3.51). bi addition, it was also 
reported that both INF^x and JLA could induce the production of postaglandins (PGs). The 
enhanced production ofPGs in human glial cells down-regulated the p-chemokine secretion 
and resulted in a negative feedback.^Vluller and Ackenheil, 1995, Faggioni et al.’ 1995). 
Another well-known phenomenon is that glucocorticoids which are known inhibitors of 
TNF-a production through a stimulation of the hypothalamus-pituitary-adrenal axis 
^7antuzzi etal., 1995). 
Since C6 cells were used as a model of astrocytes, it is doubtfiil if the proposed TNF-a-
induced signal transduction pathways in C6 glioma cells may be applicable to the TNF-a-
induced astrogliosis observed after brain injury. Results from my colleague further support 
that C6 cells behave and response to TNF-a like astrocytes (Lung, 1999). His results showed 
that the expression of TNF-R2 in rat primary cultured astrocytes was increased following 
TNFKX treatment, while the expression of TNF-R1 remained unchanged, similar to C6 
glioma cells. Moreover, he found that the expression of endogenous TNF-a was also 
increased in rat primary cultured astrocytes after TNF-a treatment. The expression of TNF-
R2 peaked after 2 hours of TNF-a treatment, while the expression of endogenous TNF-a 
after 1 hour O^ung, 1999). Therefore, the results obtained from this project can be 
incorporated to the brain injury's model. Figure 4.1 is a conclusive flow chart which shows 
the possible TNF-a-induced signalling pathways after brain injury by incorporating the 
results obtained from this project. By knowing the TNF-a signal transduction pathways in 
astrocytes, more effective dmgs can be developed to improve the outcome of brain injury. 
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This is the long-term goal of this study. 
As elevated [Ca^^j was found to be a very early event involved in the TNF-a-stimulated 
cultured astrocytes and C6 cells proliferation，together with that the acute period of TNF-a-
induced signalling pathway in brain injury is harmful (Scherbel et al., 1999)，blockade of 
[Ca2+]i increase should be seriously considered to improve the outcome of brain injury. In 
fact, intracellular calcium dyshomeostasis occurs during hypoxic/ischemic cell injury, and 
pharmacological antagonism of calcium entry into neurons has been considered to be of 
potential therapeutic value. The potentiality of some Ca!+ antagonists (i.e. flunarizine, 
nicardipine, nimodipine, etc.) which can pass the blood-brain barrier (BBB) readily have 
been initially explored (Shibuya and Watanabe, 1992). These investigators reported that 
phenylalkylamine-type calcium channel blockers which has excellent BBB penetrability 
showed variable degrees of cerebroprotection in focal and global ischemia models (Ginsberg 
et al., 1991) improve cerebral perfusion of both the normal and abnormal (post-ischemic) 
brain. 
Jn fact, simultaneous pharmacokinetics and in vivo receptor binding studies in mouse 
brain suggest a usefixlness of calcium channel antagonists, such as nimodipine, in the 
pharmacotherapy of brain diseases. For example, SM-6586 (SM), a new derivative of 
dihydropyridine that blocks intracellular calcium activity and inhibits N a W and Na7Ca^^ 
exchange transports, was effective in ameliorating the ischemic insult in global and focal 
cerebral ischemia models (Kashiwagi et al., 1994). Although verapamil, a L-type Ca'^ 
channel blocker, was very effective in blocking TNF-a-induced proliferation, it may not be a 
dmg of choice as the drug did not suppress epileptic discharges due its restricted diffusion 
(Kohling et aL, 1993). However, it was found that the expression ofL-type Ca^ ^ channels as 
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Figure 4.1 Possible signalling pathways after brain injury. After brain injury, 
TNFKX will be produced in the acute phase, which triggers the expression of 
XNF-R2 by binding to this receptor, and then in tum induces the release of 
[Ca2+]i，the expression ofPKC isoforms, and later the expression of endogenous 
TNF-a, c-fos, c-jun and D^-la. Besides autocrine pathways, negative feedback 
also appears after prolong expression of genes to avoid excessive astrogliosis 
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determined by immunostaining, in reactive astrocytes was upregulated after brain injury 
OVestenbroek et al., 1998). Thus, other L-type Ca^ ^ channel blockers that can pass the BBB 
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